{"bill": {"#text": "\n\t", "official-title-amendment": {"#tail": "\n\t", "quote": {"#tail": ".", "#text": "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to\n\t compounding drugs and the pharmaceutical distribution supply\n\t chain."}, "#text": "Amend the title so as to read:\n\t "}, "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 959"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Federal Food, Drug, and Cosmetic Act with\n\t\t  respect to compounding drugs."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": [{"action-date": {"#tail": "\n\t\t\t", "@date": "20130515", "#text": "May 15, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"@deleted-display-style": "strikethrough", "#tail": "\n      ", "@committee-id": "SSHR00", "@added-display-style": "italic", "#text": "Committee on Health, Education, Labor,\n\t\t\t and Pensions"}, "sponsor": {"#tail": " (for himself,\n\t\t\t ", "#text": "Mr. Harkin", "@name-id": "S172"}, "cosponsor": [{"#tail": ", ", "#text": "Mr. Alexander", "@name-id": "S289"}, {"#tail": ", ", "#text": "Mr. Roberts", "@name-id": "S260"}, {"#tail": ", ", "#text": "Mr.\n\t\t\t Franken", "@name-id": "S332"}, {"#tail": ", and\n\t\t\t ", "#text": "Ms. Mikulski", "@name-id": "S182"}, {"#tail": ") introduced the following\n\t\t\t bill; which was read twice and referred to the\n\t\t\t ", "#text": "Ms. Warren", "@name-id": "S366"}]}, "#text": "\n\t\t\t"}, {"#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t\t", "#text": "Reported by ", "sponsor": {"#tail": ",\n\t\t\t with an amendment and an amendment to the title", "#text": "Mr. Harkin", "@name-id": "S172"}}, "action-instruction": {"#tail": "\n\t\t", "#text": "Strike out all after the enacting clause and insert\n\t\t\t the part printed in italic"}, "action-date": {"#tail": "\n\t\t\t", "#text": "June 19, 2013"}, "#text": "\n\t\t\t", "@stage": "Reported-in-Senate"}], "calendar": {"#tail": "\n\t\t", "#text": "Calendar No. 89"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Reported-in-Senate", "endorsement": {"action-date": {"#tail": "\n\t\t", "#text": "June 19, 2013"}, "#tail": "\n", "action-desc": {"#tail": "\n\t", "#text": "Reported with an amendment and an amendment to the\n\t\t  title"}, "#text": "\n\t\t"}, "@dms-id": "A1", "@public-private": "public", "legis-body": [{"#tail": "\n\t", "section": [{"@committee-id": "SSHR00", "@changed": "deleted", "@section-type": "section-one", "#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n\t\t\t", "#text": "Short title; references in\n\t\t\t Act"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": {"short-title": {"#tail": "\n          ", "#text": "Pharmaceutical Compounding\n\t\t\t Quality and Accountability Act"}, "#tail": ".", "#text": "\n            "}, "#text": "This Act may be cited\n\t\t\t as the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Short\n\t\t\t title"}, "#text": "\n        ", "@id": "id8ACC258572204D83A85EA1849E53718F"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "Except as otherwise specified, amendments made by this Act to\n\t\t\t a section or other provision of law are amendments to such section or other\n\t\t\t provision of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et\n\t\t\t seq.)."}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "References in\n\t\t\t Act"}, "#text": "\n        ", "@id": "id21541D659B854E34B45AF7A32A158413"}], "@reported-display-style": "strikethrough", "#text": "\n      ", "@id": "S1"}, {"@committee-id": "SSHR00", "@changed": "deleted", "#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Regulation of\n\t\t\t human and animal drug compounding"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": [{"#tail": " (as defined in section 201(p) of such Act) and ", "#text": "new\n\t\t\t drug"}, {"#tail": " (as defined in section 201(v) of such Act) shall include a\n\t\t\t compounded human drug and a compounded animal drug, respectively.", "#text": "new animal\n\t\t\t drug"}], "#text": "For purposes of the Federal\n\t\t\t Food, Drug, and Cosmetic Act (", "external-xref": {"#tail": "), the terms ", "@parsable-cite": "usc/21/301", "#text": "21 U.S.C. 301 et seq.", "@legal-doc": "usc"}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Clarification of\n\t\t\t new drug and new animal drug status"}, "#text": "\n        ", "@id": "id3721FE4A11DE4BC59EDB730C55A347BC"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "Section 503A (", "external-xref": {"#tail": ")\n\t\t\t is amended to read as follows:", "@parsable-cite": "usc/21/353a", "#text": "21 U.S.C. 353a", "@legal-doc": "usc"}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Regulation of\n\t\t\t human and animal drug compounding"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "deleted", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "503A."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Human and\n\t\t\t\tanimal drug compounding"}, "subsection": [{"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Scope"}, "paragraph": [{"#tail": "\n              ", "@id": "id69BD248E560D4070A2A7680A26813ADE", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Compounding"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": [{"#tail": " and\n\t\t\t\t", "#text": "compounding"}, {"#tail": "\u2014", "#text": "compound"}], "#text": "In\n\t\t\t\tthis section, the terms "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "include\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the combining,\n\t\t\t\tadmixing, mixing, diluting, reconstituting, or otherwise altering of a marketed\n\t\t\t\tdrug;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id743AE1FA4C0E42198D7740AC4F2EA2C9", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "compounding a\n\t\t\t\tdrug from a bulk drug substance; and"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id2CD6F08226F44A0D82CC25E137729990", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "repackaging, as\n\t\t\t\tdefined in subsection (b)(5); and"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "idA522786264244150859106801D9745FD", "#text": "\n                    "}], "#text": "\n                  ", "@id": "idCF793E06B2BE4B3FB31A2D7C6526E526"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "exclude mixing,\n\t\t\t\treconstituting, or other such acts with respect to a marketed drug that are\n\t\t\t\tlimited to and performed solely in accordance with specific directions for such\n\t\t\t\tacts contained in approved labeling provided by a drug\u2019s manufacturer, when\n\t\t\t\tperformed upon receipt of a prescription order for an identified individual\n\t\t\t\tpatient."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id79E6A4A9124843DEA4E25E62C77D6431", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": [{"#tail": " or\n\t\t\t\t", "#text": "sell"}, {"#tail": " do not include dispensing to patients, or, in the case of\n\t\t\t\tanimal drugs, to the individual responsible for providing care for the animal\n\t\t\t\tfor which the drug is intended, in accordance with State law, including any fee\n\t\t\t\tassociated with such dispensing.", "#text": "resale"}], "#text": "In this section, the terms "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Dispensing not a\n\t\t\t\tsale"}, "#text": "\n                ", "@id": "idDB8DF24CECA14CB1B6558BD84C478822"}, {"#tail": "\n            ", "@id": "idF0ACB41105174CA2B39439C192726FCE", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Exemptions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "This\n\t\t\t\tsection shall not apply to\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "medical\n\t\t\t\tgases;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id677477944B45431999200DB6EE0EFD30", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "animal drugs that\n\t\t\t\tare subject to regulation as biological products by the Secretary of\n\t\t\t\tAgriculture under the Act commonly known as the Virus-Serum-Toxin Act;\n\t\t\t\tor"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id4BDBC6F85E404AC08AE5DEB6ED190072", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "human blood and\n\t\t\t\tblood components for transfusion."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id3D59E4A42AEB4A058EFF0FA7D542035F", "#text": "\n                  "}]}], "#text": "\n              ", "@id": "id124AC6E0C1C04219970442F4C28E98BA"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis section:"}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "that compounds any\n\t\t\t\tsterile drug product without receiving a prescription order for such sterile\n\t\t\t\tdrug product prior to beginning compounding, and distributes or offers to sell\n\t\t\t\tsuch compounded sterile drug product in interstate commerce; or"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "id6C27B5F97EEE46FD8EEC39A3F21C52DD", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "that repackages\n\t\t\t\tany preservative-free sterile drug product or pools any sterile drug products,\n\t\t\t\texcept as provided in paragraph (7)(B)."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "idAB3BAAAA0F7448589213D2825F1A1354", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means a\n\t\t\t\tfacility at one geographic location or address\u2014", "#text": "compounding manufacturer"}, "#text": "The term "}, "#text": "\n                  ", "@id": "idDDE1701134694C26B76AA2D207CCF86E", "@commented": "no"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "repackages drugs\n\t\t\t\tin accordance with section 506F or the final guidance described in section\n\t\t\t\t506F(d); and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "id6D8DB87DFE854CB68F6870419C69C15A", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "does not\n\t\t\t\totherwise meet the definition of compounding manufacturer under subparagraph\n\t\t\t\t(A)."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "idD9F9FE13577B4CA89808ED5695E9C45A", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Excluded\n\t\t\t\tactivities"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Notwithstanding subparagraph (A)(ii), a facility shall\n\t\t\t\tnot be considered a compounding manufacturer if such facility\u2014"}, "#text": "\n                  ", "@id": "idAF7B050D7E88489E91892A734C70EB43", "@commented": "no"}], "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Compounding\n\t\t\t\tmanufacturer"}, "#text": "\n                ", "@id": "id997D23D17191491D89FBFDEC74806287", "@commented": "no"}, {"#tail": "\n              ", "@id": "id623299A87E57435B8DEA7B4F245D4D6E", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Pooling;\n\t\t\t\tpools"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": [{"#tail": " and\n\t\t\t\t", "#text": "pooling"}, {"#tail": "\u2014", "#text": "pool"}], "#text": "The terms "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "mean taking a\n\t\t\t\tsingle drug approved under section 505 or 512, conditionally approved under\n\t\t\t\tsection 571, included on the index established under section 572(a)(1), or\n\t\t\t\tlicensed under section 351 of the Public Health Service Act from the container\n\t\t\t\tin which it is distributed by the original manufacturer and combining it with\n\t\t\t\tthe same drug from one or more other containers without or before further\n\t\t\t\tmanipulating the product (such as by diluting it or mixing it with another,\n\t\t\t\tdifferent drug or drugs);"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "#text": "\n                  ", "@id": "id6B2CBCE2FA774D859D9D198AA977298E", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "do not include\n\t\t\t\tcombining the drug from two or more separate containers of the same drug when a\n\t\t\t\tsingle container of the drug is not sufficient to prepare a single dose for\n\t\t\t\tadministration to an individual patient; and"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "idFC156E6EDE9C43D282048AAFAB965A0B", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "do not include\n\t\t\t\tcombining the drug from two or more separate containers of component products\n\t\t\t\tof a total parenteral nutrition product, if such pooling, and labeling and use\n\t\t\t\tof the finished total parenteral nutrition product, comply with State pharmacy\n\t\t\t\tlaw."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "#text": "\n                  ", "@id": "idAA22CDC4EC61454F939C294463A5D191", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " includes a physician, veterinarian, or any other\n\t\t\t\tperson that is authorized to prescribe medication under State law.", "#text": "practitioner"}, "#text": "The\n\t\t\t\tterm "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Practitioner"}, "#text": "\n                ", "@id": "id9A507F19BC7144BBBFD05655FCB5E324", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": [{"#tail": " or\n\t\t\t\t", "#text": "prescription"}, {"#tail": " means a prescription or prescription order, as\n\t\t\t\tdefined under applicable State law, that complies with requirements applicable\n\t\t\t\tunder such State law.", "#text": "prescription order"}], "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Prescription;\n\t\t\t\tprescription order"}, "#text": "\n                ", "@id": "id1E27EC8457A64DB2B5D1FD1BE3D0BD0A", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": [{"#tail": " or\n\t\t\t\t", "#text": "repackage"}, {"#tail": " means taking a drug approved under section 505 or 512,\n\t\t\t\tconditionally approved under section 571, included on the index established\n\t\t\t\tunder section 572(a)(1), or licensed under section 351 of the Public Health\n\t\t\t\tService Act from the container in which it is distributed by the original\n\t\t\t\tmanufacturer and placing it in a different container of the same or smaller\n\t\t\t\tsize without further manipulating the drug (such as by diluting it or mixing it\n\t\t\t\twith another, different drug or drugs), unless such repackaging is done\n\t\t\t\tpursuant to a prescription for an identified individual patient.", "#text": "repackaging"}], "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Repackage or\n\t\t\t\trepackaging"}, "#text": "\n                ", "@id": "id21CDB1BA3A8E4F0B8E1CE97AF20459DF", "@commented": "no"}, {"#tail": "\n              ", "@id": "idCE32000E5D2A4E67A229ACB28ADCE88D", "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n                ", "#text": "Sterile drug\n\t\t\t\tproduct"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means a drug\n\t\t\t\tthat is\u2014", "#text": "sterile drug product"}, "#text": "The term "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "intended for\n\t\t\t\tparenteral administration;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "#text": "\n                  ", "@id": "id2A1A2FFA331B46CBABF4D482B1C297DF", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "an ophthalmic or\n\t\t\t\tinhalation drug; or"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "idE3172D2848704D31ACA8D2A1E19EA6DF", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "required to be\n\t\t\t\tsterile under Federal or State law."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "#text": "\n                  ", "@id": "id7419382B9DB64E7CB7B47E497D128C67", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "wherein a drug is\n\t\t\t\tcompounded by\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "a licensed\n\t\t\t\tpharmacist, or other pharmacy personnel (to the extent permitted under State\n\t\t\t\tlaw), in a State-licensed pharmacy or a Federal facility; or"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "idf578b68c17e44a4cb168aae084dbff2b", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "a licensed\n\t\t\t\tphysician or licensed veterinarian, to the extent permitted under State\n\t\t\t\tlaw;"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "idc7f9d6b19ed341aeaf87cedf5ac3c9fb", "#text": "\n                      "}], "#text": "\n                    ", "@id": "idfbb004eb9ee14dc29877477b50f3ee6b"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "that\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "compounds a drug\n\t\t\t\tupon receipt of a prescription order for an identified individual patient;\n\t\t\t\tor"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "idF74B050AC47A4F679665A2245371C6AB", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "compounds a drug\n\t\t\t\tin limited quantities before receipt of a prescription order for an identified\n\t\t\t\tindividual patient, to the extent permitted under State law, if such\n\t\t\t\tcompounding is based on a history of the licensed pharmacist, licensed\n\t\t\t\tphysician, or licensed veterinarian receiving prescription orders for the\n\t\t\t\tcompounding of the drug, which orders have been generated solely within an\n\t\t\t\testablished relationship between the licensed pharmacist, licensed physician,\n\t\t\t\tor licensed veterinarian and\u2014"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "item": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "such individual\n\t\t\t\tpatient for whom the prescription order will be provided, or, in the case of an\n\t\t\t\tanimal drug, such individual responsible for providing care for the animal for\n\t\t\t\twhich the drug is ordered; or"}, "enum": {"#tail": "\n                        ", "#text": "(aa)"}, "#text": "\n                        ", "@id": "id7B6A562DF5E145A984E0C67A4EABC6D4", "@commented": "no"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the licensed\n\t\t\t\tphysician, licensed veterinarian, or other licensed practitioner who will write\n\t\t\t\tsuch prescription order; and"}, "enum": {"#tail": "\n                        ", "#text": "(bb)"}, "@id": "idDF65B5F40E7F4160A479610C15A860F0", "#text": "\n                        "}], "#text": "\n                      ", "@id": "id0922AEE1A8CF4215BE241F78F6DE9B31", "@commented": "no"}], "#text": "\n                    ", "@id": "id72e1ac26cc6244108fb41bf5d84491e7"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "that does not\n\t\t\t\tmeet the definition of a compounding manufacturer under paragraph (1)."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "#text": "\n                    ", "@id": "idd1bc3823bd5349409d0b0cfe12b07c31", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means an\n\t\t\t\tentity\u2014", "#text": "traditional compounder"}, "#text": "The term "}, "#text": "\n                  ", "@id": "id3B9501FEA4BB4724AAA3964C932A65E2", "@commented": "no"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "A pharmacy within a hospital, veterinary hospital, or\n\t\t\t\thealth system that compounds a drug and dispenses such drug (which may include\n\t\t\t\tinterstate shipment) within such hospital or health system or ships such drug\n\t\t\t\tfor dispensing to patients with an established relationship with the hospital\n\t\t\t\tor health system (which may include interstate shipment), or that repackages\n\t\t\t\tpreservative-free sterile drug product or pools sterile drug products, shall be\n\t\t\t\tconsidered a traditional compounder if such pharmacy otherwise meets the\n\t\t\t\tdefinition under subparagraph (A)."}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                      ", "@id": "id9A9E7AC43A8C42CDA7BB07607861BD83", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means two or more hospitals or veterinary hospitals that are\n\t\t\t\towned and operated by the same entity and that share access to databases with\n\t\t\t\tdrug order information for patients or animals, as applicable. A health system\n\t\t\t\tincludes both the inpatient and outpatient facilities of hospitals within the\n\t\t\t\thealth system.", "#text": "health\n\t\t\t\tsystem"}, "#text": "For purposes of this subparagraph, the term "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "header": {"#tail": "\n                      ", "#text": "Health system\n\t\t\t\tdefined"}, "#text": "\n                      ", "@id": "idC873139368D648A191D90864BA539C83", "@commented": "no"}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Hospitals and\n\t\t\t\thealth systems"}, "#text": "\n                    ", "@id": "id89348358A8F7472CB12861EC80C931CE", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A pharmacy that compounds positron emission\n\t\t\t\ttomography drugs or radiopharmaceuticals shall be considered a traditional\n\t\t\t\tcompounder if it does not compound other drugs that would cause it to be a\n\t\t\t\tcompounding manufacturer described in paragraph (1)(A)."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "PET and\n\t\t\t\tradiopharmaceuticals"}, "#text": "\n                    ", "@id": "id4254BC5B2EB944BC9E494758DE8B7E11", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Exceptions"}, "#text": "\n                  ", "@id": "id4fb5a2b0e8d64003991312ef5c0dba59", "@commented": "no"}], "enum": {"#tail": "\n                ", "#text": "(7)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Traditional\n\t\t\t\tcompounder"}, "#text": "\n                ", "@id": "id410980F3625745EC9972151B917D822F", "@commented": "no"}], "#text": "\n              ", "@id": "idDD20BCCAB9664E798DBF7C6632E7F85B"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Exemptions from\n\t\t\t\tcertain requirements"}, "paragraph": [{"#tail": "\n              ", "@id": "idD5C461E3CF364B4FA82EEEA954D5CE0E", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Drugs compounded\n\t\t\t\tby traditional compounders"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "\n                  Sections 501(a)(2)(B),\n\t\t\t\t502(f)(1), 505 (in the case of a human drug), section 512 (in the case of an\n\t\t\t\tanimal drug), and section 351 of the Public Health Service Act (in the case of\n\t\t\t\ta biological product) shall not apply to a compounded drug if such drug\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is compounded by a\n\t\t\t\ttraditional compounder that is in compliance with this section; and"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idAFE6CF4A1E854AB08A028FDBDEC7CBF9", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "meets the\n\t\t\t\trequirements of this section applicable to drugs compounded by traditional\n\t\t\t\tcompounders."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id93126E8B6795458996584A7EC608C561", "#text": "\n                  "}]}, {"#tail": "\n            ", "@id": "id2C92B90EEF024CE694E5F0E8AB8B934B", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Drugs compounded\n\t\t\t\tby compounding manufacturers"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "\n                  Sections 502(f)(1), 505\n\t\t\t\t(in the case of a human drug), section 512 (in the case of an animal drug), and\n\t\t\t\tsection 351 of the Public Health Service Act (in the case of a biological\n\t\t\t\tproduct) shall not apply to a compounded prescription drug if such drug\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "is compounded by a\n\t\t\t\tcompounding manufacturer\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "that is not\n\t\t\t\tlicensed as a pharmacy in any State; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id4287B01B938B4B3094779C200B1BCD45", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "that is in\n\t\t\t\tcompliance with this section; and"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idFF97E921A2494C9D9D7ECAB12246A1C9", "#text": "\n                    "}], "#text": "\n                  ", "@id": "id9A4FD255941449C88F9C2D7F2CF75685"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "meets the\n\t\t\t\trequirements of this section applicable to drugs compounded by compounding\n\t\t\t\tmanufacturers."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id876394A169354A2BB99BCC233B6CB079", "#text": "\n                  "}]}], "#text": "\n              ", "@id": "id68E8D19962D245109458F8997CCEADAB"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Drugs that may\n\t\t\t\tnot be compounded"}, "paragraph": [{"#tail": "\n              ", "@id": "id9BAE43418C2041569D9B65180E2D8ED1", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The following drugs may not be compounded, except under\n\t\t\t\tconditions specified by the Secretary:"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A drug or category of drugs\n\t\t\t\tthat presents demonstrable difficulties for compounding, which may include a\n\t\t\t\tcomplex dosage form or biological product, as designated by the Secretary\n\t\t\t\tpursuant to paragraph (2)."}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Drugs that are\n\t\t\t\tdemonstrably difficult to compound"}, "#text": "\n                  ", "@id": "id683580DDC0B746479134E18F294DE5FE"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A drug, other than a biological product, that is a copy of\n\t\t\t\ta marketed drug approved under 505 or 512, conditionally approved under section\n\t\t\t\t571, or included on the index established under section 572(a)(1), except as\n\t\t\t\tprovided in paragraph (3)."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Marketed\n\t\t\t\tdrugs"}, "#text": "\n                  ", "@id": "id42958634B4D8402C9295EEB6A18290F9"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A drug that is a biological product, except as provided\n\t\t\t\tin paragraph (4)."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Biological\n\t\t\t\tproducts"}, "#text": "\n                  ", "@id": "idC888A8C0E6114B4C836C49FE65180E1F"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A drug that appears on a list published\n\t\t\t\tby the Secretary in the Federal Register of drugs that have been withdrawn or\n\t\t\t\tremoved from the market because such drug or components of such drug have been\n\t\t\t\tfound to be unsafe or not effective, subject to paragraph (5)."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Drugs removed\n\t\t\t\tfor safety and efficacy"}, "#text": "\n                  ", "@id": "ID4D0BE8B4A67348F5A3C1B494894DFDB7", "@commented": "no"}]}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "may include the\n\t\t\t\tdesignation of drugs or categories of drugs that are complex dosage forms or\n\t\t\t\tbiological products, such as extended release products, metered dose inhalers,\n\t\t\t\ttransdermal patches, and sterile liposomal products; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "idD4E81B03C4BE4C709A42E3B096EFB256", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "shall specify,\n\t\t\t\tfor each drug included on the list, whether the prohibition or condition\n\t\t\t\tapplies to the use of the drug in humans, animals, or both."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "id8C0EDC081E6E483FB8BC7D0B798A115A", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The Secretary may promulgate a regulation that designates\n\t\t\t\tdrugs or categories of drugs that are demonstrably difficult to compound that\n\t\t\t\tmay not be compounded, or that may be compounded only under conditions\n\t\t\t\tspecified by the Secretary. Such regulation\u2014"}, "#text": "\n                  ", "@id": "id108691FE8F4B4B638FEF8C42FB4C0BB5", "@commented": "no"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "publishing a\n\t\t\t\tnotice of such drugs proposed for designation, including the rationale for such\n\t\t\t\tdesignation, in the Federal Register;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "#text": "\n                      ", "@id": "id3F0ECA26028B42EEA4DD3ED993479558", "@commented": "no"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "providing a\n\t\t\t\tperiod of not less than 60 days for comment on the notice; and"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "#text": "\n                      ", "@id": "idEC67BA0BFA74424ABC8EDF1684DD438A", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "publishing a\n\t\t\t\tnotice in the Federal Register designating the drugs that are complex dosage\n\t\t\t\tforms and biological products that cannot be compounded."}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "#text": "\n                      ", "@id": "idEED32EC05C2D45259957852FBBBE330F", "@commented": "no"}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Before the effective date of the regulation promulgated\n\t\t\t\tunder subparagraph (A), the Secretary may designate drugs that are complex\n\t\t\t\tdosage forms or biological products that cannot be compounded by\u2014"}, "#text": "\n                    ", "@id": "idDBAA2EAA2749495195AA75DBA6DB6833", "@commented": "no"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": " or on the effective date of the final\n\t\t\t\tregulation under subparagraph (A), whichever is earlier.", "#text": "Pharmaceutical Compounding Quality and\n\t\t\t\tAccountability Act"}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Any\n\t\t\t\tnotice provided under clause (i) shall cease to have force or effect on the\n\t\t\t\tdate that is 5 years after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Sunset"}, "#text": "\n                    ", "@id": "id4AB88029E0A94DF6897B85CBE6478F90", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Interim\n\t\t\t\tlist"}, "#text": "\n                  ", "@id": "id884A5FC134954D8381624206B78E550C", "@commented": "no"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Drugs that are\n\t\t\t\tdemonstrably difficult to compound"}, "#text": "\n                ", "@id": "idB80B609678C84FF58C631D50C00C9092", "@commented": "no"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "@id": "id481F27E7F74145ED9732CA16C2E3069B", "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the compounded\n\t\t\t\tvariation produces for the patient a clinical difference between the compounded\n\t\t\t\tdrug and such marketed drug, as determined by the prescribing practitioner,\n\t\t\t\tand, prior to beginning compounding a variation of such drug, the facility\n\t\t\t\tcompounding the variation receives a prescription order specifying that the\n\t\t\t\tvariation may be compounded; or"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                      ", "@id": "idBC4050AD48EA4A99AD05B7BE5481B076", "@commented": "no"}, {"@committee-id": "SSHR00", "@changed": "deleted", "@indent": "up1", "#tail": "\n                  ", "enum": {"#tail": "\n                      ", "#text": "(II)"}, "item": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "such marketed drug, at\n\t\t\t\tthe time of compounding a copy of such drug and at the time of distribution of\n\t\t\t\tthe compounded drug, is on the drug shortage list under section 506E (in the\n\t\t\t\tcase of a human drug), on the Current Drug Shortages list for veterinary\n\t\t\t\tproducts maintained on the Internet Web site of the Food and Drug\n\t\t\t\tAdministration (in the case of an animal drug), or in the Secretary\u2019s sole\n\t\t\t\tdiscretion, has otherwise been identified by the Secretary as in shortage such\n\t\t\t\tas in a specific region or on a drug shortage list maintained by a private\n\t\t\t\tparty; and"}, "enum": {"#tail": "\n                        ", "#text": "(aa)"}, "@display-inline": "yes-display-inline", "#text": "\n                        ", "@id": "idDA7D6A8A77A04D5391073F9EDAE633AE", "@commented": "no"}, {"@committee-id": "SSHR00", "@changed": "deleted", "@indent": "up1", "#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the traditional compounder or the\n\t\t\t\tcompounding manufacturer notifies the Secretary not later than 3 calendar days\n\t\t\t\tafter beginning the compounding, unless the Secretary waives the notice\n\t\t\t\trequirement; and"}, "enum": {"#tail": "\n                        ", "#text": "(bb)"}, "@reported-display-style": "strikethrough", "#text": "\n                        ", "@id": "idCBCA5C0C21904F548F02972A8B4CA9C1", "@commented": "no"}], "@reported-display-style": "strikethrough", "#text": "\n                      ", "@id": "idA5585ADD81B9464E8DC17B3B2A50D6D5", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\tmarketed drug approved under section 505 that is subject to a risk evaluation\n\t\t\t\tand mitigation strategy approved with elements to assure safe use pursuant to\n\t\t\t\tsection 505\u20131, the entity compounding the drug demonstrates to the Secretary\n\t\t\t\tthat the entity will utilize controls that are comparable to the controls\n\t\t\t\tapplicable under the relevant risk evaluation and mitigation strategy."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "idC78F9D091AA04B5EA408C799FF79D653", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A drug (other than a biological product) that is a copy\n\t\t\t\tof a marketed drug approved under 505 or 512, conditionally approved under\n\t\t\t\tsection 571, or included on the index established under section 572(a)(1),\n\t\t\t\tincluding variations of such drug compounded from bulk substances, may be\n\t\t\t\tcompounded only if\u2014"}, "#text": "\n                  ", "@id": "id1435EC34580D4AA79D435DB4E6E3CA18", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "For\n\t\t\t\tpurposes of this paragraph, repackaging a marketed drug approved under section\n\t\t\t\t505, 512, conditionally approved under section 571, or included on the index\n\t\t\t\testablished under section 572(a)(1), does not make the repackaged drug a copy\n\t\t\t\tof such marketed drug."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Exclusion"}, "#text": "\n                  ", "@id": "idC9CE09412EC446449DE4AC47C5FECC91", "@commented": "no"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Exceptions\n\t\t\t\tregarding marketed drugs"}, "#text": "\n                ", "@id": "idAE5F6C00E48644F6AF3D98B7DC3034CB", "@commented": "no"}, {"#tail": "\n              ", "@id": "idD1CEF9DC91C844BC9ACA915D926723E4", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Exceptions\n\t\t\t\tregarding biological products"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A drug that is a biological product\n\t\t\t\tmay be compounded only if\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "such drug is\n\t\t\t\tcompounded from a licensed biological product and the compounding does not\n\t\t\t\tinvolve combining or mixing the licensed biological product with\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a bulk drug\n\t\t\t\tsubstance; or"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id3C591B4C264C425DAC97D914AB727286", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "another,\n\t\t\t\tdifferent drug or drugs approved under 505 or 512, conditionally approved under\n\t\t\t\tsection 571, included on the index established under section 572(a)(1), or\n\t\t\t\tlicensed under section 351 of the Public Health Service Act, unless the\n\t\t\t\tcompounding is limited to the combining, mixing, or diluting of licensed\n\t\t\t\tallergenic products; and"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idA7F5A1287AD04E7DAF054323B2341831", "#text": "\n                    "}], "#text": "\n                  ", "@id": "id2A859AB582984865A8F33131508CBB0E"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "with respect to a\n\t\t\t\ttraditional compounder, the compounded biological product produces for the\n\t\t\t\tpatient a clinical difference between the compounded drug and the licensed\n\t\t\t\tbiological product, as determined by the prescribing practitioner, and, prior\n\t\t\t\tto beginning compounding such drug, the facility compounding the variation\n\t\t\t\treceives a prescription order specifying that the biological product may be\n\t\t\t\tcompounded;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@display-inline": "yes-display-inline", "#text": "\n                    ", "@id": "id5A8EC86B74A74A318890D21DB356524B", "@commented": "no"}, {"@committee-id": "SSHR00", "@changed": "deleted", "@indent": "up1", "#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "with respect to a\n\t\t\t\tcompounding manufacturer, the compounded variation biological product produces\n\t\t\t\tfor the patient a clinical difference between the compounded drug and the\n\t\t\t\tlicensed biological product, as determined by a licensed practitioner\n\t\t\t\tresponsible for the patient\u2019s care in a health care entity that provides\n\t\t\t\tmedical services through licensed prescribers directly to patients, and, prior\n\t\t\t\tto beginning compounding such drug, the compounding manufacturer receives a\n\t\t\t\tduly authorized medical order from a hospital or health system specifying that\n\t\t\t\tthe biological product may be compounded; or"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@reported-display-style": "strikethrough", "#text": "\n                    ", "@id": "id74F93AC177524B08AC8CE4FC00E8F06A"}, {"@committee-id": "SSHR00", "@changed": "deleted", "@indent": "up1", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the compounded\n\t\t\t\tbiological product is an allergenic product."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@reported-display-style": "strikethrough", "#text": "\n                    ", "@id": "id96F80EB163844D9DB6740CA1C6E171FE"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id86A28F6A8F054D1E906D7A2950ED88BD", "#text": "\n                  "}], "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The list published\n\t\t\t\tby the Secretary in the Federal Register of drugs that have been withdrawn or\n\t\t\t\tremoved from the market, as described in paragraph (1)(D), shall specify\n\t\t\t\twhether a human drug on such list may, notwithstanding the inclusion on such\n\t\t\t\tlist, be compounded for use in animals. The Secretary shall update the lists\n\t\t\t\tdescribed in subparagraphs (D) and (E) of subsection (e)(2), as appropriate, to\n\t\t\t\tconform with the list described in paragraph (1)(D)."}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Requirement\n\t\t\t\tregarding drugs removed for safety or efficacy"}, "#text": "\n                ", "@id": "id1E712E3DB5BC4E65B65A6DE69E770416", "@commented": "no"}], "#text": "\n              ", "@id": "id9D65C932308C4CA1A4DAE9CED5164DDD"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Quality of drug\n\t\t\t\tingredients"}, "paragraph": [{"#tail": "\n              ", "@id": "idA3C6AB0C1CA54DA3BEB491EDDDD3B666", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Human\n\t\t\t\tdrugs"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A traditional compounder or a compounding manufacturer\n\t\t\t\tshall\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "compound a human\n\t\t\t\tdrug using only bulk drug substances (as defined in regulations of the\n\t\t\t\tSecretary published at ", "external-xref": {"#tail": " of title 21, Code of Federal\n\t\t\t\tRegulations (or any successor regulations))\u2014", "@parsable-cite": "usc/21/207", "#text": "section 207.3(a)(4)", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "that\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "comply with the\n\t\t\t\tstandards of an applicable United States Pharmacopoeia or National Formulary\n\t\t\t\tmonograph, if a monograph exists and has not been identified under paragraph\n\t\t\t\t(6), and the United States Pharmacopoeia chapters on pharmacy\n\t\t\t\tcompounding;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "IDE6DB70F8D2A54DC1952C2CDBBA04AF4A", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "if such a\n\t\t\t\tmonograph does not exist, are drug substances that are components of drugs\n\t\t\t\tapproved by the Secretary; or"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "ID1EBD4FC4F6EF429AA3F850E0891BB835", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "if such a\n\t\t\t\tmonograph does not exist and the drug substance is not a component of a drug\n\t\t\t\tapproved by the Secretary, that appear on a list developed by the Secretary\n\t\t\t\tthrough regulations issued by the Secretary;"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "IDFF52C6DC676C4B57A3258D1CFF2A40F8", "#text": "\n                      "}], "#text": "\n                    ", "@id": "IDF12B697D3B224CCBA5BEF3D5BE77E849"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "that are\n\t\t\t\tmanufactured by an establishment that is registered under section 510\n\t\t\t\t(including a foreign establishment that is registered under section 510(i));\n\t\t\t\tand"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "IDA448CA33D2F74776B6E3669191AB75F5", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "that are\n\t\t\t\taccompanied by valid certificates of analysis for each specific lot of bulk\n\t\t\t\tdrug substance; and"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "ID4305EDCEBF7244C0885A94C2253A43EA", "#text": "\n                    "}], "#text": "\n                  ", "@id": "ID9C11ECEE5FA74D05A77BAAAEA173503E"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "use ingredients\n\t\t\t\t(other than bulk drug substances) that comply with the standards of an\n\t\t\t\tapplicable United States Pharmacopoeia or National Formulary monograph, if a\n\t\t\t\tmonograph exists and has not been identified under paragraph (6), and with the\n\t\t\t\tUnited States Pharmacopoeia chapter on pharmacy compounding."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "IDA7E2C87F84C7458B92DF996A79E56BCE", "@commented": "no"}]}, {"#tail": "\n              ", "@id": "id62D837E76DF74F37864249856A72A773", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Animal\n\t\t\t\tdrugs"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A traditional compounder or a compounding manufacturer\n\t\t\t\tshall\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "compound an animal\n\t\t\t\tdrug using only bulk drug substances (as defined in regulations of the\n\t\t\t\tSecretary published at ", "external-xref": {"#tail": " of title 21, Code of Federal\n\t\t\t\tRegulations (or any successor regulations)) that\u2014", "@parsable-cite": "usc/21/207", "#text": "section 207.3(a)(4)", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "are manufactured\n\t\t\t\tby an establishment that is registered under section 510 (including a foreign\n\t\t\t\testablishment that is registered under section 510(i)); and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id5e47029fde46483395e9bde38852695d", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "are accompanied\n\t\t\t\tby valid certificates of analysis for each specific lot of bulk drug\n\t\t\t\tsubstance;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idbb3e48471d20427d94a0e9af96fefbb6", "#text": "\n                    "}], "#text": "\n                  ", "@id": "ide98f91f0616f40bcac33fe596184c29e"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "use ingredients\n\t\t\t\t(other than bulk drug substances) that comply with the standards of an\n\t\t\t\tapplicable United States Pharmacopoeia or National Formulary monograph, if a\n\t\t\t\tmonograph exists and has not been identified under paragraph (6), and with the\n\t\t\t\tUnited States Pharmacopoeia chapters on pharmacy compounding;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idA7F55762CD6D44D19C91579496485B85", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\tcompounded animal drug for use in non-food-producing minor species, use bulk\n\t\t\t\tsubstances that\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "comply with the\n\t\t\t\tstandards of an applicable United States Pharmacopoeia or National Formulary\n\t\t\t\tmonograph, if a monograph exists and has not been identified under paragraph\n\t\t\t\t(6), and with the United States Pharmacopoeia chapters on pharmacy\n\t\t\t\tcompounding;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idbc72f4ddd9ae497e8eac1cc6faba8d2c", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "if such a\n\t\t\t\tmonograph does not exist, are drug substances that are components of drugs\n\t\t\t\tapproved by the Secretary; or"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id44b69f6dc5ba49a08d5bcecdb00cbdcd", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "if such a\n\t\t\t\tmonograph does not exist and the drug substance is not a component of a drug\n\t\t\t\tapproved by the Secretary, that appear on a list developed by the Secretary\n\t\t\t\tthrough regulations issued by the Secretary;"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id10227604a6e34c768e005a8dc8521eee", "#text": "\n                    "}], "#text": "\n                  ", "@id": "id7627130DE7A04EF5B9669617BB4EEC67"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\tcompounded animal drug for use in non-food-producing major species, beginning\n\t\t\t\ton the date of publication of the list established in accordance with paragraph\n\t\t\t\t(3)(A), shall use bulk substances that are included on such list, subject to\n\t\t\t\tparagraph (3)(C); and"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "idA3E265515E3E4430B6C2AF2A8534FF0B", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\tcompounded animal drug for use in food-producing major and minor species, shall\n\t\t\t\tuse bulk substances that are included on a list established by the Secretary of\n\t\t\t\tbulk substances acceptable for use in compounding a drug for one or more such\n\t\t\t\tspecies, in accordance with paragraph (4)."}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "id7D5ECD0B44E546DFBEC16F5684AEAD70", "#text": "\n                  "}], "@commented": "no"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "text": {"short-title": {"#tail": ", the Secretary shall establish a list of bulk\n\t\t\t\tsubstances acceptable for compounding a drug for use in non-food-producing\n\t\t\t\tmajor species, and any conditions applicable to such use, and may also identify\n\t\t\t\tbulk substances that the Secretary has determined not acceptable for\n\t\t\t\tcompounding with respect to a drug for use in such species.", "#text": "Pharmaceutical Compounding Quality and\n\t\t\t\tAccountability Act"}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Not later than 30 days after the effective date of the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "id004D2BC59D9844C98CC8B27705FCD8A5"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "publish a notice\n\t\t\t\tin the Federal Register identifying bulk substances proposed as acceptable and\n\t\t\t\tany bulk substance determine to be unacceptable, and the rationale for such\n\t\t\t\tproposed designations;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idd12c0692831a4c50a37301967fc92f57", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "provide a period\n\t\t\t\tof not less than 30 days for comment on the notice; and"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id44af568875364a04a4b47e785f8a588b", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "publish a notice\n\t\t\t\tin the Federal Register designating the bulk substances acceptable, and any\n\t\t\t\tbulk substances determined to be unacceptable, and the rationale for such\n\t\t\t\tdesignations and determinations."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "idad200469d99a40ea929c39c041b17f6a", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Procedure"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tdeveloping and updating the list under subparagraph (A), the Secretary\n\t\t\t\tshall\u2014"}, "#text": "\n                  ", "@id": "id7F9E5FD1328D43F3857518F907299572"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Upon\n\t\t\t\tinitial publication of the list under subparagraph (B)(iii), any traditional\n\t\t\t\tcompounder or compounding manufacturer that has received and filled a\n\t\t\t\tprescription in the 60 days prior to such publication for a compounded drug for\n\t\t\t\ta non-food-producing major species from a bulk substance not addressed in the\n\t\t\t\tnotice (either as acceptable or unacceptable), and that reasonably expect to\n\t\t\t\treceive and fill another prescription for such a drug for such species within\n\t\t\t\t60 days after such publication, may notify the Secretary of such bulk substance\n\t\t\t\twithin 30 days of such publication, in a manner to be determined by the\n\t\t\t\tSecretary and published in the Federal Register on or before publication of the\n\t\t\t\tlist under subparagraph (B)(iii). A traditional compounder or compounding\n\t\t\t\tmanufacturer that provides such notice shall not be subject to the restriction\n\t\t\t\tin paragraph (2)(D) until such time as the Secretary designates such bulk\n\t\t\t\tsubstance as acceptable or determines it to be unacceptable pursuant to the\n\t\t\t\tprocess described in subparagraph (B)(iii)."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Notification"}, "#text": "\n                  ", "@id": "id622C237CC1C74E51AB1A95F4183B7E3F"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The Secretary may amend the list at any time, in accordance\n\t\t\t\twith process described in subparagraph (B)."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Modification of\n\t\t\t\tlist"}, "#text": "\n                  ", "@id": "id4DE045D882034AB78D3FA14A8A43C5DB"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the safety of the\n\t\t\t\tbulk substance;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idF11E00CC063543EFA45AF5E0E1E29753", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "historical use of\n\t\t\t\tthe substance in pharmacy compounding;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idF041EFC729D04D29B6228C51720B58BD", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "evidence of the\n\t\t\t\teffectiveness of the bulk substance or lack of effectiveness;"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id8FEB07A930924B1782608F7334DE464C", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "whether any drug\n\t\t\t\tapproved under section 505 or 512, conditionally approved under section 571, or\n\t\t\t\tincluded on the index established under section 572(a)(1), can be used on\n\t\t\t\tlabel, or any drug approved under section 505 or 512 can be used in an\n\t\t\t\textralabel manner in accordance with section paragraphs (4) and (5) of section\n\t\t\t\t512(a), to treat the applicable condition in the identified species; and"}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "@id": "idC88B6BD87AB24B829C906E5A64B2B46F", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "whether a\n\t\t\t\tcompounded drug appropriate to treat the applicable condition in the identified\n\t\t\t\tspecies could be obtained by manipulating a drug approved under 505 or 512,\n\t\t\t\tconditionally approved under section 571, or included on the index established\n\t\t\t\tunder section 572(a)(1)."}, "enum": {"#tail": "\n                    ", "#text": "(v)"}, "@id": "idF8DDA96C109042E6BEECCB640FB72059", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Criteria"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tevaluating bulk substances for purposes of subparagraph (B), the Secretary\n\t\t\t\tshall consider, among other factors\u2014"}, "#text": "\n                  ", "@id": "idDBDE253FC8EC413D87062F90BC8F8900"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Non-food-producing\n\t\t\t\tmajor species listing procedure"}, "#text": "\n                ", "@id": "id673AA966C9BF4178B96C4BDE470F64BF"}, {"#tail": "\n              ", "@id": "id18519C3B3CBB40ECA5017CC7DC8FB05C", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Food-producing\n\t\t\t\tanimals listing procedure"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "In establishing a list of designated\n\t\t\t\tbulk substances acceptable for use in compounding a drug for use in\n\t\t\t\tfood-producing major and minor species under paragraph (2), and any conditions\n\t\t\t\tapplicable to such use, the Secretary shall\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish a notice\n\t\t\t\tin the Federal Register identifying bulk substances proposed as acceptable and\n\t\t\t\tany bulk substance determine to be unacceptable, and the rationale for such\n\t\t\t\tdesignations;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idb45c14775a4c4b6e8a44217c2f3281f2", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide a period\n\t\t\t\tof not less than 30 days for comment on the notice; and"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idbae007c8dd8f4136a816e0ced5e7015e", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish a notice\n\t\t\t\tin the Federal Register designating the bulk substances acceptable for use in\n\t\t\t\tcompounding a drug for use in food-producing major and minor species, and the\n\t\t\t\trationale for such designations."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id699a226e70714e8ba780994437cf0464", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The requirements for establishing substantially extended\n\t\t\t\twithdrawal periods in accordance with ", "external-xref": {"#tail": " of title 21, Code of\n\t\t\t\tFederal Regulations (or any successor regulations) shall apply to compounded\n\t\t\t\tanimal drugs for use in food-producing animals that are compounded using bulk\n\t\t\t\tsubstances.", "@parsable-cite": "usc/21/530", "#text": "section 530.20", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Withdrawal\n\t\t\t\tperiods"}, "#text": "\n                ", "@id": "id5311468C28574984811043E6FE21D981"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Notwithstanding the existence of an applicable monograph\n\t\t\t\tunder subparagraph (A)(i)(I) or (B) of paragraph (1) or subparagraph (B) or\n\t\t\t\t(C)(i) of paragraph (2), the Secretary may identify bulk substances that the\n\t\t\t\tSecretary determines, based on public health concerns, may not be used in\n\t\t\t\tcompounding a drug."}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "idA27167AA14C344389AAA91A445F0E19E"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "publish a notice\n\t\t\t\tof such bulk substances proposed for identification in the Federal\n\t\t\t\tRegister;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "#text": "\n                    ", "@id": "id4F4212AF65034BB0ABE1A10C7FB4AD36", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "provide a period\n\t\t\t\tof not less than 60 days for comment on the notice;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "#text": "\n                    ", "@id": "idC6F3633DF918423CB0628ED6B990E737", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "publish a notice\n\t\t\t\tin the Federal Register identifying the bulk substances that may not be used in\n\t\t\t\tcompounding a drug; and"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "#text": "\n                    ", "@id": "id771C4790F4684DB1988022FBB5E8AD05", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "state whether the\n\t\t\t\tbulk is not suitable for compounding of human drugs, animal drugs, or\n\t\t\t\tboth."}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "#text": "\n                    ", "@id": "id08A3C0901DF4453498566126140B5AA3", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Procedure"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tidentifying the bulk substances that may not be used in compounding, the\n\t\t\t\tSecretary shall\u2014"}, "#text": "\n                  ", "@id": "id4ECF80E150574AFE82373EAE986918E8"}], "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Identification\n\t\t\t\tby Secretary"}, "#text": "\n                ", "@id": "idC87C9E923A764B03B72468AF698F91A0"}], "#text": "\n              ", "@id": "idA26C9E119AB94D0E9C4EF67BEF7A6D47"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Requirements\n\t\t\t\tregarding wholesaling and labeling applicable to traditional compounders and\n\t\t\t\tcompounding manufacturers"}, "paragraph": [{"#tail": "\n              ", "@id": "id8667B99A4DA343CEA0421944645963DD", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A compounded drug\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "may not be sold by\n\t\t\t\tan entity other than the compounding manufacturer or traditional compounder\n\t\t\t\tthat compounded the drug;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id9F80D551B3A9442CAF67B62CDF7A5B60", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "compounded by a\n\t\t\t\tcompounding manufacturer may not be sold to an entity other than a health care\n\t\t\t\tentity that provides medical services through licensed prescribers directly to\n\t\t\t\tpatients or animals, or a network of such providers, except that a compounding\n\t\t\t\tmanufacturer may transfer without profit a compounded sterile drug to a\n\t\t\t\tlicensed pharmacy if\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the licensed\n\t\t\t\tpharmacy falls under the same corporate ownership as the compounding\n\t\t\t\tmanufacturer;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id32ED1352EB75411FB553D462098CC8C8", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the transfer of\n\t\t\t\tsuch compounded sterile drug is solely for the purpose of dispensing the\n\t\t\t\tcompounded sterile drug to the end user, who has been instructed by the\n\t\t\t\tprescribing physician to self-administer such compounded sterile drug;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id7611569AED0E4920B40A1786D70876CC", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"short-title": {"#tail": ", the compounding\n\t\t\t\tmanufacturer is an entity that provides pharmacy benefits management services\n\t\t\t\ton behalf of a health benefits plan;", "#text": "Pharmaceutical\n\t\t\t\tCompounding Quality and Accountability Act"}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "as of the date\n\t\t\t\tof enactment of the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "idBE87C394F3DE4C9BBC4698CD7F3B54F2", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"short-title": {"#tail": ", in a manner described\n\t\t\t\tby the Secretary; and", "#text": "Pharmaceutical\n\t\t\t\tCompounding Quality and Accountability Act"}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the compounding\n\t\t\t\tmanufacturer identifies itself to the Secretary upon registering under\n\t\t\t\tsubsection (g)(2) as an entity that qualifies for the exemption under this\n\t\t\t\tsubparagraph, and provides documentation of the compounding of such drugs as of\n\t\t\t\tthe date of enactment of the "}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "@id": "ide819637ff124446ab94e9f5b32db9405", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the compounding\n\t\t\t\tmanufacturer receives confirmation from the Secretary that the compounding\n\t\t\t\tmanufacturer qualifies for the exemption under this subparagraph and the\n\t\t\t\tsterile drug or drugs for which the exemption applies; and"}, "enum": {"#tail": "\n                    ", "#text": "(v)"}, "@id": "id35a232a12b4042a8ba02f85b53dc5a5e", "#text": "\n                    "}], "#text": "\n                  ", "@id": "id1454cdb6d39d480c880ae4f5aaae5834"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "quote": {"#tail": ".", "#text": "not for resale"}, "#text": "in the case of a\n\t\t\t\tcompounded drug sold to a health care entity described in subparagraph (B),\n\t\t\t\tshall be labeled "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id007EBD3399A5440F8659169170BC4216", "#text": "\n                  "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The advertising and promotion of compounded drugs shall\n\t\t\t\tnot be false or misleading in any particular."}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Advertising and\n\t\t\t\tpromotion"}, "#text": "\n                ", "@id": "id72B54F427E5B4FF690CCA027A388E2DE"}], "#text": "\n              ", "@id": "id833A2EC3FBFE468B8D50C90196E09D5E"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Other\n\t\t\t\trequirements applicable to compounding manufacturers"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "A compounding manufacturer shall ensure that\n\t\t\t\ta pharmacist licensed in the State where the compounding manufacturer is\n\t\t\t\tlocated exercises direct supervision over the operations of the compounding\n\t\t\t\tmanufacturer."}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Licensed\n\t\t\t\tpharmacist oversight"}, "#text": "\n                ", "@id": "idC2C2F2F332384A32B1F3F961DCA27047"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "During the period beginning on October 1 and ending\n\t\t\t\ton December 31 each year, each compounding manufacturer shall register with the\n\t\t\t\tSecretary its name, place of business, and unique facility identifier (which\n\t\t\t\tshall conform to the requirements for the unique facility identifier\n\t\t\t\testablished under section 510), and a point of contact e-mail address."}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Annual\n\t\t\t\tregistration"}, "#text": "\n                    ", "@id": "id55D2A2BD15664785B3156A02208583E0"}, {"#tail": "\n                  ", "text": {"short-title": {"#tail": ". In no case may registration be required until at least 60\n\t\t\t\tdays following publication of the timeline in the Federal Register.", "#text": "Pharmaceutical Compounding Quality and Accountability\n\t\t\t\tAct"}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each compounding manufacturer, upon first engaging\n\t\t\t\tin the operations described in subsection (b)(1), shall immediately register\n\t\t\t\twith the Secretary and provide the information described under clause (i). The\n\t\t\t\tSecretary shall establish a timeline for registration for the first year\n\t\t\t\tfollowing the effective date of the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "New compounding\n\t\t\t\tmanufacturers"}, "#text": "\n                    ", "@id": "id4D1E5A1E60F84FCC9BB2069CA196916D"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each compounding manufacturer duly registered in\n\t\t\t\taccordance with clauses (i) and (ii) shall immediately identify to the\n\t\t\t\tSecretary any additional facility that engages in the activities described in\n\t\t\t\tsubsection (b)(1) and that is owned or operated in any State by the person that\n\t\t\t\towns or operates the compounding manufacturer."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Additional\n\t\t\t\tfacilities"}, "#text": "\n                    ", "@id": "idF12E4B8D32A34B56ADDA893692F47877"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The Secretary shall make available\n\t\t\t\tfor inspection, to any person so requesting, any registration filed pursuant to\n\t\t\t\tthis subparagraph, except that any drug reporting information submitted\n\t\t\t\tpursuant to this subparagraph and the information accompanying such reporting\n\t\t\t\tshall be exempt from such inspection, unless the Secretary finds that such an\n\t\t\t\texemption would be inconsistent with the protection of the public\n\t\t\t\thealth."}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "header": {"#tail": "\n                    ", "#text": "Availability of\n\t\t\t\tregistration for inspection"}, "#text": "\n                    ", "@id": "idE6108384DC254E90AF11B6F2A04A5B9E"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Registration of\n\t\t\t\tcompounding manufacturers"}, "#text": "\n                  ", "@id": "id421F01E533DE4C6495C4A8BB825D3957"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "identifying the\n\t\t\t\tdrugs compounded by such compounding manufacturer during the previous 6-month\n\t\t\t\tperiod; and"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "id4E491B24598F408F97A107C169C65C20", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "with respect to\n\t\t\t\teach drug identified under subclause (I), providing the active ingredient, the\n\t\t\t\tsource of such active ingredient, the National Drug Code number of the source\n\t\t\t\tdrug or bulk active ingredient, the strength of the active ingredient per unit,\n\t\t\t\tthe dosage form and route of administration, the package description, the\n\t\t\t\tnumber of individual units produced, the National Drug Code number of the final\n\t\t\t\tproduct, and which conforms to other applicable requirements identified by the\n\t\t\t\tSecretary in accordance with clause (ii)."}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "id9E178B7CEB35439B8523C2F5EDF28D60", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Each com\u00adpound\u00ading manufacturer who registers with the\n\t\t\t\tSecretary under subparagraph (A) shall submit to the Secretary, once during the\n\t\t\t\tmonth of June of each year and once during the month of December of each year,\n\t\t\t\ta report\u2014"}, "#text": "\n                    ", "@id": "id79D78C95B30443CD97CCF7889C7A1704"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each\n\t\t\t\treport under clause (i) shall be prepared in such form and manner as the\n\t\t\t\tSecretary may prescribe by regulation or guidance."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Form"}, "#text": "\n                    ", "@id": "idF983F6DC1A4241C998F39FCDE54F619C"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Drug reporting\n\t\t\t\tby compounding manufacturers"}, "#text": "\n                  ", "@id": "id2BDD2002550E4AEF8E20F578EBCFD917"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Registrations and drug reporting under\n\t\t\t\tthis paragraph (including the submission of updated information) shall be\n\t\t\t\tsubmitted to the Secretary by electronic means unless the Secretary grants a\n\t\t\t\trequest for waiver of such requirement because use of electronic means is not\n\t\t\t\treasonable for the person requesting waiver."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Electronic\n\t\t\t\tregistration and reporting"}, "#text": "\n                  ", "@id": "id76AA4E93AED944B88336D10189BE2A80"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Compounding manufacturers shall be subject to inspection\n\t\t\t\tpursuant to section 704."}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "id6A6A6D7936F44888910435CA0A2AB587"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The Secretary, acting through one or more officers or\n\t\t\t\temployees duly designated by the Secretary, shall inspect compounding\n\t\t\t\tmanufacturers described in clause (i) in accordance with a risk-based schedule\n\t\t\t\testablished by the Secretary."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Risk-based\n\t\t\t\tschedule"}, "#text": "\n                    ", "@id": "id95FC98A78AD34CCBAF3BE86B12A0DB0B"}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The compliance\n\t\t\t\thistory of the compounding manufacturer."}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "iddf7ad7d8bca24352a6c54bda15d6b340", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The record,\n\t\t\t\thistory, and nature of recalls linked to the compounding manufacturer."}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "id669be2a27d274711abde0fd3d7fa5925", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The inherent\n\t\t\t\trisk of the drug compounded at the compounding manufacturer."}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "ideee744146b644e7faf6bf099a7f18545", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The inspection\n\t\t\t\tfrequency and history of the compounding manufacturer, including whether the\n\t\t\t\tcompounding manufacturer has been inspected pursuant to section 704 within the\n\t\t\t\tlast 4 years."}, "enum": {"#tail": "\n                      ", "#text": "(IV)"}, "@id": "id5333a41d04664e27bcc45d90140e353b", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Any other criteria\n\t\t\t\tdeemed necessary and appropriate by the Secretary for purposes of allocating\n\t\t\t\tinspection resources."}, "enum": {"#tail": "\n                      ", "#text": "(V)"}, "@id": "idfff4cdba7e524939a1f5515718d1a032", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Risk\n\t\t\t\tfactors"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "In establishing the risk-based schedule under clause\n\t\t\t\t(ii), the Secretary shall inspect compounding manufacturers according to the\n\t\t\t\tknown safety risks of such compounding manufacturers, which shall be based on\n\t\t\t\tthe following factors:"}, "#text": "\n                    ", "@id": "id0A044EC7F35A42B8B438B9F7F2950F87"}], "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Risk-based\n\t\t\t\tinspection frequency"}, "#text": "\n                  ", "@id": "id1A157CED2E5E4E738F515EB1065B7CE0"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Registration of\n\t\t\t\tcompounding manufacturers and reporting of drugs"}, "#text": "\n                ", "@id": "id66BFC03B77664C5BA2C3C84B37514540"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "an event occurring\n\t\t\t\tin the course of the use of the drug in professional practice;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "idBDF4A3435B704D018BED4DD4D018DF82", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "an event\n\t\t\t\toccurring from an overdose of the drug, whether accidental or\n\t\t\t\tintentional;"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "idF1290E15DB084AF0958FDE6E547CAF28", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "an event\n\t\t\t\toccurring from abuse of the drug;"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "idB5E137513FF845BA83B442E3D90E7B3F", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "an event\n\t\t\t\toccurring from withdrawal of the drug; and"}, "enum": {"#tail": "\n                      ", "#text": "(IV)"}, "@id": "id0EDE3AE2211F45C7A4DEA30C4744231F", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "any failure of\n\t\t\t\texpected pharmacological action of the drug."}, "enum": {"#tail": "\n                      ", "#text": "(V)"}, "@id": "id6CB54B1422254B769A931A8B0C53B3AF", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Adverse\n\t\t\t\tevent"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means any\n\t\t\t\thealth-related event associated with the use of a compounded drug that is\n\t\t\t\tadverse, including\u2014", "#text": "adverse event"}, "#text": "The term "}, "#text": "\n                    ", "@id": "idD6C72C0E69244B5C80B2ADA097A5ACD2"}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "results in\u2014"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "item": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "death;"}, "enum": {"#tail": "\n                        ", "#text": "(aa)"}, "@id": "id707F247BC508464498B73C16CBEF99C7", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "an adverse drug\n\t\t\t\tevent that places the patient at immediate risk of death from the adverse drug\n\t\t\t\tevent as it occurred (not including an adverse drug event that might have\n\t\t\t\tcaused death had it occurred in a more severe form);"}, "enum": {"#tail": "\n                        ", "#text": "(bb)"}, "@id": "id67D5890F9EE440FF94259B5DBAA8D596", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "inpatient\n\t\t\t\thospitalization or prolongation of existing hospitalization;"}, "enum": {"#tail": "\n                        ", "#text": "(cc)"}, "@id": "idFD5AA951FD1549E090DF2ECF24838530", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "a persistent or\n\t\t\t\tsignificant incapacity or substantial disruption of the ability to conduct\n\t\t\t\tnormal life functions; or"}, "enum": {"#tail": "\n                        ", "#text": "(dd)"}, "@id": "id7502DCE8F78647CE973914EE20D4A85A", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "a congenital\n\t\t\t\tanomaly or birth defect; or"}, "enum": {"#tail": "\n                        ", "#text": "(ee)"}, "@id": "id7BF02EF5275841AABC502E9BC101331C", "#text": "\n                        "}], "#text": "\n                      ", "@id": "idC27D838102D545148AA12428BFCDDE59"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "based on\n\t\t\t\tappropriate medical judgment, may jeopardize the patient and may require a\n\t\t\t\tmedical or surgical intervention to prevent an outcome described in subclause\n\t\t\t\t(I)."}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "id9A4C9B9A971046D0B70BE7F59BF3E854", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Serious adverse\n\t\t\t\tevent"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means an\n\t\t\t\tadverse event that\u2014", "#text": "serious adverse event"}, "#text": "The term "}, "#text": "\n                    ", "@id": "id709065EB47584C41AE8C186A1A0B2E1F"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Definitions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis paragraph:"}, "#text": "\n                  ", "@id": "idB9E1BC71ACC04D8BB89AC89AF587F7A2"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "If a compounding manufacturer becomes aware of any serious\n\t\t\t\tadverse event, such manufacturer shall submit reports of each instance to the\n\t\t\t\tSecretary as soon as practicable, but in no case later than 15 calendar days\n\t\t\t\tafter the initial receipt of the applicable information. Such manufacturer\n\t\t\t\tshall investigate and submit to the Secretary followup reports for each such\n\t\t\t\tinstance not later than 15 calendar days after receipt of new information or as\n\t\t\t\trequested by the Secretary. Unless and until the Secretary establishes the\n\t\t\t\tcontent and format of adverse event reports by guidance or regulation, reports\n\t\t\t\tshall be submitted in accordance with the content and format requirements under\n\t\t\t\t", "external-xref": [{"#tail": " of title 21, Code of Federal Regulations (or any successor\n\t\t\t\tregulations) (in the case of human drugs), ", "@parsable-cite": "cfr/21/310.305", "#text": "section 310.305", "@legal-doc": "regulation"}, {"#tail": " of title 21, Code of\n\t\t\t\tFederal Regulations (or any successor regulations) (in the case of biological\n\t\t\t\tproducts), or ", "@parsable-cite": "usc/21/600", "#text": "section 600.80", "@legal-doc": "usc"}, {"#tail": " of title 21, Code of Federal Regulations (or any\n\t\t\t\tsuccessor regulations) (in the case of animal drugs).", "@parsable-cite": "cfr/21/514.80", "#text": "section 514.80", "@legal-doc": "regulation"}]}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "header": {"#tail": "\n                      ", "#text": "15-day\n\t\t\t\treport"}, "#text": "\n                      ", "@id": "idA887D231F05345EC90B0D51406572265"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Compounding manufacturers that report serious adverse\n\t\t\t\tevents shall submit in December of each year a narrative summary of any\n\t\t\t\tanalysis of each report submitted under subclause (I), including a history of\n\t\t\t\tactions taken during the year because of each report, using the content,\n\t\t\t\tformat, and manner established by the Secretary by guidance or regulation.\n\t\t\t\tUntil such time as the Secretary publishes such guidance or regulation, each\n\t\t\t\tcompounding manufacturer shall retain such summaries as part of the records to\n\t\t\t\tbe maintained in accordance with subparagraph (C)."}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "header": {"#tail": "\n                      ", "#text": "Annual\n\t\t\t\treport"}, "#text": "\n                      ", "@id": "id9B633185565A4948A6368D616B7887C3"}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Adverse event\n\t\t\t\treporting requirement"}, "#text": "\n                    ", "@id": "id67869B18A5034A44A677FC89C2B0C6CF"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Not later than 3 calendar days after the\n\t\t\t\tcompounding manufacturer becomes aware of information pertaining to sterility,\n\t\t\t\tstability, or other product quality concerns that could result in serious\n\t\t\t\tadverse events, the compounding manufacturer shall submit to the Secretary a\n\t\t\t\tproduct quality report, in a form and manner established by the Secretary by\n\t\t\t\tguidance or regulation."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Product quality\n\t\t\t\treporting requirement"}, "#text": "\n                    ", "@id": "id6D321165B54A4077BDFA7E5A6604A8C6", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Reports"}, "#text": "\n                  ", "@id": "id0C33697C3DA74047B5F12E0E1AA3FC13"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A compounding manufacturer shall maintain for a period of\n\t\t\t\t10 years records of all serious adverse drug events known to the compound\n\t\t\t\tmanufacturer in accordance with ", "external-xref": {"#tail": " of title 21, Code of Federal\n\t\t\t\tRegulations (or any successor regulation), or as otherwise directed by the\n\t\t\t\tSecretary in regulations.", "@parsable-cite": "usc/21/314", "#text": "section 314.80(i)", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Maintenance of\n\t\t\t\trecords"}, "#text": "\n                  ", "@id": "id44536B0037694181B0485E6C23AB0067"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Adverse event\n\t\t\t\treporting"}, "#text": "\n                ", "@id": "id9537AC2124CD44C99DE9A3E16EF9CD9B"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "quote": {"#tail": " or a reasonable comparable\n\t\t\t\talternative statement (as specified by the Secretary) that identifies the drug\n\t\t\t\tas a compounded drug;", "#text": "This is a compounded drug."}, "#text": "the statement\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idF9E7F797F950465EB7274D7887D5F8E3", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the name,\n\t\t\t\taddress, and phone number of the applicable compounding manufacturer;\n\t\t\t\tand"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idEB7899A57B684FA79D17102976B10755", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "with respect to\n\t\t\t\tthe compounded drug\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the lot or batch\n\t\t\t\tnumber;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "id62F76063D1DC4B87B46BD6271B486168", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the established\n\t\t\t\tname of the medication;"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "idC016A9A56CF541FCAADB648774474679", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the dosage form\n\t\t\t\tand strength;"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "idD549A01C9C7D4090B1928597960B4E53", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the statement of\n\t\t\t\tquantity or volume, as appropriate;"}, "enum": {"#tail": "\n                      ", "#text": "(IV)"}, "@id": "id35006F734B9A4EFE993F5315480589B6", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\tdrug intended for use in a food-producing animal, the withdrawal period\n\t\t\t\testablished pursuant to subsection (e)(5) to ensure that no residues from the\n\t\t\t\tcompounded drug can be detected in edible tissues of the treated animal;"}, "enum": {"#tail": "\n                      ", "#text": "(V)"}, "#text": "\n                      ", "@id": "idF155FE2DFFC943C8A890E6AECF0A334C", "@commented": "no"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the date that the\n\t\t\t\tdrug was compounded;"}, "enum": {"#tail": "\n                      ", "#text": "(VI)"}, "@id": "id9A4E22B47FF24DA58509C5A3AC0C3043", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the expiration\n\t\t\t\tdate;"}, "enum": {"#tail": "\n                      ", "#text": "(VII)"}, "@id": "idBA6A6BA1F5224E48BA527F9C9FA10EB3", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "storage and\n\t\t\t\thandling instructions;"}, "enum": {"#tail": "\n                      ", "#text": "(VIII)"}, "@id": "id00ED99928063475198FD493712A63AD0", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the National Drug\n\t\t\t\tCode number, if available;"}, "enum": {"#tail": "\n                      ", "#text": "(IX)"}, "@id": "id89912486FA3E4795AC229EC8799C8346", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "quote": {"#tail": " statement required as required by subsection (f)(1)(C);\n\t\t\t\tand", "#text": "not\n\t\t\t\tfor resale"}, "#text": "the "}, "enum": {"#tail": "\n                      ", "#text": "(X)"}, "@id": "id16D3AEFC29F849E9910F7BFC4F8F6706", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "subject to\n\t\t\t\tsubparagraph (B)(i), a list of active and inactive ingredients, identified by\n\t\t\t\testablished name and the quantity or proportion of each ingredient."}, "enum": {"#tail": "\n                      ", "#text": "(XI)"}, "@id": "id4A5481B063E242438C52367809D2F800", "#text": "\n                      "}], "#text": "\n                    ", "@id": "idDA79C079705C49D680CB5D5A73939C49"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Label"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tlabel of a drug compounded by a compounding manufacturer shall include\u2014"}, "#text": "\n                  ", "@id": "id4160257BA70E4DB09C183EB7536E8BD5"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the information\n\t\t\t\tdescribed under subparagraph (A)(iii)(XI), if there is not space on the label\n\t\t\t\tfor such information;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id1D3436D0D1964BAEBD418037FA980897", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the following\n\t\t\t\tinformation to facilitate adverse event reporting: www.fda.gov/medwatch and\n\t\t\t\t1\u2013800\u2013FDA\u20131088; and"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idF2AD1B75764C47BA8843EF9FF7C35F09", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the directions\n\t\t\t\tfor use, including dosage and administration, as appropriate."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id402E5EEB89C74CD9BE1FD41ACA0510BD", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Container"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tcontainer from which the individual units of a drug compounded by a compounding\n\t\t\t\tmanufacturer are removed for dispensing or for administration (such as a\n\t\t\t\tplastic bag containing individual product syringes) shall include\u2014"}, "#text": "\n                  ", "@id": "idBF9D24476221410DB739170EA4A20223"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The label and labeling of a drug compounded by a\n\t\t\t\tcompounding manufacturer shall include any other information as determined\n\t\t\t\tnecessary and specified in regulations promulgated by the Secretary."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Additional\n\t\t\t\tinformation"}, "#text": "\n                  ", "@id": "id2E2F356AB737472DADCF85AC0772A43B"}], "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Labeling of\n\t\t\t\tdrugs"}, "#text": "\n                ", "@id": "id0AA77FC0E39444BAB5F72E640E31C6A5"}], "#text": "\n              ", "@id": "idA1CF6C69CC38432C8CE3FB744EF3A80B"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(h)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Compounding\n\t\t\t\tmanufacturer establishment and reinspection fees"}, "paragraph": [{"#tail": "\n              ", "@id": "idFBE027F0B55B435B8358609AD0D8B6F1", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Definitions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis subsection\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " has the meaning given such term in section\n\t\t\t\t735(11);", "#text": "affiliate"}, "#text": "the term\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id0E812543AC0C4B628D41944F106355F2", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means the total worldwide gross annual sales,\n\t\t\t\tin United States dollars, for a compounding manufacturer, including the sales\n\t\t\t\tof all the affiliates of the compounding manufacturer; and", "#text": "gross annual sales"}, "#text": "the term\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id05593E120B514D3EAB554172E2A92A80", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means, with respect to a compounding manufacturer,\n\t\t\t\tone or more inspections conducted under section 704 subsequent to an inspection\n\t\t\t\tconducted under such provision which identified noncompliance materially\n\t\t\t\trelated to an applicable requirement of this Act, specifically to determine\n\t\t\t\twhether compliance has been achieved to the Secretary's satisfaction.", "#text": "reinspection"}, "#text": "the term\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id1BBD8AD567AE484A8660B9D434340031", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "id0AC78BF864B945B4B9A7296026CE7BF1", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Establishment\n\t\t\t\tand reinspection fees"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "For fiscal year 2015 and each subsequent\n\t\t\t\tfiscal year, the Secretary shall, in accordance with this subsection, assess\n\t\t\t\tand collect\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "an annual\n\t\t\t\testablishment fee from each compounding manufacturer to cover\n\t\t\t\tinspection-related costs relating to inspections of drug compounders for such\n\t\t\t\tyear; and"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idD0B43E623D4F4E5DA9978793DFCB5966", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "a reinspection fee\n\t\t\t\tfrom each compounding manufacturer subject to a reinspection in such fiscal\n\t\t\t\tyear."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id9EDA004698854CF885E6476F8590800E", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The Secretary shall establish the\n\t\t\t\testablishment and reinspection fee to be collected under this subsection for\n\t\t\t\teach fiscal year, based on the methodology described in paragraph (4) and shall\n\t\t\t\tpublish such fee in a Federal Register notice not later than 60 days before the\n\t\t\t\tstart of each such year."}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Establishment\n\t\t\t\tand reinspection fee setting"}, "#text": "\n                ", "@id": "id6719D59CBC3643459A8CDBCA43374558"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "$15,000 per compounding\n\t\t\t\tmanufacturer, multiplied by"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                      ", "@id": "id1C21232DACE6477BBC689ECFEB746A81", "@commented": "no"}, {"@committee-id": "SSHR00", "@changed": "deleted", "@indent": "up1", "#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the inflation adjustment factor\n\t\t\t\tdescribed in subparagraph (B); plus"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@reported-display-style": "strikethrough", "#text": "\n                      ", "@id": "id5DABEF08D4EF48C0A72803614A4D5FF3"}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idD20AB76C5BC04657BE997C28041CF09F", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the small\n\t\t\t\tbusiness adjustment factor described in subparagraph (C)."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id188D198538E946DFA112125CA3D09F50", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Except as provided in subparagraph (D), the amount of the\n\t\t\t\tannual establishment fee and the reinspection fee (if applicable) under\n\t\t\t\tparagraph (2) for each compounding manufacturer in a fiscal year shall be equal\n\t\t\t\tto the sum of\u2014"}, "#text": "\n                  ", "@id": "idC23EA184F02D4C9EA1EE4FCBAF700759"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "one;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "ID86599264058A44F785C46FEAB22F3EFA", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the average\n\t\t\t\tannual percent change in the cost, per full-time equivalent position of the\n\t\t\t\tFood and Drug Administration, of all personnel compensation and benefits paid\n\t\t\t\twith respect to such positions for the first 3 years of the preceding 4 fiscal\n\t\t\t\tyears, multiplied by the proportion of personnel compensation and benefits\n\t\t\t\tcosts to total costs of an average full-time equivalent position of the Food\n\t\t\t\tand Drug Administration for the first 3 years of the preceding 4 fiscal years,\n\t\t\t\tand"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "ID71524C26EF4E4DAFB92C29E93D94BDC6", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the average\n\t\t\t\tannual percent change that occurred in the Consumer Price Index for urban\n\t\t\t\tconsumers (U.S. City Average; Not Seasonally Adjusted; All items; Annual Index)\n\t\t\t\tfor the first 3 years of the preceding 4 years of available data multiplied by\n\t\t\t\tthe proportion of all costs other than personnel compensation and benefits\n\t\t\t\tcosts to total costs of an average full-time equivalent position of the Food\n\t\t\t\tand Drug Administration for the first 3 years of the preceding 4 fiscal\n\t\t\t\tyears."}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "IDA60B05E9F00446FCA95561C70192E769", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "For fiscal year 2015 and subsequent fiscal years, the\n\t\t\t\trevenues established in subparagraph (A) shall be adjusted by the Secretary by\n\t\t\t\tnotice, published in the Federal Register, for a fiscal year by the amount\n\t\t\t\tequal to the sum of\u2014"}, "#text": "\n                    ", "@id": "ID6E333A3737EA4C18B5D81B506A2CD4E5"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The adjustment made each fiscal year under clause (i) shall\n\t\t\t\tbe added on a compounded basis to the sum of all adjustments made each fiscal\n\t\t\t\tyear after fiscal year 2014 under clause (i)."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Compounded\n\t\t\t\tbasis"}, "#text": "\n                    ", "@id": "ID8C4991E0CD3042B693EB4CACB0D9E9B6"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Inflation\n\t\t\t\tadjustment factor"}, "#text": "\n                  ", "@id": "idDE58CF307A464477992F58B17836C296"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the number of\n\t\t\t\tsmall businesses that will pay a reduced establishment fee for such fiscal\n\t\t\t\tyear; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idf96d564b5bc14f51b89b2c6a6b5be5af", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the adjustment to\n\t\t\t\tthe establishment fee necessary to achieve total fees equaling the total fees\n\t\t\t\tthat the Secretary would have collected if no entity qualified for the small\n\t\t\t\tbusiness exception in subparagraph (D)."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id32d67b5fe01f44bc8b28926f847eead9", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Small business\n\t\t\t\tadjustment factor"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The small business adjustment factor described\n\t\t\t\tin subparagraph (A)(ii) shall be an amount established by the Secretary for\n\t\t\t\teach fiscal year based on the Secretary\u2019s estimate of\u2014"}, "#text": "\n                  ", "@id": "id8D2CB783774947D7A168BAB953D107C0"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "In the case of a compounding manufacturer with gross\n\t\t\t\tannual sales of $1,000,000 or less in the 12 months ending June 1 of the fiscal\n\t\t\t\tyear immediately preceding the fiscal year in which the fees under this\n\t\t\t\tsubsection are assessed, the amount of the establishment fee and reinspection\n\t\t\t\tfee under paragraph (2) for a fiscal year shall be equal to\n\t\t\t\t", "fraction": {"#tail": " of the amount calculated under subparagraph (A)(i) in\n\t\t\t\tsuch fiscal year.", "#text": "1/3"}}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "id5BF05A8C2F5B43A4A7F08623C2952E5D"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tSecretary may require a small business to apply for the exception under this\n\t\t\t\tsubparagraph by certifying its gross annual sales for the 12 months ending June\n\t\t\t\t1 of the fiscal year immediately preceding the fiscal year in which fees under\n\t\t\t\tthis subsection are assessed. Any such application must be submitted to the\n\t\t\t\tSecretary prior to August 1 for the following fiscal year. Any statement or\n\t\t\t\trepresentation made to the Secretary shall be subject to section 1001 of title\n\t\t\t\t18, United States Code."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Application"}, "#text": "\n                    ", "@id": "idABD9ACED9D2E443C9D9082AFCD35903D"}], "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Exception for\n\t\t\t\tsmall businesses"}, "#text": "\n                  ", "@id": "id29BAF1FF035D4E6688AEF1AEE562F685"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "In establishing the small business adjustment factor under\n\t\t\t\tsubparagraph (C) for a fiscal year, the Secretary shall provide for the\n\t\t\t\tcrediting of fees from the previous year to the next year if the Secretary\n\t\t\t\toverestimated the amount of the small business adjustment factor for such\n\t\t\t\tprevious fiscal year, and consider the need to account for any adjustment of\n\t\t\t\tfees and such other factors as the Secretary determines appropriate."}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Crediting of\n\t\t\t\tfees"}, "#text": "\n                  ", "@id": "id802D70D4249C48E6BA41B241D9774888"}], "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Amount of\n\t\t\t\testablishment and reinspection fee"}, "#text": "\n                ", "@id": "id1054C35293E94A20A55797AD35A5B63E"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The Secretary shall make all of the fees collected pursuant\n\t\t\t\tto subparagraph (A) and (B) of paragraph (2) available solely to pay for the\n\t\t\t\tinspection-related costs (including re-inspection) for the oversight of drug\n\t\t\t\tcompounding."}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Use of\n\t\t\t\tfees"}, "#text": "\n                ", "@id": "id00B30E856F5F4EDCA8C17944D67BB9A5"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Funds received by the Secretary pursuant to this\n\t\t\t\tsubsection shall be used to supplement and not supplant any other Federal funds\n\t\t\t\tavailable to carry out the activities described in this subsection."}, "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n                ", "#text": "Supplement not\n\t\t\t\tsupplant"}, "#text": "\n                ", "@id": "ide5364325e8034b1a86c67e90f8af77e6"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Fees authorized under this subsection shall\n\t\t\t\tbe collected and available for obligation only to the extent and in the amount\n\t\t\t\tprovided in advance in appropriations Acts. Such fees are authorized to remain\n\t\t\t\tavailable until expended. Such sums as may be necessary may be transferred from\n\t\t\t\tthe Food and Drug Administration salaries and expenses appropriation account\n\t\t\t\twithout fiscal year limitation to such appropriation account for salaries and\n\t\t\t\texpenses with such fiscal year limitation. The sums transferred shall be\n\t\t\t\tavailable solely for the purpose of paying the inspection-related costs\n\t\t\t\t(including reinspection) for the oversight of drug compounding."}, "enum": {"#tail": "\n                ", "#text": "(7)"}, "header": {"#tail": "\n                ", "#text": "Crediting and\n\t\t\t\tavailability of fees"}, "#text": "\n                ", "@id": "ID7A6A9D0587AC4CBE986A2BE6AC3FFE74"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A compounding manufacturer shall remit the establishment fee\n\t\t\t\tdue under this subsection in a fiscal year when submitting a registration\n\t\t\t\tpursuant to subsection (g) for such fiscal year."}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Establishment\n\t\t\t\tfee"}, "#text": "\n                  ", "@id": "idE1E8407602FD43A3BDB112066558EF95"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The Secretary shall specify in the Federal Register notice\n\t\t\t\tdescribed in paragraph (3) the manner in which reinspection fees assessed under\n\t\t\t\tthis subsection shall be collected and the timeline for payment of such fees.\n\t\t\t\tSuch a fee shall be collected after the Secretary has conducted a reinspection\n\t\t\t\tof the compounding manufacturer involved."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Reinspection\n\t\t\t\tfee"}, "#text": "\n                  ", "@id": "ID5C0310B27F7E4602A1DD22A717221E39"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\tcompounding manufacturer shall not be considered registered under subsection\n\t\t\t\t(g) in a fiscal year until the date that the compounding manufacturer remits\n\t\t\t\tthe establishment fee under this subsection for such fiscal year."}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Registration"}, "#text": "\n                    ", "@id": "id4721DF18986A44648676921A6864255A"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "All\n\t\t\t\tdrugs compounded by a compounding manufacturer for which any establishment fee\n\t\t\t\tor reinspection fee has not been paid as required by this subsection shall be\n\t\t\t\tdeemed misbranded under section 502(cc) until the fees owed for such\n\t\t\t\tcompounding manufacturer under this subsection have been paid."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Misbranding"}, "#text": "\n                    ", "@id": "id0EAB03EFFE334F0FB4CEAA0DAA05F667"}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Effect of\n\t\t\t\tfailure to pay fees"}, "#text": "\n                  ", "@id": "idCA36C67CD9A94D7593B21209A1F1199B"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "In any case where the Secretary does not receive\n\t\t\t\tpayment of a fee assessed under this subsection within 30 days after it is due,\n\t\t\t\tsuch fee shall be treated as a claim of the United States Government subject to\n\t\t\t\tprovisions of subchapter II of ", "external-xref": {"#tail": " of title 31, United States\n\t\t\t\tCode.", "@parsable-cite": "usc-chapter/31/37", "#text": "chapter 37", "@legal-doc": "usc-chapter"}}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Collection of\n\t\t\t\tunpaid fees"}, "#text": "\n                  ", "@id": "IDD835A99A591A4272B9C3554ED59B5A64"}], "enum": {"#tail": "\n                ", "#text": "(8)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Collection of\n\t\t\t\tfees"}, "#text": "\n                ", "@id": "ID84BCEC0EE2534EC0AAFFF080FC3C8F77"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Not later than 120 days after each fiscal year in\n\t\t\t\twhich fees are assessed and collected under this subsection, the Secretary\n\t\t\t\tshall submit a report to the Committee on Health, Education, Labor, and\n\t\t\t\tPensions of the Senate and the Committee on Energy and Commerce of the House of\n\t\t\t\tRepresentatives, to include a description of fees assessed and collected for\n\t\t\t\teach year, a summary description of entities paying the fees, and the number of\n\t\t\t\tinspections and reinspections of such entities performed each year."}, "enum": {"#tail": "\n                ", "#text": "(9)"}, "header": {"#tail": "\n                ", "#text": "Annual report to\n\t\t\t\tcongress"}, "#text": "\n                ", "@id": "ID0A6668F2D1AC43238BF35D57E3032C90", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "For fiscal year 2015 and each subsequent fiscal\n\t\t\t\tyear, there is authorized to be appropriated for fees under this subsection an\n\t\t\t\tamount equivalent to the total amount of fees assessed for such fiscal year\n\t\t\t\tunder this subsection."}, "enum": {"#tail": "\n                ", "#text": "(10)"}, "header": {"#tail": "\n                ", "#text": "Authorization\n\t\t\t\tof appropriations"}, "#text": "\n                ", "@id": "ID00940E566BAF4BCAA03683F6C010BBF9"}], "#text": "\n              ", "@id": "idD8FB9353725F4B0CAF2CD7C4B706210C"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Action by\n\t\t\t\tSecretary regarding complaints from State boards of pharmacy"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tSecretary shall designate a point of contact and establish a format and\n\t\t\t\tprocedure for a State Board of Pharmacy to notify the Secretary if it appears\n\t\t\t\tto a State Board of Pharmacy that an entity licensed by a State as a pharmacy\n\t\t\t\tis required to be registered with the Secretary as a compounding\n\t\t\t\tmanufacturer."}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Designation"}, "#text": "\n                ", "@id": "id8d3d69653815448f9c07e50fe468179f"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "If\n\t\t\t\tthe Secretary determines that such an entity described in paragraph (1) is\n\t\t\t\trequired to be registered with the Secretary as a compounding manufacturer, the\n\t\t\t\tSecretary shall transmit such determination to the State Board of Pharmacy in\n\t\t\t\tthe State in which the entity is located, and to the State Board of Pharmacy in\n\t\t\t\tthe notifying State, if different, within 15 days of such determination."}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Determination"}, "#text": "\n                ", "@id": "ide7fc305dcedd4b96ab0f8908ab885d23"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tSecretary shall encourage direct communications between States regarding\n\t\t\t\ttraditional compounders. Nothing in this subsection shall expand the\n\t\t\t\tSecretary\u2019s authority over or responsibility for traditional\n\t\t\t\tcompounding."}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Effect"}, "#text": "\n                ", "@id": "idd1e3de8f0c724857988f1c04046e2b6d"}], "#text": "\n              ", "@id": "id0fd8d114d3264442917d796b95fe9936", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "For purposes of this section, reference to a\n\t\t\t\tprescription order for an identified individual patient includes, in the case\n\t\t\t\tof animal drugs, a prescription order for a specific herd or flock (or other\n\t\t\t\tidentified group) of\n\t\t\t\tanimals."}, "enum": {"#tail": "\n              ", "#text": "(j)"}, "header": {"#tail": "\n              ", "#text": "Prescription\n\t\t\t\torder reference"}, "#text": "\n              ", "@id": "idBC94F52C9BC041CD9D70142EA0CBB338"}], "#text": "\n            ", "@id": "idE07EB9835DF84C7DAFCF5DC95A117686"}, "@reported-display-style": "strikethrough", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "idB47FC16A0245444EA736D7F23B24F1D1"}, "#text": "\n        ", "@id": "idA9E0FBDB0FBB4DF4A49C2AF54628A533"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "Section 301 (", "external-xref": {"#tail": ") is amended\u2014", "@parsable-cite": "usc/21/331", "#text": "21 U.S.C. 331", "@legal-doc": "usc"}}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Prohibited\n\t\t\t act"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "417, 416, 504"}, {"#tail": "; and", "#text": "417, 416,\n\t\t\t 503A(g), 504"}], "#text": "in subsection (e),\n\t\t\t by striking "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "id7A14832EB8C1435489E8DD9F70C2E396", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "by adding at the\n\t\t\t end the following:"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "deleted", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "@reported-display-style": "strikethrough", "subsection": {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "quote": {"#tail": " as required by\n\t\t\t\tsection\n\t\t\t\t503A.", "#text": "not for resale"}, "#text": "The resale of a\n\t\t\t\tcompounded drug that is labeled "}, "enum": {"#tail": "\n              ", "#text": "(ccc)"}, "@id": "id05F3DE114692403E955BC88352C2CA87", "#text": "\n              "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "idBAF5A9A10D1742DB9F1C8AFCBB8A1D23"}, "#text": "\n          ", "@id": "id4F611AF35DB04390893F9E21D418EF10"}], "#text": "\n        ", "@id": "idB3D5A38BF4604BD2910BDDC6E0ADEA18"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "Not later than November 1, 2016, the Comptroller General of\n\t\t\t the United States shall conduct study and submit to Congress a report regarding\n\t\t\t the impact of this Act (and the amendments made by this Act) on the safety of\n\t\t\t animal drug compounding and the availability of safe and effective drugs for\n\t\t\t animals."}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Report by\n\t\t\t GAO"}, "#text": "\n        ", "@id": "idF2B2954B49D24184A34078B8D8D700C7"}], "@reported-display-style": "strikethrough", "#text": "\n      ", "@id": "id7E19EFA14F4B4868A468C60F026D1740"}, {"@committee-id": "SSHR00", "@changed": "deleted", "#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Other\n\t\t\t requirements relating to compounding manufacturers"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "Section 502 (", "external-xref": {"#tail": ") is amended by\n\t\t\t adding at the end the following:", "@parsable-cite": "usc/21/352", "#text": "21 U.S.C. 352", "@legal-doc": "usc"}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Labeling"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "deleted", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "@reported-display-style": "strikethrough", "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "If it is a\n\t\t\t\tcompounded drug and the labeling does not include the information as required\n\t\t\t\tby subsections (f)(1)(C) and (g)(4) of section 503A, as applicable."}, "enum": {"#tail": "\n            ", "#text": "(bb)"}, "@id": "idF96D8B759C15433EB5C85A511CC5F631", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "If it is a drug,\n\t\t\t\tand it was compounded by a compounding manufacturer for which fees have not\n\t\t\t\tbeen paid as required by section\n\t\t\t\t503A(g)."}, "enum": {"#tail": "\n            ", "#text": "(cc)"}, "@id": "id15EF37DE857C4A019473B0B540DF25A6", "#text": "\n            "}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id763EF671E5794D229D0C570CB18BF934"}, "#text": "\n        ", "@id": "id66EB604B5AD848C0B9CF6B6B22E2CE9E"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "Section\n\t\t\t 704(a)(2) (", "external-xref": {"#tail": ") is amended by adding at the end the following\n\t\t\t flush text:", "@parsable-cite": "usc/21/374", "#text": "21 U.S.C. 374(a)(2)", "@legal-doc": "usc"}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Application of\n\t\t\t inspection requirements to compounding manufacturers"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "deleted", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "@reported-display-style": "strikethrough", "quoted-block-continuation-text": {"@committee-id": "SSHR00", "@changed": "deleted", "#tail": "\n          ", "@reported-display-style": "strikethrough", "#text": "The exemption in subparagraph (A)\n\t\t\t\tdoes not apply with respect to compounding manufacturers (as such term is\n\t\t\t\tdefined in section\n\t\t\t\t503A).", "@quoted-block-continuation-text-level": "subsection"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "idD905BE9E04294D2FAF4510F9751D906A"}, "#text": "\n        ", "@id": "id8A1FF9E1E4354A3196B3516BC7A5431A"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "quote": [{"#tail": " and inserting\n\t\t\t ", "#text": "\n            512;"}, {"#tail": ".", "#text": "\n            512; or (iii) any residue from a compounded animal drug;"}], "#text": "\n          Section\n\t\t\t 402(a)(2)(C) is amended by striking "}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Adulteration of\n\t\t\t compounded animal drugs containing drug residues"}, "#text": "\n        ", "@id": "id6C4CD85E10E040ACB3F6EADBDEC5670B"}], "@reported-display-style": "strikethrough", "#text": "\n      ", "@id": "id7198612A26904983A02CEDBD7F6F812C"}, {"@committee-id": "SSHR00", "@changed": "deleted", "#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "In promulgating any regulations to implement\n\t\t\t this Act (and the amendments made by this Act), the Secretary of Health and\n\t\t\t Human Services shall\u2014", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Implementation"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "issue a notice of\n\t\t\t proposed rulemaking that includes the proposed regulation;"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "idfaa21d2a856d46b7b3b3c81f9530e1cd", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "provide a period\n\t\t\t of not less than 60 days for comments on the proposed regulation; and"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "idb08c95274883468194c989ad5d9cbe72", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "publish the final\n\t\t\t regulation not more than 18 months following publication of the proposed rule\n\t\t\t and not less than 30 days before the effective date of such final\n\t\t\t regulation."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "idaecff12bfa6548d79f9f852978b98d21", "@commented": "no"}], "@reported-display-style": "strikethrough", "#text": "\n      ", "@id": "id310111ED2A9245A3BED7174E7D1C2811"}, {"@committee-id": "SSHR00", "enum": {"#tail": "\n      ", "#text": "5."}, "@changed": "deleted", "#tail": "\n  ", "text": {"#tail": "\n\t\t", "#text": "This Act (and the\n\t\t\t amendments made by this Act) shall take effect on the date that is 1 year after\n\t\t\t the date of enactment of this Act.", "@display-inline": "no-display-inline"}, "@display-inline": "no-display-inline", "header": {"#tail": "\n      ", "#text": "Effective\n\t\t\t date"}, "@reported-display-style": "strikethrough", "#text": "\n      ", "@id": "idA41E64A175CA4A088F1F8B1EFFE7F414", "@commented": "no"}], "#text": "\n\t\t"}, {"#tail": "\n  ", "section": [{"@committee-id": "SSHR00", "@changed": "added", "@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "act", "#text": "Pharmaceutical Quality, Security, and Accountability Act", "@value": "Pharmaceutical Quality, Security, and Accountability Act", "@proposed": "true"}, "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "@reported-display-style": "italic", "#text": "\n      ", "@id": "idfd343c50-6731-42ce-8353-f90f70b87aae"}, {"@committee-id": "SSHR00", "@changed": "added", "#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "References in Act; table\n\t\t\t of contents"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Except as otherwise specified, amendments made by this Act to\n\t\t\t a section or other provision of law are amendments to such section or other\n\t\t\t provision of the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 301 et\n\t\t\t seq.", "@value": "usc/21/301/etseq"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "References in\n\t\t\t Act"}, "#text": "\n        ", "@id": "ide801a56b-b7a2-4675-bfc0-a19cb9942497"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "The table of contents of this Act is as follows:"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Table of\n\t\t\t contents"}, "toc": {"@committee-id": "SSHR00", "@changed": "added", "#tail": "\n\t\t\t", "toc-entry": [{"@idref": "S1", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 1. Short\n\t\t\t\ttitle.", "@level": "section"}, {"@idref": "id03DB57E1CB21492D8E239D090FC9D3F3", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 2. References in Act; table of\n\t\t\t\tcontents.", "@level": "section"}, {"@idref": "idEB894060157D477FA065F99E8E3BF89C", "#tail": "\n\t\t\t\t\t", "#text": "TITLE I\u2014Human drug\n\t\t\t\tcompounding", "@level": "title"}, {"@idref": "idADC92DCF496143B5A177CE0EC4852745", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 101. Short title.", "@level": "section"}, {"@idref": "idd84bc06e0d654f88a98b823dcd2bddd9", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 102. Regulation of human drug\n\t\t\t\tcompounding.", "@level": "section"}, {"@idref": "idad2964bbb9084e169acf987e8c5c6734", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 103. Other requirements.", "@level": "section"}, {"@idref": "ide6ee348803ae4fb8bc4c5a7c5e75897d", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 104. Implementation.", "@level": "section"}, {"@idref": "id8e3448708e0a42a8a3391b881e33f907", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 105. Effective date.", "@level": "section"}, {"@idref": "idA6D5B3EFFDD347388F74014AC6650496", "#tail": "\n\t\t\t\t\t", "#text": "TITLE II\u2014Drug Supply Chain\n\t\t\t\tSecurity", "@level": "title"}, {"@idref": "id564FD637D4154F21AC4047FDB1025B55", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 201. Short title.", "@level": "section"}, {"@idref": "id152ccba45d2d4c529aa71d3141e42f5d", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 202. Pharmaceutical distribution supply\n\t\t\t\tchain.", "@level": "section"}, {"@idref": "id78139f99bfa44fd6bfe76849e3b3d206", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 203. Enhanced drug distribution\n\t\t\t\tsecurity.", "@level": "section"}, {"@idref": "id789f8b5aea394bc2b27455cbec46e78f", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 204. National licensure standards for\n\t\t\t\tprescription drug wholesale distributors.", "@level": "section"}, {"@idref": "idd67351dddf004eff9e0b4ae9d0e45e95", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 205. National licensure standards for\n\t\t\t\tthird-party logistics providers; uniform national policy.", "@level": "section"}, {"@idref": "idbc50988f765742969ebc9251bee48e0c", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 206. Penalties.", "@level": "section"}, {"@idref": "id919BAF362748462F8C1AB792EDD7E534", "#tail": "\n\t\t\t\t\t", "#text": "Sec. 207. Conforming amendment.", "@level": "section"}, {"@idref": "id5374815F273F423C980ED14B747BC243", "#tail": "\n\t\t\t\t", "#text": "Sec. 208. Savings clause.", "@level": "section"}], "@reported-display-style": "italic", "#text": "\n\t\t\t\t\t"}, "#text": "\n        ", "@id": "idF1F015C5DDD6418D87FD482CD1CBF5D8"}], "@reported-display-style": "italic", "#text": "\n      ", "@id": "id03DB57E1CB21492D8E239D090FC9D3F3"}], "#text": "\n\t\t", "@display-enacting-clause": "no-display-enacting-clause", "title": [{"@committee-id": "SSHR00", "@changed": "added", "#tail": "\n    ", "section": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": {"short-title": {"#tail": "\n          ", "#text": "Pharmaceutical Compounding\n\t\t\t Quality and Accountability Act"}, "#tail": ".", "#text": "\n            "}, "#text": "This title may be cited\n\t\t\t as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "101."}, "header": {"#tail": "\n        ", "#text": "Short\n\t\t\t title"}, "#text": "\n        ", "@id": "idADC92DCF496143B5A177CE0EC4852745"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "102."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Regulation of human\n\t\t\t drug compounding"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ") shall include a compounded human drug.", "@entity-type": "act", "#text": "section 201(p) of such Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:201/ss:p"}, "term": {"#tail": " (as defined in\n\t\t\t ", "#text": "new drug"}, "#text": "For purposes of the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", the term ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Federal Food, Drug and Cosmetic\n\t\t\t Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 301 et seq.", "@value": "usc/21/301/etseq"}, "@parsable-cite": "usc/21/301", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Clarification of new\n\t\t\t drug status"}, "#text": "\n          ", "@id": "id6d80bc9ae8e84881b154d68c9e0adf46"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read\n\t\t\t as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 353a", "@value": "usc/21/353a"}, "@parsable-cite": "usc/21/353a", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Regulation of human\n\t\t\t drug compounding"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "section": {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "503A."}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Human drug\n\t\t\t\tcompounding"}, "subsection": [{"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Scope"}, "paragraph": [{"#tail": "\n                ", "@id": "id248f81f546c94aa6936a37ea86995f9f", "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "Compounding"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "quote": [{"#tail": " and\n\t\t\t\t", "#text": "compounding"}, {"#tail": "\u2014", "#text": "compound"}], "#text": "In\n\t\t\t\tthis section, the terms "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "include\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the combining, admixing,\n\t\t\t\tmixing, diluting, reconstituting, or otherwise altering of a marketed\n\t\t\t\tdrug;"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "id6b8875ed4c5a4802a85401f51647c8de", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "compounding a drug from\n\t\t\t\ta bulk drug substance; and"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id4a1dd7e14480419eb88e680e6c3370a4", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "repackaging; and"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "idede6bff275ca406f8a3bb88ef8aa2b47", "#text": "\n                      "}], "#text": "\n                    ", "@id": "ida6876edb4a9b4ba79e834a12e6962371"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "exclude mixing,\n\t\t\t\treconstituting, or other such acts with respect to a marketed drug that are\n\t\t\t\tlimited to and performed in accordance with specific directions for such acts\n\t\t\t\tcontained in approved labeling provided by a drug\u2019s manufacturer, when\n\t\t\t\tperformed based upon a prescription order for an identified individual\n\t\t\t\tpatient."}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "idc9113f54c0c04dbaad7cf5fb78e8c936", "#text": "\n                    "}]}, {"#tail": "\n                ", "@id": "id1d127b4c86f8499f909ec93cde281dd0", "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Administration and\n\t\t\t\tdispensing not a sale"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": [{"#tail": " or ", "#text": "sell"}, {"#tail": " do not include\u2014", "#text": "resale"}], "#text": "In this section, the terms\n\t\t\t\t"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "circumstances in which\n\t\t\t\tdrug is administered to a patient or provided to a patient who has been\n\t\t\t\tinstructed to self-administer the drug;"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "id7E1F1259559A457D90F6654E508BB9A5", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";\n\t\t\t\tor", "@entity-type": "act", "#text": "section 503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "#text": "the dispensing of a drug\n\t\t\t\tpursuant to a prescription executed in accordance with "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "id6930C0290E944FFB947EA027B859F8D4", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "any fee associated with\n\t\t\t\tsuch administration, provision, or dispensing of the drug."}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "id4F878AE3C179402A9698948B76E54958", "#text": "\n                    "}]}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall not be considered ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:1", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:a/p:3/sp:A", "@proposed": "true"}], "#text": "For purposes of this section, the activities described in\n\t\t\t\t", "quote": {"#tail": " if such\n\t\t\t\tactivities are conducted in whole or in part with respect to a drug described\n\t\t\t\tin ", "#text": "compounding"}}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "idbf3ba2b5988b438182bb6f1bf2fac039"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Blood and blood\n\t\t\t\tcomponents for transfusion."}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "id0f54bb7c03414e5a97dbf174652e4996", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 575", "@value": "Federal Food, Drug, and Cosmetic Act/s:575"}, "#text": "Medical gases, as\n\t\t\t\tdefined in "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "ide98906dc5c2a49d5bd85bc77a73d053c", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Excluded\n\t\t\t\tdrugs"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The drugs described in this subparagraph are the\n\t\t\t\tfollowing:"}, "#text": "\n                    ", "@id": "id1fabd82341224ac3862ad5737010837e"}], "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Inapplicability to\n\t\t\t\tcertain drugs"}, "#text": "\n                  ", "@id": "ide53af4caeb3c43cea2a167536f295401"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Nothing in this section shall be construed to permit the use\n\t\t\t\tof animal drugs in compounding a drug for human use."}, "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Animal drugs for human\n\t\t\t\tuse"}, "#text": "\n                  ", "@id": "idcfb7a1b94be84a2aacc1d0bd38831312", "@commented": "no"}], "#text": "\n                ", "@id": "id5c6e98bef3c8476d8ee400d366a5527e"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis section:"}, "enum": {"#tail": "\n                ", "#text": "(b)"}, "header": {"#tail": "\n                ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "that compounds any\n\t\t\t\tsterile drug without receiving a prescription order for an identified\n\t\t\t\tindividual patient for such sterile drug prior to beginning compounding, and\n\t\t\t\tdistributes or offers to sell such compounded sterile drug in interstate\n\t\t\t\tcommerce; or"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "ide4a590a596de42e4a8ed509107a9d838", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "that repackages any\n\t\t\t\tpreservative-free sterile drug or engages in sterile pooling."}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "idfbfeb9d75d4a4883bccae5f4078f4bd7", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means a\n\t\t\t\tfacility at one geographic location or address\u2014", "#text": "compounding manufacturer"}, "#text": "The term "}, "#text": "\n                    ", "@id": "id4829ac0aef914ea1a45ca64e1d1d7af2"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or the final guidance described in ", "@entity-type": "act", "#text": "section 506F", "@value": "Federal Food, Drug, and Cosmetic Act/s:506F"}, {"#tail": "\n\t\t\t\tonce the final guidance is published; and", "@entity-type": "act", "#text": "section 506F(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:506F/ss:d"}], "#text": "repackages drugs in\n\t\t\t\taccordance with "}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id35d415f944be4a89abacb5f3e7b7d366", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1/sp:A", "@proposed": "true"}, "#text": "does not otherwise meet\n\t\t\t\tthe definition of compounding manufacturer under "}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id5ffaea0fe7e24cfda8ce0ffcaf69c681", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "Excluded\n\t\t\t\tactivities"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a facility shall\n\t\t\t\tnot be considered a compounding manufacturer if such facility\u2014", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1/sp:A/cl:ii", "@proposed": "true"}, "#text": "Notwithstanding "}, "#text": "\n                      ", "@id": "idB0315F425DD34328BB43898878CBB4E8"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "term": {"#tail": " shall not\n\t\t\t\tinclude a compounding nuclear pharmacy.", "#text": "compounding manufacturer"}, "#text": "The term "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Compounding nuclear\n\t\t\t\tpharmacy"}, "#text": "\n                      ", "@id": "id447B308C6706472E96B2BEB41AD4368C"}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Exclusions"}, "#text": "\n                    ", "@id": "id40f31fc5f49e47b1bcbeb064be303096"}], "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Compounding\n\t\t\t\tmanufacturer"}, "#text": "\n                  ", "@id": "id42d184d4e9b54d068b4bf41499cc6108"}, {"#tail": "\n                ", "@id": "idd491c6fb4f2d47ad87d611b1fd73f679", "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Compounding nuclear\n\t\t\t\tpharmacy"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means\n\t\t\t\tan entity that\u2014", "#text": "compounding nuclear pharmacy"}, "#text": "The term "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "is a State-licensed\n\t\t\t\tpharmacy or a Federal facility;"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "ide3640b7ac7b34017907f3b4e18e54b01", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or from a State pursuant to an\n\t\t\t\tagreement with such commission under ", "@entity-type": "federal-body", "#text": "Nuclear Regulatory Commission", "@entity-id": "3100"}, {"#tail": "; and", "@entity-type": "act", "#text": "section 274 of the Atomic Energy Act of\n\t\t\t\t1954", "@value": "Atomic Energy Act of 1954/s:274"}], "#text": "holds a license currently\n\t\t\t\tin effect from the "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "id36c0533ab50648179afdf0adbe9d1280", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1/sp:A", "@proposed": "true"}, "#text": "does not compound\n\t\t\t\tnon-radioactive drugs that would cause the entity to be a compounding\n\t\t\t\tmanufacturer described in "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "id6f546b4757bd48729ab4c6213dc8e9a3", "#text": "\n                    "}]}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means an identical or nearly identical version of a\n\t\t\t\tdrug.", "#text": "copy"}, "#text": "The\n\t\t\t\tterm "}, "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Copy"}, "#text": "\n                  ", "@id": "id7ec5ba6b75dd431ea9c405ed13cc1697"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " includes a physician or any other person that is\n\t\t\t\tauthorized to prescribe medication under State law.", "#text": "practitioner"}, "#text": "The\n\t\t\t\tterm "}, "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Practitioner"}, "#text": "\n                  ", "@id": "id190ba7fcd4394acf928e186ff62ab2de"}, {"#tail": "\n                ", "@id": "idf6acf19aa2ce45ae807ab49a0ed97e22", "enum": {"#tail": "\n                  ", "#text": "(5)"}, "header": {"#tail": "\n                  ", "#text": "Radioactive\n\t\t\t\tdrug"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": {"#tail": "\u2014", "#text": "radioactive drug"}, "#text": "The term "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that exhibits spontaneous disintegration\n\t\t\t\tof unstable nuclei with the emission of nuclear particles or photons and\n\t\t\t\tincludes any nonradioactive reagent kit or nuclide regenerator which is\n\t\t\t\tintended to be used in the preparation of any such substance but does not\n\t\t\t\tinclude drugs such as carbon-containing compounds or potassium-containing salts\n\t\t\t\twhich contain trace quantities of naturally occurring radionuclides; and", "@entity-type": "act", "#text": "section 201(g)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:201/ss:g/p:1"}, "#text": "means any substance\n\t\t\t\tdefined as a drug in "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "idF1C72F34521E4DF5BA5E7ECE5966AFE4", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "quote": {"#tail": " which means a biological product\n\t\t\t\twhich is labeled with a radionuclide or intended solely to be labeled with a\n\t\t\t\tradionuclide.", "#text": "radioactive biological product,"}, "#text": "includes a\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "id6CA4777C2A6F4B4CA2D44BC2DEE15781", "#text": "\n                    "}]}, {"#tail": "\n                ", "@id": "id09d8a34c84f740989d3aadd252a683ee", "enum": {"#tail": "\n                  ", "#text": "(6)"}, "header": {"#tail": "\n                  ", "#text": "Repackage or\n\t\t\t\trepackaging"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "quote": {"#tail": "\u2014", "#text": "repackaging"}, "term": {"#tail": " or\n\t\t\t\t", "#text": "repackage"}, "#text": "The term "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or licensed under ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " from the container in which it is distributed by the original\n\t\t\t\tmanufacturer and placing it in a different container of the same or smaller\n\t\t\t\tsize without further manipulating the drug (such as by diluting it or mixing it\n\t\t\t\twith another, different drug or drugs); and", "@entity-type": "act", "#text": "section 351 of the Public Health\n\t\t\t\tService Act", "@value": "Public Health Service Act/s:351"}], "#text": "means taking a drug\n\t\t\t\tapproved under "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "id20775FC52DD34BF8868C189974BA4A9A", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "does not include removing\n\t\t\t\tthe drug from its original container for immediate administration to an\n\t\t\t\tidentified individual patient, such as withdrawing a drug into a syringe for\n\t\t\t\timmediate injection or filling a cassette for immediate use within a drug\n\t\t\t\tdelivery device."}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "id1BC1FBAF22894C45BFA4DD832BCFA494", "#text": "\n                    "}]}, {"#tail": "\n                ", "@id": "idc96e2f9a66b84d2bb958d162fdad07e9", "enum": {"#tail": "\n                  ", "#text": "(7)"}, "header": {"#tail": "\n                  ", "#text": "Sterile\n\t\t\t\tdrug"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means a drug that\n\t\t\t\tis\u2014", "#text": "sterile drug"}, "#text": "The term "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "intended for parenteral\n\t\t\t\tadministration;"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "ida408cc330ed64322b5aec51486373997", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "an ophthalmic or oral\n\t\t\t\tinhalation drug in aqueous format; or"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "idd2fe1dcfc6504cde8a681aeba15f5f66", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "required to be sterile\n\t\t\t\tunder Federal or State law."}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "id44dcac841a414e17a11dee1e403f7b4e", "#text": "\n                    "}]}, {"#tail": "\n                ", "@id": "idd0c5f81f83334bac9e0a4e9117a8d72d", "enum": {"#tail": "\n                  ", "#text": "(8)"}, "header": {"#tail": "\n                  ", "#text": "Sterile\n\t\t\t\tpooling"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": {"#tail": "\u2014", "#text": "sterile pooling"}, "#text": "The term "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " from the container in which it is\n\t\t\t\tdistributed by the original manufacturer and combining it with the same sterile\n\t\t\t\tdrug from one or more other containers without or before further manipulating\n\t\t\t\tthe product (such as by diluting it or mixing it with another, different drug\n\t\t\t\tor drugs);", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, "#text": "means taking a single\n\t\t\t\tsterile drug approved under "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "id6b23d50349b74d3286503dbd573a5fe0", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "does not include\n\t\t\t\tcombining the drug from two or more separate containers of the same drug when a\n\t\t\t\tsingle container of the drug is not sufficient to prepare a single dose for\n\t\t\t\tadministration to an individual patient; and"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "id85fd21c9164f4888b09f6e191a02b71b", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "does not include\n\t\t\t\tcombining a single drug from two or more separate containers of component\n\t\t\t\tproducts of a parenteral nutrition product, if such pooling, labeling, and use\n\t\t\t\tof the finished parenteral nutrition product, comply with State pharmacy\n\t\t\t\tlaw."}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "ide34c4923513e4009ab4882994f821c7c", "#text": "\n                    "}]}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "wherein a drug is\n\t\t\t\tcompounded by\u2014"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "a licensed pharmacist in\n\t\t\t\ta State-licensed pharmacy or a licensed Federal facility; or"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "ided4500beaba04edeb4873068a1b20211", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "a licensed\n\t\t\t\tphysician;"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id71ab1eefa192452b98e712b16a6b9a77", "#text": "\n                        "}], "#text": "\n                      ", "@id": "idee6811e9b2b54fde8c91428fb0de9d04"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "that\u2014"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "compounds a drug upon\n\t\t\t\treceipt of a prescription order for an identified individual patient; or"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id5220c85b24aa4c76b2fab1e0e2ff0a37", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "compounds a drug in\n\t\t\t\tlimited quantities before receipt of a prescription order for an identified\n\t\t\t\tindividual patient, if such compounding is based on a history of the licensed\n\t\t\t\tpharmacist or licensed physician receiving prescription orders for the\n\t\t\t\tcompounding of the drug, which orders have been generated solely within an\n\t\t\t\testablished relationship between the licensed pharmacist or licensed physician\n\t\t\t\tand\u2014"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "item": [{"#tail": "\n                        ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "such individual patient\n\t\t\t\tfor whom the prescription order will be provided; or"}, "enum": {"#tail": "\n                          ", "#text": "(aa)"}, "@id": "id3c22672ea34c4c7d97f41a3f753e74c4", "#text": "\n                          "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "the licensed physician\n\t\t\t\tor other licensed practitioner who will write such prescription order;\n\t\t\t\tand"}, "enum": {"#tail": "\n                          ", "#text": "(bb)"}, "@id": "ide2b262f8399e4515bc4391d13c8c79b2", "#text": "\n                          "}], "#text": "\n                        ", "@id": "idc2fc8e149d544104a6e39f3a2a29533d"}], "#text": "\n                      ", "@id": "id770166ec362843b9b4c2f6ca28823393"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:1", "@proposed": "true"}, "#text": "that does not meet the\n\t\t\t\tdefinition of a compounding manufacturer under "}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "idca439322284c42af892fa95e6b2c094b", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means a\n\t\t\t\tfacility operating pursuant to State law\u2014", "#text": "traditional compounder"}, "#text": "The term "}, "#text": "\n                    ", "@id": "ida1090d1e201c4a40bdad79f105e04ff2"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and if, with respect to a drug compounded by\n\t\t\t\tsuch pharmacy, the only activity conducted by the pharmacy is to dispense or\n\t\t\t\tadminister such drug (which may include interstate shipment) solely to a\n\t\t\t\tpatient of such hospital or health system.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:9/sp:A", "@proposed": "true"}, "#text": "A pharmacy within a hospital or health system shall be\n\t\t\t\tconsidered a traditional compounder if such pharmacy otherwise meets the\n\t\t\t\tdefinition under "}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "Hospitals and health\n\t\t\t\tsystems"}, "#text": "\n                      ", "@id": "id0c5f161985e6447c93d5bb985d68cfff"}, {"#tail": "\n                  ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "means an entity that owns\n\t\t\t\tand operates\u2014"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "item": [{"#tail": "\n                        ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "one hospital; or"}, "enum": {"#tail": "\n                          ", "#text": "(aa)"}, "@id": "ide16990bb39744cc69a6bba7ad4c54b0a", "#text": "\n                          "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "two or more hospitals\n\t\t\t\tthat have common access to databases with drug order information for patients;\n\t\t\t\tand"}, "enum": {"#tail": "\n                          ", "#text": "(bb)"}, "@id": "idf66581aeaaaa472ab6f5312ed50da21e", "#text": "\n                          "}], "#text": "\n                        ", "@id": "idf54bb5a3699746f188ea6b666708efba"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "includes only the\n\t\t\t\tinpatient, outpatient, and ambulatory facilities wholly owned and operated by\n\t\t\t\tsuch entity, and accredited by a national accreditation body recognized by the\n\t\t\t\tSecretary."}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id1511769193ad4afe8ab243cf6b94445d", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Health system\n\t\t\t\tdefined"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "term": {"#tail": "\u2014", "#text": "health system"}, "#text": "The term "}, "#text": "\n                      ", "@id": "id3ac0c14631314838839cfebe0f52fb36"}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Exceptions"}, "#text": "\n                    ", "@id": "id98ec826369e147838aa1a5e0b2790329"}], "enum": {"#tail": "\n                  ", "#text": "(9)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Traditional\n\t\t\t\tcompounder"}, "#text": "\n                  ", "@id": "iddebbe6278097492f913e8457bd8dd23b"}], "#text": "\n                ", "@id": "id9bbc65aa703a481687844e8cc7631595"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Exemptions from certain\n\t\t\t\trequirements"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "paragraphs (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:c/p:2", "@proposed": "true"}, {"#tail": ", and\n\t\t\t\t", "@entity-type": "act", "#text": "(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:c/p:3", "@proposed": "true"}, {"#tail": ", a compounded drug shall be subject to all the requirements of this Act\n\t\t\t\tapplicable to new drugs.", "@entity-type": "act", "#text": "(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:c/p:4", "@proposed": "true"}], "#text": "Except as otherwise provided in "}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "idCA029320C26848A6BC7155D174E5353F"}, {"#tail": "\n                ", "@id": "idb6614206708641fca03bf9b0597f003e", "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Drugs compounded by\n\t\t\t\ttraditional compounders"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "Sections 501(a)(2)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:501/ss:a/p:2/sp:B"}, {"#tail": ", and ", "@entity-type": "act", "#text": "502(f)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:f/p:1"}, {"#tail": " and ", "@entity-type": "act", "#text": "505\n\t\t\t\tof this Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " shall not apply to\n\t\t\t\ta compounded drug if such drug\u2014", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "#text": "\n                    "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "is compounded by a\n\t\t\t\ttraditional compounder that is in compliance with this section; and"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "id0790785a38fa4809a1d52a4e19b69c91", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "meets the requirements of\n\t\t\t\tthis section applicable to drugs compounded by traditional compounders."}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "ida1dbfaf8693c4c1896555097a8adb363", "#text": "\n                    "}]}, {"#tail": "\n                ", "@id": "id16c1d2aade6544a6b6f5e31b2beda801", "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Drugs compounded by\n\t\t\t\tcompounding manufacturers"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "Sections 502(f)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:f/p:1"}, {"#tail": "\n\t\t\t\tand ", "@entity-type": "act", "#text": "505 of this Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " shall not apply to a\n\t\t\t\tcompounded prescription drug, if such prescription drug\u2014", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "#text": "\n                    "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "is compounded by a\n\t\t\t\tcompounding manufacturer\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "that is not licensed as a\n\t\t\t\tpharmacy in any State; and"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "idad18355715fc498ca0e9ee014bf68466", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "that is in compliance\n\t\t\t\twith this section; and"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id823f3139d516434486a4782ea3fd8f60", "#text": "\n                      "}], "#text": "\n                    ", "@id": "id211e86c27eea46eba6a70aa0cd15db7b"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "meets the requirements of\n\t\t\t\tthis section applicable to drugs compounded by compounding\n\t\t\t\tmanufacturers."}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "id31109c98c4d24ad7bddd716d919dd0ba", "#text": "\n                    "}]}, {"#tail": "\n              ", "@id": "idc0e31fca5e19411898798dc552756211", "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Drugs compounded by\n\t\t\t\tcompounding nuclear pharmacies"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "Sections 501(a)(2)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:501/ss:a/p:2/sp:B"}, {"#tail": ",\n\t\t\t\tand ", "@entity-type": "act", "#text": "502(f)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:f/p:1"}, {"#tail": " and ", "@entity-type": "act", "#text": "505 of this Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " shall not\n\t\t\t\tapply to a compounded radioactive drug if such drug is compounded\u2014", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "#text": "\n                    "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "by a licensed pharmacist\n\t\t\t\tin a compounding nuclear pharmacy;"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "id5bb94e478047487eac478e220122f950", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or licensed under ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ", and one or more ingredients in compliance with\n\t\t\t\t", "@entity-type": "act", "#text": "section 351 of\n\t\t\t\tthe Public Health Service Act", "@value": "Public Health Service Act/s:351"}, {"#tail": "; and", "@entity-type": "act", "#text": "subsection (e)(1)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:1/sp:B", "@proposed": "true"}], "#text": "solely using a\n\t\t\t\tradioactive drug approved under "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "ida380b0a6854f403ea661cef8ceb33a21", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "in compliance with the\n\t\t\t\tUnited States Pharmacopoeia chapters on pharmacy compounding."}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "iddca52e0080604599a0503205b7ef8b5c", "#text": "\n                    "}]}], "#text": "\n                ", "@id": "id7dfee572a9d44cc28df55a70779903bd"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Drugs that may not be\n\t\t\t\tcompounded"}, "paragraph": [{"#tail": "\n                ", "@id": "idd6a45c5982dc4006bb278729c637627e", "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The following drugs may not be compounded:"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tpursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2", "@proposed": "true"}], "#text": "A drug or category of drugs\n\t\t\t\tthat presents demonstrable difficulties for compounding, which may include a\n\t\t\t\tcomplex dosage form or biological product, as designated by the "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "Drugs that are\n\t\t\t\tdemonstrably difficult to compound"}, "#text": "\n                    ", "@id": "id23dd8126b8d94a119a823461fd3e4552"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or a variation of such drug compounded from\n\t\t\t\tbulk drug substances, except as provided in ", "@entity-type": "act", "#text": "505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:3", "@proposed": "true"}], "#text": "A drug (other than a biological product) that is a copy of\n\t\t\t\ta marketed drug approved under "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Marketed\n\t\t\t\tdrugs"}, "#text": "\n                    ", "@id": "idb11c615852f44cf190e6020ae87a74e0"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:4", "@proposed": "true"}, "#text": "A drug that is a biological product, except as provided\n\t\t\t\tin "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Biological\n\t\t\t\tproducts"}, "#text": "\n                    ", "@id": "id80cc9c97b1df4c918525aaef6e530a97"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or licensed under ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " that is the subject of a risk evaluation and mitigation strategy\n\t\t\t\tapproved with elements to assure safe use pursuant to ", "@entity-type": "act", "#text": "section 351 of the Public Health\n\t\t\t\tService Act", "@value": "Public Health Service Act/s:351"}, {"#tail": ", except\n\t\t\t\tprovided in ", "@entity-type": "act", "#text": "section 505\u20131", "@value": "Federal Food, Drug, and Cosmetic Act/s:505\u20131"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:5", "@proposed": "true"}], "#text": "A copy or variation of a drug\n\t\t\t\tapproved under "}, "enum": {"#tail": "\n                    ", "#text": "(D)"}, "header": {"#tail": "\n                    ", "#text": "Drugs subject to risk\n\t\t\t\tevaluation and mitigation strategy"}, "#text": "\n                    ", "@id": "id1995b2cdf5c64621b6ca8351648d6018"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in the Federal Register of drugs that have been withdrawn or\n\t\t\t\tremoved from the market because such drug or components of such drug have been\n\t\t\t\tfound to be unsafe or not effective.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "A drug that appears on a list published by\n\t\t\t\tthe "}, "enum": {"#tail": "\n                    ", "#text": "(E)"}, "header": {"#tail": "\n                    ", "#text": "Drugs removed for\n\t\t\t\tsafety and efficacy"}, "#text": "\n                    ", "@id": "id087efa7978074fbe847fd32700533708"}]}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may promulgate a regulation that designates\n\t\t\t\tdrugs or categories of drugs that are demonstrably difficult to compound that\n\t\t\t\tmay not be compounded, or that may be compounded only under conditions\n\t\t\t\tspecified by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". Such regulation may include the designation of\n\t\t\t\tdrugs or categories of drugs that are complex dosage forms or biological\n\t\t\t\tproducts, such as extended release products, metered dose inhalers, transdermal\n\t\t\t\tpatches, and sterile liposomal products.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "ida6f284e3ff164864b3f44b4cbcd6b5a9"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "publishing a notice of\n\t\t\t\tsuch drugs or categories of drugs proposed for designation, including the\n\t\t\t\trationale for such designation, in the Federal Register;"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id937d75fb6eca43c2926a8e5531b39394", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "providing a period of\n\t\t\t\tnot less than 60 calendar days for comment on the notice; and"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "idfef330b254f14740a722824e729803d6", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "publishing a notice in\n\t\t\t\tthe Federal Register designating such drugs or categories of drugs that cannot\n\t\t\t\tbe compounded, including the rationale for such designation."}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@id": "id09d9141c5eac401386a9d709b7617824", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2/sp:A", "@proposed": "true"}, {"#tail": " may designate drugs or categories of\n\t\t\t\tdrugs that present demonstrable difficulties for compounding, which may include\n\t\t\t\tcomplex dosage forms or biological products that cannot be compounded, except\n\t\t\t\tunder conditions specified by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", by\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Before the effective date of the regulation promulgated\n\t\t\t\tunder "}, "#text": "\n                      ", "@id": "idde33dcc2dbd240f3a42d14bf4e0d7e71"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall cease to have force or effect on the\n\t\t\t\tdate that is 5 years after the date of enactment of the ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2/sp:B/cl:i", "@proposed": "true"}, {"#tail": " or on the effective date of the\n\t\t\t\tfinal regulation under ", "@entity-type": "act", "#text": "Pharmaceutical\n\t\t\t\tCompounding Quality and Accountability Act", "@value": "Pharmaceutical Compounding Quality and Accountability Act", "@proposed": "true"}, {"#tail": ", whichever is earlier.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2/sp:A", "@proposed": "true"}], "#text": "Any\n\t\t\t\tnotice provided under "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Sunset"}, "#text": "\n                      ", "@id": "idc6ab921a581647cb95a441e1d9f9b3e6"}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Interim list"}, "#text": "\n                    ", "@id": "id857fb482a99445a382e1b448b7616966"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall consult with relevant stakeholders including\n\t\t\t\tpharmacists, professional associations, patient and public health advocacy\n\t\t\t\tgroups, manufacturers and physicians about the need for the compounded drugs to\n\t\t\t\tbe included or excluded from the lists.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Prior to establishing the lists described in this\n\t\t\t\tparagraph, the "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Consultation with\n\t\t\t\tstakeholders"}, "#text": "\n                    ", "@id": "id1a1dd1452f844b87b184ac64f21893be"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and every 5 years thereafter, the\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2/sp:A", "@proposed": "true"}, {"#tail": " shall publish a Federal Register notice seeking public input about\n\t\t\t\tthe need for the compounded drugs to be included or excluded from the list\n\t\t\t\tdescribed in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". Nothing in the previous sentence prohibits\n\t\t\t\tnotifications or submissions before or during any 5-year period described under\n\t\t\t\tsuch sentence regarding the need for the compounded drugs to be included or\n\t\t\t\texcluded from the list.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:2/sp:A", "@proposed": "true"}], "#text": "Five years after the effective date of the\n\t\t\t\tregulation described in "}, "enum": {"#tail": "\n                    ", "#text": "(D)"}, "header": {"#tail": "\n                    ", "#text": "Updates to difficult to\n\t\t\t\tcompound list"}, "#text": "\n                    ", "@id": "id10f65d42f4cd419f8c6e099d676d77fb"}], "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Drugs that are\n\t\t\t\tdemonstrably difficult to compound"}, "#text": "\n                  ", "@id": "id054af55fb7ee46a1a57937a5bc1d1f32"}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the compounded variation\n\t\t\t\tproduces for the individually identified patient a clinical difference between\n\t\t\t\tthe compounded drug and such marketed drug, as determined by the prescribing\n\t\t\t\tpractitioner, and, prior to beginning compounding such variation, the\n\t\t\t\ttraditional compounder compounding the variation receives a prescription order\n\t\t\t\tfor an identified individual patient specifying that the variation may be\n\t\t\t\tcompounded; or"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "id89bbcbd525a54ed187072bf18b422cc5", "#text": "\n                      "}, {"#tail": "\n                  ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or has\n\t\t\t\totherwise been identified by the ", "@entity-type": "act", "#text": "section 506E", "@value": "Federal Food, Drug, and Cosmetic Act/s:506E"}, {"#tail": ", in the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " sole discretion,\n\t\t\t\tas in shortage, such as in a specific region or on a drug shortage list\n\t\t\t\tmaintained by a private party;", "@entity-type": "federal-body", "#text": "Secretary's", "@entity-id": "7500"}], "#text": "such marketed drug, at\n\t\t\t\tthe time of compounding a copy of such drug and at the time of distribution of\n\t\t\t\tthe compounded drug, is on the drug shortage list under "}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                        ", "@id": "idD2FFEB745E3E4B2B92B1C977029456DA", "@commented": "no"}, {"@committee-id": "SSHR00", "@changed": "added", "@indent": "up1", "#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " not later than 3 calendar days after beginning\n\t\t\t\tthe compounding; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the facility compounding\n\t\t\t\tthe drug notifies the "}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@reported-display-style": "italic", "#text": "\n                        ", "@id": "idD0ABC165DF514AFE8488826CF2977DA2"}, {"@committee-id": "SSHR00", "@changed": "added", "@indent": "up1", "#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as an entity that intends to compound pursuant to this\n\t\t\t\tparagraph and notifies the ", "@entity-type": "act", "#text": "subsection (g)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:2", "@proposed": "true"}, {"#tail": " at least 14 calendar days prior to\n\t\t\t\tbeginning the compounding.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "in the case of a\n\t\t\t\tcompounding manufacturer, the compounding manufacturer has registered under\n\t\t\t\t"}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@reported-display-style": "italic", "#text": "\n                        ", "@id": "id964C029CEBCD4CE28C3D98B0EE3ADDD9"}], "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id173fb265cd8e48789e0d7c9b5a8c1552", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", including variations of such drug\n\t\t\t\tcompounded from bulk drug substances, may be compounded only if\u2014", "@entity-type": "act", "#text": "505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, "#text": "A drug (other than a biological product) that is a copy\n\t\t\t\tof a marketed drug approved under "}, "#text": "\n                    ", "@id": "id48ce58d049e844d98fc26b52608b7901"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may waive a notice required under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:3/sp:A/cl:ii", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Notice\n\t\t\t\twaiver"}, "#text": "\n                    ", "@id": "idB8912E95056C4ABF95A8269CBA44E547"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not make the repackaged drug a copy of such marketed drug, unless the\n\t\t\t\trepackaged drug is also a marketed drug approved under ", "@entity-type": "act", "#text": "section\n\t\t\t\t505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": ".", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}], "#text": "For\n\t\t\t\tpurposes of this paragraph, repackaging a marketed drug approved under "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Exclusion"}, "#text": "\n                    ", "@id": "ided4b8423a9f04593b6a33062ae76d607"}], "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Exceptions regarding\n\t\t\t\tmarketed drugs"}, "#text": "\n                  ", "@id": "id85eeb0bd2a2246a1a01f7f19d245886e"}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "act", "#text": "subsection (e)(1)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:1/sp:B", "@proposed": "true"}, "#text": "such compounded\n\t\t\t\tvariation is compounded solely using a licensed biological product, or solely\n\t\t\t\tusing a licensed biological product and one or more ingredients in compliance\n\t\t\t\twith "}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                        ", "@id": "id3F32CF0D65D6427E9BE994DCA10D1977", "@commented": "no"}, {"@committee-id": "SSHR00", "@changed": "added", "@indent": "up1", "#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(e)(1)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:1/sp:B", "@proposed": "true"}, "#text": "in the case of a\n\t\t\t\tlicensed allergenic product, such variation is compounded solely using one or\n\t\t\t\tmore licensed allergenic products, or solely using one or more licensed\n\t\t\t\tallergenic products and one or more ingredients in compliance with "}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@reported-display-style": "italic", "#text": "\n                        ", "@id": "id13E93487B20D4783A857EA7B6F4A0C95"}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "id05c196c2866d43f799f94b5deaa7bf4c", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "such compounded\n\t\t\t\tvariation produces for the patient a clinical difference between such\n\t\t\t\tcompounded variation and the licensed biological product, as determined\n\t\t\t\tby\u2014"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the prescribing\n\t\t\t\tpractitioner (in the case of a variation compounded by a traditional\n\t\t\t\tcompounder); or"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "idEB9BCF3A9F774508B3BC39FB540B9C8D", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "a licensed practitioner\n\t\t\t\tresponsible for the patient\u2019s care in a health care entity that provides\n\t\t\t\tmedical services through licensed practitioners directly to patients (in the\n\t\t\t\tcase of a variation compounded by a compounding manufacturer);"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id03BC78E0140F4ABD9C656746BF61FC84", "#text": "\n                        "}], "#text": "\n                      ", "@id": "idfd8d02ebc57d40a99ea0c7675f428101"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "prior to beginning\n\t\t\t\tcompounding\u2014"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the traditional compounder receives a prescription order for\n\t\t\t\tan identified individual patient specifying that the biological product may be\n\t\t\t\tcompounded for an identified individual patient; or", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:4/sp:B", "@proposed": "true"}, "#text": "except as provided in\n\t\t\t\t"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id1B584E1DD76D4AC3A092747FAC6C9C76", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the compounding\n\t\t\t\tmanufacturer receives a duly authorized medical order from a health care entity\n\t\t\t\tthat provides medical services through licensed practitioners directly to\n\t\t\t\tpatients, specifying that the biological product may be compounded based on\n\t\t\t\tsuch order for an identified patient or patients; and"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "idBD8162769FB048B59602EA16045A43B1", "#text": "\n                        "}], "#text": "\n                      ", "@id": "idD6C38DE007754B95A27984A6908D7B94"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:b/p:2", "@proposed": "true"}, "#text": "in the case of a\n\t\t\t\tradioactive biological product, the compounded variation is compounded by a\n\t\t\t\tcompounding nuclear pharmacy in accordance with "}, "enum": {"#tail": "\n                      ", "#text": "(iv)"}, "@id": "id82E68B79309C438096896A28F7072C6A", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "A drug that is a variation of a licensed biological\n\t\t\t\tproduct may be compounded only if\u2014"}, "#text": "\n                    ", "@id": "idD25E8A840BC741CBBD07D48831EB9CAA"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "such compounded variation\n\t\t\t\tis a diluted or repackaged variation of the licensed biological product for\n\t\t\t\temergent use in pediatric patients; and"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "idD810729E76404E92B6D5DC1001F69812", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "such compounded\n\t\t\t\tvariation produces for the patient a clinical difference between such\n\t\t\t\tcompounded variation and the licensed biological product, as determined by a\n\t\t\t\tlicensed practitioner responsible for the patient\u2019s care in the hospital or\n\t\t\t\thealth system."}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "idA7B39A2E31D04FAD875AA3E98B158299", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Special rule for\n\t\t\t\tpediatric uses"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " if\u2014", "@entity-type": "act", "#text": "subparagraph (A)(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:4/sp:A/cl:iii", "@proposed": "true"}, "#text": "A traditional compounder that is a hospital or\n\t\t\t\thealth system may begin compounding a drug that is a variation of a licensed\n\t\t\t\tbiological product prior to receiving a prescription order as required under\n\t\t\t\t"}, "#text": "\n                    ", "@id": "idAC036299F1A34A68BBB46593B0A620B2"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "Clauses\n\t\t\t\t(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:4/sp:A/cl:ii", "@proposed": "true"}, {"#tail": " shall not apply to a compounded allergenic\n\t\t\t\tproduct.", "@entity-type": "act", "#text": "(iii) of subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:4/sp:A/cl:iii", "@proposed": "true"}], "#text": "\n                      "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Inapplicability"}, "#text": "\n                    ", "@id": "id075B92157F8248B795157668B9C83B18"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Notwithstanding\n\t\t\t\tany other provision of this section, sterile pooling of a biological product is\n\t\t\t\tnot permitted."}, "enum": {"#tail": "\n                    ", "#text": "(D)"}, "header": {"#tail": "\n                    ", "#text": "Pooling"}, "#text": "\n                    ", "@id": "idB1331ACC2E5C48D6B38BA6D041F82F43", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Exceptions regarding\n\t\t\t\tbiological products"}, "#text": "\n                  ", "@id": "idf917426ef9df422d847c5d3f81166de3"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the entity compounding\n\t\t\t\tthe copy or variation receives a prescription order for an identified\n\t\t\t\tindividual patient specifying that the drug or biological product may be\n\t\t\t\tcompounded; and"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "id7b5a0d4b28714965ad03a9776b238d26", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", prior to beginning\n\t\t\t\tcompounding, that the entity will utilize controls that are comparable to the\n\t\t\t\tcontrols applicable under the relevant risk evaluation and mitigation strategy\n\t\t\t\tfor the approved drug or licensed biological product.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the entity compounding\n\t\t\t\tthe copy or variation demonstrates to the "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id19911b9ff40c45478a1da629b0ca3d18", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tor biological product licensed under ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " that is the subject of a risk evaluation and mitigation strategy approved\n\t\t\t\twith elements to assure safe use pursuant to ", "@entity-type": "act", "#text": "section 351 of the Public Health Service\n\t\t\t\tAct", "@value": "Public Health Service Act/s:351"}, {"#tail": ", may be compounded\n\t\t\t\tonly if\u2014", "@entity-type": "act", "#text": "section 505\u20131", "@value": "Federal Food, Drug, and Cosmetic Act/s:505\u20131"}], "#text": "A copy or variation of a drug approved under "}, "#text": "\n                    ", "@id": "id6c1d04b28606410db986d67aeb2d06cb"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "paragraphs (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:3", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:d/p:4", "@proposed": "true"}], "#text": "Nothing\n\t\t\t\tin this paragraph shall be construed to permit compounding a copy or variation\n\t\t\t\tof a drug other than as permitted in "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Effect"}, "#text": "\n                    ", "@id": "id2c49b0e22a7448978eb0f537a7596a76"}], "enum": {"#tail": "\n                  ", "#text": "(5)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Requirement for drugs\n\t\t\t\tthat have risk evaluation and mitigation strategies"}, "#text": "\n                  ", "@id": "ida9706c7561874d1da01ed745430bc97e"}], "#text": "\n                ", "@id": "id3200f66925994377a05838e49f32c75d"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Quality of drug\n\t\t\t\tingredients"}, "paragraph": [{"#tail": "\n                ", "@id": "id0d31e70c68d849ab81627459b97d4723", "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "Human\n\t\t\t\tdrugs"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A traditional compounder or a compounding manufacturer\n\t\t\t\tshall\u2014"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " published\n\t\t\t\tat ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "if compounding a drug\n\t\t\t\tfrom bulk drug substances (as defined in regulations of the ", "external-xref": {"#tail": " of title 21, Code of Federal Regulations (or any\n\t\t\t\tsuccessor regulations)), use only bulk substances\u2014", "@parsable-cite": "cfr/21/207.3", "#text": "section 207.3(a)(4)", "@legal-doc": "regulation"}}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "that\u2014"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:2", "@proposed": "true"}, "#text": "comply with the standards\n\t\t\t\tof an applicable United States Pharmacopoeia or National Formulary monograph,\n\t\t\t\tif a monograph exists and has not been identified under "}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id21c1c998f0e94f7099b3267b162efa9d", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "if such a monograph does\n\t\t\t\tnot exist, are drug substances that are components of drugs approved by the\n\t\t\t\t"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id00491a0d2318484eb340278250b00ba1", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", that appear on a list developed by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " through\n\t\t\t\tregulations issued by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ";", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "if such a monograph\n\t\t\t\tdoes not exist and the drug substance is not a component of a drug approved by\n\t\t\t\tthe "}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@id": "id6bc17c0030274da691981b0ec34ed461", "#text": "\n                        "}], "#text": "\n                      ", "@id": "id353f0340182141fa9a6ce34fd8af295f"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (including a foreign\n\t\t\t\testablishment that is registered under ", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, {"#tail": "); and", "@entity-type": "act", "#text": "section 510(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:510/ss:i"}], "#text": "that are manufactured by\n\t\t\t\tan establishment that is registered under "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id2221835463884c3e9297c2372466dcb1", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "that are accompanied by\n\t\t\t\tvalid certificates of analysis for each specific lot of bulk drug\n\t\t\t\tsubstance;"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "idee4cd281994d40789673af6f415a7eda", "#text": "\n                      "}], "#text": "\n                    ", "@id": "id85000cfddb884e789a4f03c4bbe8ebc9"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:2", "@proposed": "true"}, "#text": "use ingredients (other\n\t\t\t\tthan bulk drug substances) that comply with the standards of an applicable\n\t\t\t\tUnited States Pharmacopoeia or National Formulary monograph, if a monograph\n\t\t\t\texists and has not been identified under "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "idd26b55f3cd984d31bdcb7c0eb83a4f2b", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\ttraditional compounder, comply with the standards of the United States\n\t\t\t\tPharmacopoeia chapters on pharmacy compounding."}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "idEB1DC1F6D20B4B95BC4609B7CF1A3235", "#text": "\n                    "}]}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "subparagraph (A)(i)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:1/sp:A/cl:i/scl:I", "@proposed": "true"}, {"#tail": ", the ", "@entity-type": "act", "#text": "(B) of paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:e/p:1/sp:B", "@proposed": "true"}, {"#tail": " may\n\t\t\t\tidentify bulk substances that the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " determines, based on public health\n\t\t\t\tconcerns, may not be used in compounding a drug.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Notwithstanding the existence of an applicable monograph\n\t\t\t\tunder "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "id87bfd3df5e44475d953a64c51365c556"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "publish a notice of such\n\t\t\t\tbulk substances proposed for identification in the Federal Register, including\n\t\t\t\tthe rationale for such proposal;"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "id636a576ee33e4dbbad61506fdd934c04", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "provide a period of not\n\t\t\t\tless than 60 calendar days for comment on the notice; and"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id0a9e74fa4a9449f1be4090ec7e0fc105", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "publish a notice in the\n\t\t\t\tFederal Register identifying the bulk substances that may not be used in\n\t\t\t\tcompounding a drug."}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "id530a03893f6d4163a8792a7a3ba9bd30", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Procedure"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "In\n\t\t\t\tidentifying the bulk substances that may not be used in compounding, the\n\t\t\t\t"}, "#text": "\n                    ", "@id": "id87371d0d71a940d0b8f60063252e7af8"}], "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Identification by\n\t\t\t\tsecretary"}, "#text": "\n                  ", "@id": "ide5bcc7ba758b4ec9b7c84199994f43ed"}], "#text": "\n                ", "@id": "id778390f20710418bae343dad97fc8a0b"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A compounded drug\u2014"}, "enum": {"#tail": "\n                ", "#text": "(f)"}, "header": {"#tail": "\n                ", "#text": "Requirements regarding\n\t\t\t\twholesaling and labeling applicable to traditional compounders and compounding\n\t\t\t\tmanufacturers"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "may not be sold by an\n\t\t\t\tentity other than the compounding manufacturer or traditional compounder that\n\t\t\t\tcompounded the drug;"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "@id": "idef88a52d64a848b9a5f41630d9fc2ae6", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "compounded by a\n\t\t\t\tcompounding manufacturer may not be sold or transferred to an entity other than\n\t\t\t\ta health care entity that provides medical services through licensed\n\t\t\t\tpractitioners directly to patients, or a network of such providers, except that\n\t\t\t\ta compounding manufacturer may transfer without profit a compounded sterile\n\t\t\t\tdrug to a licensed pharmacy if\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "#text": "\n                  ", "@id": "idbc004dff5ae34e2591f9923671879a32", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", and\n\t\t\t\tat the time of such transfer, the licensed pharmacy falls under the same\n\t\t\t\tcorporate ownership as the compounding manufacturer;", "@entity-type": "act", "#text": "Pharmaceutical Compounding Quality and Accountability Act", "@value": "Pharmaceutical Compounding Quality and Accountability Act", "@proposed": "true"}, "#text": "as of the date of\n\t\t\t\tenactment of the "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "id6e5eeca71a434b26b480d6b83fb66092", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the transfer of such\n\t\t\t\tcompounded sterile drug is solely for the purpose of dispensing the compounded\n\t\t\t\tsterile drug to the end user, who has been instructed by the prescribing\n\t\t\t\tphysician to self-administer such compounded sterile drug;"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "idd251ea9d60204b138f29c4eb1cf47d87", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", and\n\t\t\t\tat the time of such transfer, the compounding manufacturer is an entity wholly\n\t\t\t\towned by an entity that provides pharmacy benefits management services on\n\t\t\t\tbehalf of a health benefits plan;", "@entity-type": "act", "#text": "Pharmaceutical Compounding Quality and Accountability Act", "@value": "Pharmaceutical Compounding Quality and Accountability Act", "@proposed": "true"}, "#text": "as of the date of\n\t\t\t\tenactment of the "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "id37183a7328324c42b3b64d310bfbb577", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " upon registering under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " as an entity that qualifies for the exception under this\n\t\t\t\tparagraph, and provides documentation of the compounding of such drugs as of\n\t\t\t\tthe date of enactment of the ", "@entity-type": "act", "#text": "subsection (g)(2)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:503A/ss:g/p:2", "@proposed": "true"}, {"#tail": ", in a manner described by the ", "@entity-type": "act", "#text": "Pharmaceutical Compounding Quality and\n\t\t\t\tAccountability Act", "@value": "Pharmaceutical Compounding Quality and Accountability Act", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "the compounding\n\t\t\t\tmanufacturer identifies itself to the "}, "enum": {"#tail": "\n                    ", "#text": "(D)"}, "@id": "id8faa6b57a7c741268944a7b13437266b", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that the compounding\n\t\t\t\tmanufacturer qualifies for the exception under this paragraph and the sterile\n\t\t\t\tdrug or drugs for which the exemption applies; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the compounding\n\t\t\t\tmanufacturer receives confirmation from the "}, "enum": {"#tail": "\n                    ", "#text": "(E)"}, "@id": "ida93b8f9434674e7da68002d9c5041842", "#text": "\n                    "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "quote": {"#tail": ".", "#text": "not for\n\t\t\t\tresale"}, "#text": "in the case of a\n\t\t\t\tcompounded drug offered for sale, shall be labeled "}, "enum": {"#tail": "\n                  ", "#text": "(3)"}, "@id": "ide2c24370cff54ae6a14d24a479f17892", "#text": "\n                  "}], "#text": "\n                ", "@id": "ida0ad46ae2c724b59a439e494394fe9b6"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Other requirements\n\t\t\t\tapplicable to compounding manufacturers"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A compounding manufacturer shall ensure that a\n\t\t\t\tpharmacist licensed in the State where the compounding manufacturer is located\n\t\t\t\texercises direct supervision over the operations of the compounding\n\t\t\t\tmanufacturer."}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "Licensed pharmacist\n\t\t\t\toversight"}, "#text": "\n                  ", "@id": "ide43c5f039b7043e0a01f3b2caca8b3a3"}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " its name, place of business, and unique facility identifier (which\n\t\t\t\tshall conform to the requirements for the unique facility identifier\n\t\t\t\testablished under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "), and a point of contact e-mail address, and\n\t\t\t\tshall indicate whether the compounding manufacturer intends to compound drug in\n\t\t\t\tshortage pursuant to ", "@entity-type": "act", "#text": "section 510", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:510"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (d)(3)(A)(ii)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:503A/ss:d/p:3/sp:A/cl:ii", "@proposed": "true"}], "#text": "During the period beginning on October 1 and ending\n\t\t\t\ton December 31 each year, each compounding manufacturer shall register with the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "Annual\n\t\t\t\tregistration"}, "#text": "\n                      ", "@id": "idba6ce7dbaee64711b0e39c45006cc985"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", shall immediately register\n\t\t\t\twith the ", "@entity-type": "act", "#text": "subsection (b)(1)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:503A/ss:b/p:1", "@proposed": "true"}, {"#tail": " and provide the information described under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". The\n\t\t\t\tSecretary shall establish a timeline for registration for the first year\n\t\t\t\tfollowing the effective date of the ", "@entity-type": "act", "#text": "clause (i)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:503A/ss:g/p:2/sp:A/cl:i", "@proposed": "true"}, {"#tail": ". In no case may registration be required until at least 60\n\t\t\t\tcalendar days following publication of the timeline in the Federal\n\t\t\t\tRegister.", "@entity-type": "act", "#text": "Pharmaceutical Compounding Quality and\n\t\t\t\tAccountability Act", "@value": "Pharmaceutical Compounding Quality and Accountability Act", "@proposed": "true"}], "#text": "Each compounding manufacturer, upon first engaging\n\t\t\t\tin the operations described in "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "New compounding\n\t\t\t\tmanufacturers"}, "#text": "\n                      ", "@id": "id27a0f8b72f994d4a9cf6f621db53fe03"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall make available\n\t\t\t\tfor inspection, to any person so requesting, any registration filed pursuant to\n\t\t\t\tthis subparagraph.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Availability of\n\t\t\t\tregistration for inspection"}, "#text": "\n                      ", "@id": "id0e55c097e7664826b3875ca09c0eb62a"}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Registration of\n\t\t\t\tcompounding manufacturers"}, "#text": "\n                    ", "@id": "idbe8f3efbad2f4bd1ac995131857262f0"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "identifying the drugs\n\t\t\t\tcompounded by such compounding manufacturer during the previous 6-month period;\n\t\t\t\tand"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id2927a2dcd85641a9b117def3bed8fa99", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", providing the active ingredient, the\n\t\t\t\tsource of such active ingredient, the National Drug Code number, if available,\n\t\t\t\tof the source drug or bulk active ingredient, the strength of the active\n\t\t\t\tingredient per unit, the dosage form and route of administration, the package\n\t\t\t\tdescription, the number of individual units produced, the National Drug Code\n\t\t\t\tnumber of the final product, if assigned.", "@entity-type": "act", "#text": "subclause (I)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:503A/ss:g/p:2/sp:B/cl:i/scl:I", "@proposed": "true"}, "#text": "with respect to each\n\t\t\t\tdrug identified under "}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "idbca12792019a46ec91ab9748f058f066", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall submit to the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:503A/ss:g/p:2/sp:A", "@proposed": "true"}, {"#tail": ", once during the\n\t\t\t\tmonth of June of each year and once during the month of December of each year,\n\t\t\t\ta report\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Each compounding manufacturer who registers with the\n\t\t\t\t"}, "#text": "\n                      ", "@id": "id3decbc45d57f4d4083e4928f722c72ee"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be prepared in such form and manner as the\n\t\t\t\t", "@entity-type": "act", "#text": "clause (i)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:503A/ss:g/p:2/sp:B/cl:i", "@proposed": "true"}, {"#tail": " may prescribe by regulation or guidance.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Each\n\t\t\t\treport under "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Form"}, "#text": "\n                      ", "@id": "id585a8607b78e4476a0577d203c939d73"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", unless the ", "@entity-type": "act", "#text": "subparagraph (A)(iii)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:503A/ss:g/p:2/sp:A/cl:iii", "@proposed": "true"}, {"#tail": " finds that such an exemption would\n\t\t\t\tbe inconsistent with the protection of the public health.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Reports\n\t\t\t\tsubmitted pursuant to this subparagraph shall be exempt from inspection under\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Confidentiality"}, "#text": "\n                      ", "@id": "id8953DD0A14714917A54BFCFC25C951A7"}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Drug reporting by\n\t\t\t\tcompounding manufacturers"}, "#text": "\n                    ", "@id": "id93373ff8b90045b3a84dcd2fd38d7361"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " by electronic means unless the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " grants a request for\n\t\t\t\twaiver of such requirement because use of electronic means is not reasonable\n\t\t\t\tfor the person requesting waiver.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Registrations and drug reporting under this\n\t\t\t\tparagraph (including the submission of updated information) shall be submitted\n\t\t\t\tto the "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Electronic registration\n\t\t\t\tand reporting"}, "#text": "\n                    ", "@id": "id12fa974cab8a40f7a183ccea3767be28"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 704", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:704"}, "#text": "Compounding manufacturers shall be subject to inspection\n\t\t\t\tpursuant to "}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                      ", "@id": "ide56a8141242f4208a8ad4e2b4853fd57"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through one or more officers or\n\t\t\t\temployees duly designated by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall inspect compounding\n\t\t\t\tmanufacturers described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in accordance with a risk-based schedule\n\t\t\t\testablished by the Secretary.", "@entity-type": "act", "#text": "clause (i)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:503A/ss:g/p:2/sp:D/cl:i", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Risk-based\n\t\t\t\tschedule"}, "#text": "\n                      ", "@id": "idfe374fff1fd64ac89f484e4e1b61f683"}, {"#tail": "\n                  ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "The compliance history of\n\t\t\t\tthe compounding manufacturer."}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id6adb0a9ca1f645189c5d49cf171fb51c", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "The record, history, and\n\t\t\t\tnature of recalls linked to the compounding manufacturer."}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "idcd34db1a40444826875693ec276bdfc6", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "The inherent risk of\n\t\t\t\tthe drug compounded at the compounding manufacturer."}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@id": "id41f8e8795373405e9b7df430490f1a1c", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "The inspection frequency\n\t\t\t\tand history of the compounding manufacturer, including whether the compounding\n\t\t\t\tmanufacturer has been inspected pursuant to section 704 within the last 4\n\t\t\t\tyears."}, "enum": {"#tail": "\n                        ", "#text": "(IV)"}, "@id": "id6ed0ab7e409643f799f4a948c9a1861f", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as an entity that intends\n\t\t\t\tto compound pursuant to ", "@entity-type": "act", "#text": "subsection (g)(2)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:503A/ss:g/p:2", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (d)(3)(A)(ii)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:503A/ss:d/p:3/sp:A/cl:ii", "@proposed": "true"}], "#text": "Whether the compounding\n\t\t\t\tmanufacturer has registered under "}, "enum": {"#tail": "\n                        ", "#text": "(V)"}, "@id": "id308C1E1D4F874DC89BFC9647D60A09FA", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for purposes of allocating\n\t\t\t\tinspection resources.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Any other criteria\n\t\t\t\tdeemed necessary and appropriate by the "}, "enum": {"#tail": "\n                        ", "#text": "(VI)"}, "@id": "id5bf233fa992345ddb0700fc574679aba", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Risk\n\t\t\t\tfactors"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "clause\n\t\t\t\t(ii)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:503A/ss:g/p:2/sp:D/cl:ii", "@proposed": "true"}, {"#tail": " shall inspect compounding manufacturers according to the\n\t\t\t\tknown safety risks of such compounding manufacturers, which shall be based on\n\t\t\t\tthe following factors:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In establishing the risk-based schedule under "}, "#text": "\n                      ", "@id": "id272e6b267a96408e90b43cfe25035d8b"}], "enum": {"#tail": "\n                    ", "#text": "(D)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Risk-based inspection\n\t\t\t\tfrequency"}, "#text": "\n                    ", "@id": "idf94086caad924d09ae1ecbff4413895c"}], "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Registration of\n\t\t\t\tcompounding manufacturers and reporting of drugs"}, "#text": "\n                  ", "@id": "idbf6b203779854262b4d0f4344413896a"}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "an event occurring in the\n\t\t\t\tcourse of the use of the drug in professional practice;"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id468159450af44743b0a83d155ebdc677", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "an event occurring from\n\t\t\t\tan overdose of the drug, whether accidental or intentional;"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "idd6fe423581e64328a3b50ac50649305b", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "an event occurring from\n\t\t\t\tabuse of the drug;"}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@id": "idfe68787d05514503b3ed2ff4debe1ee1", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "an event occurring from\n\t\t\t\twithdrawal of the drug; and"}, "enum": {"#tail": "\n                        ", "#text": "(IV)"}, "@id": "id55d42d31df4d4312839a494d819bd186", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "any failure of expected\n\t\t\t\tpharmacological action of the drug."}, "enum": {"#tail": "\n                        ", "#text": "(V)"}, "@id": "id80a98a1d6edc46adb1bbd248364d874f", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "Adverse\n\t\t\t\tevent"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means any\n\t\t\t\thealth-related event associated with the use of a compounded drug that is\n\t\t\t\tadverse, including\u2014", "#text": "adverse event"}, "#text": "The term "}, "#text": "\n                      ", "@id": "id28a97e7d0cfb44a9b78ffa98e4e4861a"}, {"#tail": "\n                  ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "results in\u2014"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "item": [{"#tail": "\n                        ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "death;"}, "enum": {"#tail": "\n                          ", "#text": "(aa)"}, "@id": "id8333af37896343b4a532b9fbc76f2155", "#text": "\n                          "}, {"#tail": "\n                        ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "an adverse drug event\n\t\t\t\tthat places the patient at immediate risk of death from the adverse drug event\n\t\t\t\tas it occurred (not including an adverse drug event that might have caused\n\t\t\t\tdeath had it occurred in a more severe form);"}, "enum": {"#tail": "\n                          ", "#text": "(bb)"}, "@id": "idc2c2252f28ad4486aa3ba412d4d74f62", "#text": "\n                          "}, {"#tail": "\n                        ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "inpatient\n\t\t\t\thospitalization or prolongation of existing hospitalization;"}, "enum": {"#tail": "\n                          ", "#text": "(cc)"}, "@id": "id4b6d2565ef1945d599d40da8b38ee0d0", "#text": "\n                          "}, {"#tail": "\n                        ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "a persistent or\n\t\t\t\tsignificant incapacity or substantial disruption of the ability to conduct\n\t\t\t\tnormal life functions; or"}, "enum": {"#tail": "\n                          ", "#text": "(dd)"}, "@id": "id2987632179c943c38384e58245d1d636", "#text": "\n                          "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "a congenital anomaly or\n\t\t\t\tbirth defect; or"}, "enum": {"#tail": "\n                          ", "#text": "(ee)"}, "@id": "id5323a1ecf19943848aafadc0162d8015", "#text": "\n                          "}], "#text": "\n                        ", "@id": "idf0511a08e2bc47868d3ad4d88e1941f0"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subclause (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:3/sp:A/cl:ii/scl:I", "@proposed": "true"}, "#text": "based on appropriate\n\t\t\t\tmedical judgment, may jeopardize the patient and may require a medical or\n\t\t\t\tsurgical intervention to prevent an outcome described in "}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id5410a93ba55047b096092f000389c883", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Serious adverse\n\t\t\t\tevent"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means an\n\t\t\t\tadverse event that\u2014", "#text": "serious adverse event"}, "#text": "The term "}, "#text": "\n                      ", "@id": "id923eda2a98224e48af05d4a8d1f60de8"}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "Definitions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis paragraph:"}, "#text": "\n                    ", "@id": "id81292a1059cc440d9b1de0facab4df76"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as soon as practicable, but in no case later than 15 calendar days\n\t\t\t\tafter the initial receipt of the applicable information. Such manufacturer\n\t\t\t\tshall investigate and submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " followup reports for each such\n\t\t\t\tinstance not later than 15 calendar days after receipt of new information or as\n\t\t\t\trequested by the Secretary. Unless and until the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " establishes the\n\t\t\t\tcontent and format of adverse event reports by guidance or regulation, reports\n\t\t\t\tshall be submitted in accordance with the content and format requirements under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If a compounding manufacturer becomes aware of any serious\n\t\t\t\tadverse event, such manufacturer shall submit reports of each instance to the\n\t\t\t\t", "external-xref": [{"#tail": " of title 21, Code of Federal Regulations (or any successor\n\t\t\t\tregulations) or ", "@parsable-cite": "cfr/21/310.305", "#text": "section 310.305", "@legal-doc": "regulation"}, {"#tail": " of title 21, Code of Federal Regulations (or any\n\t\t\t\tsuccessor regulations).", "@parsable-cite": "cfr/21/600.80", "#text": "section 600.80", "@legal-doc": "regulation"}]}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "header": {"#tail": "\n                        ", "#text": "15-day\n\t\t\t\treport"}, "#text": "\n                        ", "@id": "ide3a131298ac04333bca6764de8d1ef3a"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", including a history of\n\t\t\t\tactions taken during the year because of each report, using the content,\n\t\t\t\tformat, and manner established by the ", "@entity-type": "act", "#text": "subclause (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:3/sp:B/cl:i/scl:I", "@proposed": "true"}, {"#tail": " by guidance or regulation.\n\t\t\t\tUntil such time as the Secretary publishes such guidance or regulation, each\n\t\t\t\tcompounding manufacturer shall retain such summaries as part of the records to\n\t\t\t\tbe maintained in accordance with ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:3/sp:C", "@proposed": "true"}], "#text": "Compounding manufacturers that report serious adverse\n\t\t\t\tevents shall submit in December of each year a narrative summary of any\n\t\t\t\tanalysis of each report submitted under "}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "header": {"#tail": "\n                        ", "#text": "Annual\n\t\t\t\treport"}, "#text": "\n                        ", "@id": "idce400218e3244a3786977df2da216f13"}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "Adverse event reporting\n\t\t\t\trequirement"}, "#text": "\n                      ", "@id": "id531395721efd4253ab12596b9aa6b7da"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " a\n\t\t\t\tproduct quality report, in a form and manner established by the Secretary by\n\t\t\t\tguidance or regulation.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Not later than 3 calendar days after the\n\t\t\t\tcompounding manufacturer becomes aware of information pertaining to sterility,\n\t\t\t\tstability, or other product quality concerns that could result in serious\n\t\t\t\tadverse events, the compounding manufacturer shall submit to the "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Product quality\n\t\t\t\treporting requirement"}, "#text": "\n                      ", "@id": "id926abd868bd6472ea151e785fa879cd9"}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Reports"}, "#text": "\n                    ", "@id": "id81b01225ae01462cb8c6936f3c2cbeb2"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in regulations.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "A compounding manufacturer shall maintain for a period of\n\t\t\t\t10 years records of all serious adverse drug events known to the compound\n\t\t\t\tmanufacturer in accordance with ", "external-xref": {"#tail": " of title 21, Code of Federal\n\t\t\t\tRegulations (or any successor regulation), or as otherwise directed by the\n\t\t\t\t", "@parsable-cite": "usc/21/314", "#text": "section 314.80(i)", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Maintenance of\n\t\t\t\trecords"}, "#text": "\n                    ", "@id": "idd87a376ba44942e2ab7156ab51568172"}], "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Adverse event\n\t\t\t\treporting"}, "#text": "\n                  ", "@id": "id7f513631d07145d282222c5e373d39fe"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "quote": {"#tail": " or a reasonable comparable alternative statement\n\t\t\t\t(as specified by the ", "#text": "This\n\t\t\t\tis a compounded drug."}, "#text": "the statement ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ") that prominently identifies the drug as a\n\t\t\t\tcompounded drug;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "ide5d35ad95d314ddbbc2553f8450b1198", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the name, address, and\n\t\t\t\tphone number of the applicable compounding manufacturer; and"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id7d5295b9e78d46f898d2467f481c3b40", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "with respect to the\n\t\t\t\tcompounded drug\u2014"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the lot or batch\n\t\t\t\tnumber;"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id05cb2b6f8c8d44c28a6432603c3f6ecf", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the established name of\n\t\t\t\tthe medication;"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id029b7c1356f64f33ae111648a8e321de", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the dosage form and\n\t\t\t\tstrength;"}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@id": "idc98b6a647a0f4a2c914ff3536f878440", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the statement of\n\t\t\t\tquantity or volume, as appropriate;"}, "enum": {"#tail": "\n                        ", "#text": "(IV)"}, "@id": "id75058c4e17524d1cb15dfe13a2fd3939", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the date that the drug\n\t\t\t\twas compounded;"}, "enum": {"#tail": "\n                        ", "#text": "(V)"}, "@id": "idc1f6f2402af447029f5602a918ee673f", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the expiration\n\t\t\t\tdate;"}, "enum": {"#tail": "\n                        ", "#text": "(VI)"}, "@id": "id6f80c6b7daf747e19182e2820b15d189", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "storage and handling\n\t\t\t\tinstructions;"}, "enum": {"#tail": "\n                        ", "#text": "(VII)"}, "@id": "id3a405c3b57b747ba9a741d84a8998494", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the National Drug Code\n\t\t\t\tnumber, if available;"}, "enum": {"#tail": "\n                        ", "#text": "(VIII)"}, "@id": "iddac39d6c9ab54ae2a3052729e1f46ff1", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "quote": {"#tail": " statement as required by ", "#text": "not for\n\t\t\t\tresale"}, "#text": "the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "subsection (f)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:f/p:3", "@proposed": "true"}}, "enum": {"#tail": "\n                        ", "#text": "(IX)"}, "@id": "id0f9634bf852e47f393693ce37ebca988", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a list of active and inactive ingredients, identified by established\n\t\t\t\tname and the quantity or proportion of each ingredient.", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(B)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:4/sp:B/cl:i", "@proposed": "true"}, "#text": "subject to "}, "enum": {"#tail": "\n                        ", "#text": "(X)"}, "@id": "id8f8e36b7bf3c4ff3b5f19f0f411430c7", "#text": "\n                        "}], "#text": "\n                      ", "@id": "id6bb40f5966eb4bb793c5ef95a97c8c54"}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "Label"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tlabel of a drug compounded by a compounding manufacturer shall include\u2014"}, "#text": "\n                    ", "@id": "id24b3f5ffddf94d60a08a1a06729ed1ac"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", if there is not space on the label for such\n\t\t\t\tinformation;", "@entity-type": "act", "#text": "subparagraph (A)(iii)(X)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:4/sp:A/cl:iii/scl:X", "@proposed": "true"}, "#text": "the information described\n\t\t\t\tunder "}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "idb636d8a2192143e390781e55c3c41047", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the following\n\t\t\t\tinformation to facilitate adverse event reporting: www.fda.gov/medwatch and\n\t\t\t\t1\u2013800-FDA-1088; and"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id24e75cf8470f4ee59a9c1e8d6d4efecf", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the directions for use,\n\t\t\t\tincluding, as appropriate, dosage and administration."}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "idfa756a0e4aac4e6aa4321e26fc02f2d6", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Container"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tcontainer from which the individual units of a drug compounded by a compounding\n\t\t\t\tmanufacturer are removed for dispensing or for administration (such as a\n\t\t\t\tplastic bag containing individual product syringes) shall include\u2014"}, "#text": "\n                    ", "@id": "idaae5438c18384ebeab1d4a57eec01284"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The label and labeling of a drug compounded by a\n\t\t\t\tcompounding manufacturer shall include any other information as determined\n\t\t\t\tnecessary and specified in regulations promulgated by the "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Additional\n\t\t\t\tinformation"}, "#text": "\n                    ", "@id": "id59bb8e8d68454c6e81909e6de08e0caf"}], "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Labeling of\n\t\t\t\tdrugs"}, "#text": "\n                  ", "@id": "idcefa210248204c5cb20403b579f5510d"}], "#text": "\n                ", "@id": "id3e8c8a6dea9e49f5b362978fc472e067"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(h)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Compounding\n\t\t\t\tmanufacturer establishment and reinspection fees"}, "paragraph": [{"#tail": "\n                ", "@id": "idf06dbf92b4c04ec397a09780ab7b7f3e", "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "Definitions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis subsection\u2014"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section\n\t\t\t\t735(11)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:11"}, "term": {"#tail": " has the meaning given such term in ", "#text": "affiliate"}, "#text": "the term\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "ida30997ca601e426b93b43cc01d711c99", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means the total worldwide gross annual sales, in United\n\t\t\t\tStates dollars, for a compounding manufacturer, including the sales of all the\n\t\t\t\taffiliates of the compounding manufacturer; and", "#text": "gross\n\t\t\t\tannual sales"}, "#text": "the term "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "idf9a4a3970ff741af82eadfe02303de41", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " subsequent to an inspection\n\t\t\t\tconducted under such provision which identified noncompliance materially\n\t\t\t\trelated to an applicable requirement of this Act, specifically to determine\n\t\t\t\twhether compliance has been achieved to the ", "@entity-type": "act", "#text": "section 704", "@value": "Federal Food, Drug, and Cosmetic Act/s:704"}, {"#tail": " satisfaction.", "@entity-type": "federal-body", "#text": "Secretary\u2019s", "@entity-id": "7500"}], "term": {"#tail": " means, with respect to a compounding manufacturer, 1\n\t\t\t\tor more inspections conducted under ", "#text": "reinspection"}, "#text": "the term\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "id80be8f9fe43c464485367ee48b339553", "#text": "\n                    "}]}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "an annual establishment\n\t\t\t\tfee from each compounding manufacturer; and"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "id88306b62729444d985dc737adddee953", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "a reinspection fee from\n\t\t\t\teach compounding manufacturer subject to a reinspection in such fiscal\n\t\t\t\tyear."}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "idabea42da173946fda75e40ca795ba2fc", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall, in accordance with this subsection, assess and collect\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "For fiscal year 2015 and each subsequent fiscal year, the\n\t\t\t\t"}, "#text": "\n                    ", "@id": "idF0A0BC277E0A4469925265D712E6B1D0"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A compounding manufacturer subject to multiple\n\t\t\t\treinspections in a fiscal year shall be subject to a reinspection fee for each\n\t\t\t\treinspection."}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Multiple\n\t\t\t\treinspections"}, "#text": "\n                    ", "@id": "id29B241CFFE8E43228EF35FAE66E7E9A0"}], "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Establishment and\n\t\t\t\treinspection fees"}, "#text": "\n                  ", "@id": "idac7e73d9858e4947999b164cffb12bcc"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish the\n\t\t\t\testablishment and reinspection fee to be collected under this subsection for\n\t\t\t\teach fiscal year, based on the methodology described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and shall\n\t\t\t\tpublish such fee in a Federal Register notice not later than 60 calendar days\n\t\t\t\tbefore the start of each such year.", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Establishment and\n\t\t\t\treinspection fee setting"}, "#text": "\n                  ", "@id": "id974e8036a4b047dd9307fafd481d5b1a"}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the amount of the annual establishment fee under ", "@entity-type": "act", "#text": "subparagraph (D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:D", "@proposed": "true"}, {"#tail": " shall be equal to the sum of\u2014", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:2", "@proposed": "true"}], "#text": "except as provided\n\t\t\t\tin "}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";\n\t\t\t\tplus", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:B", "@proposed": "true"}, "#text": "$15,000,\n\t\t\t\tmultiplied by the inflation adjustment factor described in "}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id756FEA7A89B14D96B26469DE7D333269", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:C", "@proposed": "true"}, "#text": "the small\n\t\t\t\tbusiness adjustment factor described in "}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id49d8f1fcfdfa4372ac26a9805874e0b2", "#text": "\n                        "}], "#text": "\n                      ", "@id": "id812F4D15CDBB4A1B8ADEE6804FD60002"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be equal to $15,000,\n\t\t\t\tmultiplied by the inflation adjustment factor described in ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:2", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:B", "@proposed": "true"}], "#text": "the amount of any\n\t\t\t\treinspection fee (if applicable) under "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "idB6CAA63035B74ADD830F9F8AA9140262", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "For each compounding manufacturer in a fiscal\n\t\t\t\tyear\u2014"}, "#text": "\n                    ", "@id": "id5897436d9d9b4413a23781170f38e9d3"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "one;"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id4ed805c038364db09ead2e88ca4994ff", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", of all personnel compensation and benefits paid\n\t\t\t\twith respect to such positions for the first 3 years of the preceding 4 fiscal\n\t\t\t\tyears, multiplied by the proportion of personnel compensation and benefits\n\t\t\t\tcosts to total costs of an average full-time equivalent position of the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " for the first 3 years of the preceding 4 fiscal years;\n\t\t\t\tand", "@entity-type": "federal-body", "#text": "Food\n\t\t\t\tand Drug Administration", "@entity-id": "7524"}], "#text": "the average\n\t\t\t\tannual percent change in the cost, per full-time equivalent position of the\n\t\t\t\t"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id233f6077d30a41b985dae881f55795ef", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for the first 3 years of the preceding 4 fiscal years.", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}, "#text": "the average annual\n\t\t\t\tpercent change that occurred in the Consumer Price Index for urban consumers\n\t\t\t\t(U.S. City Average; Not Seasonally Adjusted; All items; Annual Index) for the\n\t\t\t\tfirst 3 years of the preceding 4 years of available data multiplied by the\n\t\t\t\tproportion of all costs other than personnel compensation and benefits costs to\n\t\t\t\ttotal costs of an average full-time equivalent position of the "}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@id": "idfad9158887a648e3aa84d3d4c7f8b25c", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be adjusted by the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:A", "@proposed": "true"}, {"#tail": " by\n\t\t\t\tnotice, published in the Federal Register, for a fiscal year by the amount\n\t\t\t\tequal to the sum of\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For fiscal year 2015 and subsequent fiscal years, the fee\n\t\t\t\tamounts established in "}, "#text": "\n                      ", "@id": "id9865dd76cf854ad3b4416c738ee346b3"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t\tbe added on a compounded basis to the sum of all adjustments made each fiscal\n\t\t\t\tyear after fiscal year 2014 under ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:B/cl:i", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:B/cl:i", "@proposed": "true"}], "#text": "The adjustment made each fiscal year under "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Compounded\n\t\t\t\tbasis"}, "#text": "\n                      ", "@id": "id0b5e3f6477254c6fb4626b2c0e9549d2"}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Inflation adjustment\n\t\t\t\tfactor"}, "#text": "\n                    ", "@id": "ida18c3a0e3a564e639dec3f99c1c3583f"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the number of small\n\t\t\t\tbusinesses that will pay a reduced establishment fee for such fiscal year;\n\t\t\t\tand"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "idd454a93e55be4ec3895bbbb246ee46c0", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:D", "@proposed": "true"}, "#text": "the adjustment to the\n\t\t\t\testablishment fee necessary to achieve total fees equaling the total fees that\n\t\t\t\tthe Secretary would have collected if no entity qualified for the small\n\t\t\t\tbusiness exception in "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "idf0d541a4a46a4d0e97f1183e2056d251", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Small business\n\t\t\t\tadjustment factor"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be an amount established by the ", "@entity-type": "act", "#text": "subparagraph (A)(i)(II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:A/cl:i/scl:II", "@proposed": "true"}, {"#tail": " for\n\t\t\t\teach fiscal year based on the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\u2019s estimate of\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The small business adjustment factor referred\n\t\t\t\tto "}, "#text": "\n                    ", "@id": "id1f50613fbe6d4e848190d16ba9602a86"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal year shall be equal to ", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:2", "@proposed": "true"}, {"#tail": " in such fiscal year.", "@entity-type": "act", "#text": "subparagraph (A)(i)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:A/cl:i/scl:I", "@proposed": "true"}], "#text": "In the case of a compounding manufacturer with gross\n\t\t\t\tannual sales of $1,000,000 or less in the 12 months ending April 1 of the\n\t\t\t\tfiscal year immediately preceding the fiscal year in which the fees under this\n\t\t\t\tsubsection are assessed, the amount of the establishment fee under ", "fraction": {"#tail": " of the amount\n\t\t\t\tcalculated under ", "#text": "1/3"}}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                      ", "@id": "idc92c3ada8c204c3e874ef717421fe629"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " a written request for such exception, in a format\n\t\t\t\tspecified by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in guidance, certifying its gross annual sales for\n\t\t\t\tthe 12 months ending April 1 of the fiscal year immediately preceding the\n\t\t\t\tfiscal year in which fees under this subsection are assessed. Any such\n\t\t\t\tapplication must be submitted to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " not later than April 30 for the\n\t\t\t\tfollowing fiscal year. Any statement or representation made to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tshall be subject to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "uscode", "#text": "\n                        ", "external-xref": {"#tail": " of title 18, United States Code", "@parsable-cite": "usc/18/1001", "#text": "section 1001", "@legal-doc": "usc"}, "@value": "usc/18/1001"}], "#text": "To\n\t\t\t\tqualify for the exception under this subparagraph, a small business shall\n\t\t\t\tsubmit to the "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Application"}, "#text": "\n                      ", "@id": "id53495fecda514a5da4f8d3dc8bae423c"}], "enum": {"#tail": "\n                    ", "#text": "(D)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Exception for small\n\t\t\t\tbusinesses"}, "#text": "\n                    ", "@id": "id9a02275438d24f51931468268f91c1fb"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal year, the ", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:4/sp:C", "@proposed": "true"}, {"#tail": " shall provide for the\n\t\t\t\tcrediting of fees from the previous year to the next year if the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\toverestimated the amount of the small business adjustment factor for such\n\t\t\t\tprevious fiscal year, and consider the need to account for any adjustment of\n\t\t\t\tfees and such other factors as the Secretary determines appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In establishing the small business adjustment factor under\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(E)"}, "header": {"#tail": "\n                    ", "#text": "Crediting of\n\t\t\t\tfees"}, "#text": "\n                    ", "@id": "id6f15f87ccf5040f099749f9eb31a52c0"}], "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Amount of establishment\n\t\t\t\tfee and reinspection fee"}, "#text": "\n                  ", "@id": "id9557988DA6C34821B84C39BECEB8BC80"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make all of the fees collected pursuant\n\t\t\t\tto ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "clauses (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:2/sp:A/cl:i", "@proposed": "true"}, {"#tail": " available solely to pay for the\n\t\t\t\tcosts of oversight of compounding manufacturers.", "@entity-type": "act", "#text": "(ii) of paragraph (2)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(5)"}, "header": {"#tail": "\n                  ", "#text": "Use of\n\t\t\t\tfees"}, "#text": "\n                  ", "@id": "id438d918d22fd4fceb606cfbe63da1273"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " pursuant to this\n\t\t\t\tsubsection shall be used to supplement and not supplant any other Federal funds\n\t\t\t\tavailable to carry out the activities described in this section.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Funds received by the "}, "enum": {"#tail": "\n                  ", "#text": "(6)"}, "header": {"#tail": "\n                  ", "#text": "Supplement not\n\t\t\t\tsupplant"}, "#text": "\n                  ", "@id": "id8d56ad346cae4fa39b4e24590b0ccc1d"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " salaries and expenses appropriation account\n\t\t\t\twithout fiscal year limitation to such appropriation account for salaries and\n\t\t\t\texpenses with such fiscal year limitation. The sums transferred shall be\n\t\t\t\tavailable solely for the purpose of paying the costs of oversight of\n\t\t\t\tcompounding manufacturers.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "Fees authorized under this subsection shall\n\t\t\t\tbe collected and available for obligation only to the extent and in the amount\n\t\t\t\tprovided in advance in appropriations Acts. Such fees are authorized to remain\n\t\t\t\tavailable until expended. Such sums as may be necessary may be transferred from\n\t\t\t\tthe "}, "enum": {"#tail": "\n                  ", "#text": "(7)"}, "header": {"#tail": "\n                  ", "#text": "Crediting and\n\t\t\t\tavailability of fees"}, "#text": "\n                  ", "@id": "id6bada36eb2b54dc1b2f53878dc0b0cbc"}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for such fiscal year.", "@entity-type": "act", "#text": "subsection (g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g", "@proposed": "true"}, "#text": "A compounding manufacturer shall remit the establishment fee\n\t\t\t\tdue under this subsection in a fiscal year when submitting a registration\n\t\t\t\tpursuant to "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "Establishment\n\t\t\t\tfee"}, "#text": "\n                    ", "@id": "ideccb464b15f448f68d61b1c0f6948a70"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall specify in the Federal Register notice\n\t\t\t\tdescribed in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " the manner in which reinspection fees assessed under\n\t\t\t\tthis subsection shall be collected and the timeline for payment of such fees.\n\t\t\t\tSuch a fee shall be collected after the ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:h/p:3", "@proposed": "true"}, {"#tail": " has conducted a reinspection\n\t\t\t\tof the compounding manufacturer involved.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Reinspection\n\t\t\t\tfee"}, "#text": "\n                    ", "@id": "idd90c129d36604bb0a21814b9f262d153"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in a fiscal year until the date that the compounding manufacturer remits\n\t\t\t\tthe establishment fee under this subsection for such fiscal year.", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g", "@proposed": "true"}, "#text": "A\n\t\t\t\tcompounding manufacturer shall not be considered registered under "}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "Registration"}, "#text": "\n                      ", "@id": "idead9bf1088f44aa8aeba019ac0fc9783"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " until the fees owed for such compounding manufacturer\n\t\t\t\tunder this subsection have been paid.", "@entity-type": "act", "#text": "section 502(cc)", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:cc"}, "#text": "All\n\t\t\t\tdrugs manufactured, prepared, propagated, compounded, or processed by a\n\t\t\t\tcompounding manufacturer for which any establishment fee or reinspection fee\n\t\t\t\thas not been paid as required by this subsection shall be deemed misbranded\n\t\t\t\tunder "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Misbranding"}, "#text": "\n                      ", "@id": "id4efc5ac806b449dfac6de098014e0bd9"}], "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Effect of failure to\n\t\t\t\tpay fees"}, "#text": "\n                    ", "@id": "ide4ca8af7c7db4d6fbc5b014ec507067f"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not receive payment of\n\t\t\t\ta fee assessed under this subsection within 30 calendar days after it is due,\n\t\t\t\tsuch fee shall be treated as a claim of the United States Government subject to\n\t\t\t\tprovisions of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "uscode", "#text": "subchapter II of ", "external-xref": {"#tail": " of title 31, United States\n\t\t\t\tCode", "@parsable-cite": "usc-chapter/31/37", "#text": "chapter 37", "@legal-doc": "usc-chapter"}, "@value": "usc-chapter/31/37/II"}], "#text": "In any case where the "}, "enum": {"#tail": "\n                    ", "#text": "(D)"}, "header": {"#tail": "\n                    ", "#text": "Collection of unpaid\n\t\t\t\tfees"}, "#text": "\n                    ", "@id": "id9b7e5a158bf04effba83fd19b0f3d90c"}], "enum": {"#tail": "\n                  ", "#text": "(8)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Collection of\n\t\t\t\tfees"}, "#text": "\n                  ", "@id": "id9bf6d321983745008d2703fac3492f93"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tshall submit a report to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Health Education Labor and Pensions\n\t\t\t\tof the Senate", "@entity-id": "SSHR00"}, {"#tail": ", to include a description of fees assessed and collected for\n\t\t\t\teach year, a summary description of entities paying the fees, and the number of\n\t\t\t\tinspections and reinspections of such entities performed each year.", "@entity-type": "committee", "#text": "Committee on Energy and Commerce of the House of\n\t\t\t\tRepresentatives", "@entity-id": "HIF00"}], "#text": "Not later than 120 calendar days after each fiscal year\n\t\t\t\tin which fees are assessed and collected under this subsection, the "}, "enum": {"#tail": "\n                  ", "#text": "(9)"}, "header": {"#tail": "\n                  ", "#text": "Annual report to\n\t\t\t\tcongress"}, "#text": "\n                  ", "@id": "id39e674a293bf4b9cb48371dbda5e97cf"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "\n                    ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n                  ", "@entity-type": "auth-auth-approp", "#text": "\n                      ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ", there is authorized to be appropriated ", "#text": "For fiscal year 2015 and each subsequent fiscal\n\t\t\t\tyear", "@amount": "indefinite", "@year": "2015,.."}, "{http://namespaces.cato.org/catoxml}property": {"#tail": ".", "#text": "for fees under this subsection an\n\t\t\t\tamount equivalent to the total amount of fees assessed for such fiscal year\n\t\t\t\tunder this subsection", "@name": "purpose"}}}, "enum": {"#tail": "\n                  ", "#text": "(10)"}, "header": {"#tail": "\n                  ", "#text": "Authorization of\n\t\t\t\tappropriations"}, "#text": "\n                  ", "@id": "iddaa332140cb4492ba1a59215dcfa53ad"}], "#text": "\n                ", "@id": "id7087cc151e13442aa2540203186ca4a2"}, {"#tail": "\n            ", "enum": {"#tail": "\n                ", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Action by secretary\n\t\t\t\tregarding complaints from state boards of pharmacy"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall encourage States to\n\t\t\t\tidentify to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " facilities that are licensed by a State as a pharmacy\n\t\t\t\tthat appear to be entities that are required to be registered with the\n\t\t\t\tSecretary as a compounding manufacturer.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "Identification of\n\t\t\t\tcompounding manufacturers"}, "#text": "\n                  ", "@id": "id19013B2BF73F45638669BB88CE84C968"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall designate a point of contact and establish a format and\n\t\t\t\tprocedure for a State Board of Pharmacy to notify the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " if it appears\n\t\t\t\tto a State Board of Pharmacy that an entity licensed by a State as a pharmacy\n\t\t\t\tis required to be registered with the Secretary as a compounding\n\t\t\t\tmanufacturer.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Designation"}, "#text": "\n                  ", "@id": "idc5024a1e81b8470ab5bb065c86213ab8"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " determines that such an entity described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " is\n\t\t\t\trequired to be registered with the ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:i/p:2", "@proposed": "true"}, {"#tail": " as a compounding manufacturer, the\n\t\t\t\tSecretary shall transmit such determination to the State Board of Pharmacy in\n\t\t\t\tthe State in which the entity is located, and to the State Board of Pharmacy in\n\t\t\t\tthe notifying State, if different, within 15 calendar days of such\n\t\t\t\tdetermination and shall make such determination publicly available on the\n\t\t\t\tInternet Web site of the Food and Drug Administration.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If\n\t\t\t\tthe "}, "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Determination"}, "#text": "\n                  ", "@id": "id2f727e726f8e43fb98f0cda47e8386a8"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall encourage direct communications between States regarding\n\t\t\t\ttraditional compounders. Nothing in this subsection shall expand the\n\t\t\t\tSecretary\u2019s authority over or responsibility for traditional\n\t\t\t\tcompounders.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Effect"}, "#text": "\n                  ", "@id": "id31afcf63000c48619639d31afdd8591a"}], "#text": "\n                ", "@id": "id4d6796f1a44a46df975fa8496551a1b6"}], "#text": "\n              ", "@id": "id8994ab4e162a418d9ee81cfd07186b84"}, "@reported-display-style": "italic", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "id83856A282B5F4F7C859969D3931ECFD2"}, "#text": "\n          ", "@id": "ida5655f6e37844fb0ab2856c0fbae689d"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 301", "@value": "Federal Food, Drug, and Cosmetic Act/s:301"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 331", "@value": "usc/21/331"}, "@parsable-cite": "usc/21/331", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(c)"}, "header": {"#tail": "\n          ", "#text": "Prohibited\n\t\t\t act"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by\n\t\t\t striking ", "@entity-type": "act", "#text": "subsection (e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:e"}, "#text": "in ", "quote": [{"#tail": " and inserting ", "#text": "417, 416, 504"}, {"#tail": "; and", "#text": "417, 416, 503A(g),\n\t\t\t 504"}]}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "@id": "id7750ca3bb4da4f48bbe52c20aba25bc2", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "by adding at the end the\n\t\t\t following:"}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n\t\t\t\t\t", "@reported-display-style": "italic", "subsection": {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(ccc)"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "quote": {"#tail": " as required by\n\t\t\t\t", "#text": "not for resale"}, "#text": "The resale of a\n\t\t\t\tcompounded drug that is labeled ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A", "@proposed": "true"}}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "@display-inline": "yes-display-inline", "#text": "\n                  ", "@id": "id1C516EFB10A444D9BA73C270E792FAAD", "@commented": "no"}, {"@committee-id": "SSHR00", "@changed": "added", "@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or the failure to submit a\n\t\t\t\treport as required by ", "@entity-type": "act", "#text": "subsection (g) of section 503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g", "@proposed": "true"}, {"#tail": " or ", "@entity-type": "act", "#text": "subsection (g)(2)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:2/sp:B", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(g)(3) of such\n\t\t\t\tsection", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:3", "@proposed": "true"}], "#text": "The failure to register\n\t\t\t\tin accordance with "}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "@reported-display-style": "italic", "#text": "\n                  ", "@id": "idBE7D41F4D2EE40359F22886AD1F8EC97", "@commented": "no"}], "#text": "\n                ", "@id": "idB240394C7F40429D850AF85AE859C065", "@commented": "no"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t\t", "@id": "idA77E9CEA27BB467497A1283C0E8F834B"}, "#text": "\n            ", "@id": "id51a62f1c609341d2bfe008cdaeda3b7d"}], "#text": "\n          ", "@id": "idda700afb73f547ef93f8f6f031b622f6"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall conduct a study and submit to ", "@entity-type": "federal-body", "#text": "Comptroller General of\n\t\t\t the United States", "@entity-id": "0500"}, {"#tail": " a report on the\n\t\t\t safety of animal drug compounding and the availability of safe and effective\n\t\t\t drugs for animals.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#text": "Not later than November 1, 2016, the "}, "enum": {"#tail": "\n          ", "#text": "(d)"}, "header": {"#tail": "\n          ", "#text": "Report by\n\t\t\t GAO"}, "#text": "\n          ", "@id": "id8787c88655224bb1b12301108d9b8c4a"}], "#text": "\n        ", "@id": "idd84bc06e0d654f88a98b823dcd2bddd9"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "103."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Other\n\t\t\t requirements"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 502", "@value": "Federal Food, Drug, and Cosmetic Act/s:502"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 352", "@value": "usc/21/352"}, "@parsable-cite": "usc/21/352", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Labeling"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "@reported-display-style": "italic", "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subsections (f)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:f/p:3", "@proposed": "true"}, {"#tail": ", as applicable.", "@entity-type": "act", "#text": "(g)(4) of section 503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g/p:4", "@proposed": "true"}], "#text": "If it is a compounded\n\t\t\t\tdrug and the labeling does not include the information as required by\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(bb)"}, "@id": "id1ea2e402a2b04a83b1f0099db1a240ab", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "If the advertising or\n\t\t\t\tpromotion of a compounded drug is false or misleading in any particular."}, "enum": {"#tail": "\n              ", "#text": "(cc)"}, "@id": "id316779C71B9C43CB8596820C5CE7C7F1", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t503A(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A/ss:g", "@proposed": "true"}, "#text": "If it is a drug, and it\n\t\t\t\twas manufactured, prepared, propagated, compounded, or processed by a\n\t\t\t\tcompounding manufacturer for which fees have not been paid as required by\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(dd)"}, "@id": "idce00a289ea9747ae9ac4730eee141556", "#text": "\n              "}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "id0fee8a42123b4519bfa327d8a30eb13f"}, "#text": "\n          ", "@id": "idacfc9170a57d420199b68a040339fc21"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following\n\t\t\t flush text:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 704(a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:704/ss:a/p:2"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 374(a)(2)", "@value": "usc/21/374/a/2"}, "@parsable-cite": "usc/21/374", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Application of\n\t\t\t inspection requirements to compounding manufacturers"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "@reported-display-style": "italic", "quoted-block-continuation-text": {"{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not apply with respect to compounding\n\t\t\t\tmanufacturers (as such term is defined in ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:704/ss:a/p:2/sp:A"}, {"#tail": ").", "@entity-type": "act", "#text": "section\n\t\t\t\t503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A", "@proposed": "true"}], "@committee-id": "SSHR00", "@changed": "added", "#tail": "\n            ", "@reported-display-style": "italic", "#text": "The\n\t\t\t\texemption in ", "@quoted-block-continuation-text-level": "section"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "idAC24258CBBD8411AA381B0B43C891363"}, "#text": "\n          ", "@id": "idec03e494f1fe488a849df20f9dce519a"}], "#text": "\n        ", "@id": "idad2964bbb9084e169acf987e8c5c6734"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "104."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Implementation"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall consult with\n\t\t\t relevant stakeholders including pharmacists, professional associations, patient\n\t\t\t and public health advocacy groups, manufacturers and physicians.", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "#text": "In implementing this title (and the amendments made\n\t\t\t by this title), the "}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Consultation with\n\t\t\t stakeholders"}, "#text": "\n          ", "@id": "id8119ef23916349e78d30d0695a54b12f"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "#text": "In\n\t\t\t promulgating any regulations to implement this title (and the amendments made\n\t\t\t by this title), the "}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Regulations"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "issue a notice of\n\t\t\t proposed rulemaking that includes the proposed regulation;"}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "@id": "idf52f8c24e019477884648838d7d8eea4", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "provide a period of not\n\t\t\t less than 60 calendar days for comments on the proposed regulation; and"}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "@id": "idbfa83df662564bae9bc87292cb173183", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "publish the final\n\t\t\t regulation not more than 18 months following publication of the proposed rule\n\t\t\t and not less than 30 calendar days before the effective date of such final\n\t\t\t regulation."}, "enum": {"#tail": "\n            ", "#text": "(3)"}, "@id": "id86ff6839b27a475db2588b432c9eee98", "#text": "\n            "}], "#text": "\n          ", "@id": "idefe7444ece3c494a9defe14f266ca5cd"}], "#text": "\n        ", "@id": "ide6ee348803ae4fb8bc4c5a7c5e75897d"}, {"@section-type": "subsequent-section", "#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "This title (and the\n\t\t\t amendments made by this title) shall take effect on the date that is 1 year\n\t\t\t after the date of enactment of this Act.", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "105."}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "id8e3448708e0a42a8a3391b881e33f907", "@commented": "no"}], "enum": {"#tail": "\n      ", "#text": "I"}, "header": {"#tail": "\n\t\t\t", "#text": "Human drug\n\t\t\t compounding"}, "@reported-display-style": "italic", "#text": "\n      ", "@id": "idEB894060157D477FA065F99E8E3BF89C"}, {"@committee-id": "SSHR00", "@changed": "added", "#tail": "\n  ", "section": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": {"short-title": {"#tail": "\n          ", "#text": "Drug Supply Chain Security\n\t\t\t Act"}, "#tail": ".", "#text": "\n            "}, "#text": "This title may be cited\n\t\t\t as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "201."}, "header": {"#tail": "\n        ", "#text": "Short\n\t\t\t title"}, "#text": "\n        ", "@id": "id564FD637D4154F21AC4047FDB1025B55"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\n\t\t\t by adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Chapter V", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 351 et seq.", "@value": "usc/21/351/etseq"}, "@parsable-cite": "usc/21/351", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "202."}, "header": {"#tail": "\n        ", "#text": "Pharmaceutical\n\t\t\t distribution supply chain"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "@reported-display-style": "italic", "subchapter": {"#tail": "\n          ", "section": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "In this subchapter:", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n              ", "#text": "581."}, "header": {"#tail": "\n              ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n              ", "@id": "ideef85786e6e4448a82a8fdc3a8d0cd4b", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Authorized"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "authorized"}, "#text": "The\n\t\t\t\tterm "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, "#text": "in the case of a\n\t\t\t\tmanufacturer or repackager, having a valid registration in accordance with\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id5fd0b970ed59442ebd08725e85b9f2a6", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act"}, "#text": "\n                      "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t\tin accordance with ", "@entity-type": "act", "#text": "section 583", "@value": "Federal Food, Drug, and Cosmetic Act/s:583", "@proposed": "true"}, {"#tail": " and complying with the licensure reporting\n\t\t\t\trequirements under ", "@entity-type": "act", "#text": "section 582(a)(6)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:6", "@proposed": "true"}, {"#tail": ", as amended by the\n\t\t\t\t", "@entity-type": "act", "#text": "section 503(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e"}], "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\twholesale distributor, having a valid license under State law or "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idc777bdcd84684193a11ff361923eb832", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", in accordance with ", "@entity-type": "act", "#text": "section 584(a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:a/p:1", "@proposed": "true"}, {"#tail": " and complying with the\n\t\t\t\tlicensure reporting requirements under ", "@entity-type": "act", "#text": "section 582(a)(7)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:7", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "act", "#text": "section 584(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:b", "@proposed": "true"}], "#text": "in the case of a\n\t\t\t\tthird-party logistics provider, having a valid license under State law or\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "idb5edff8174814ba48dbf752f38eadfe8", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\tdispenser, having a valid license under State law."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id973ebb0363c24427b1fc03b88e389579", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "id0DE960C30F5D4659AF50A28B7C172896", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Dispenser"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": "\u2014", "#text": "dispenser"}, "#text": "The\n\t\t\t\tterm "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "means a retail pharmacy,\n\t\t\t\thospital pharmacy, a group of chain pharmacies under common ownership and\n\t\t\t\tcontrol that do not act as a wholesale distributor, or any other person\n\t\t\t\tauthorized by law to dispense or administer prescription drugs, and the\n\t\t\t\taffiliated warehouses or distribution centers of such entities under common\n\t\t\t\townership and control that do not act as a wholesale distributor; and"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id867DB2E332B64235BDB11DF0611DDB89", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t512(a)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:a/p:5"}, "#text": "does not include a person\n\t\t\t\twho dispenses only products to be used in animals in accordance with "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idF2DAD3182D2941A496F0B699068ED4A4", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": ", with respect to a product within the possession\n\t\t\t\tor control of an entity, means the removal of such product from the\n\t\t\t\tpharmaceutical distribution supply chain, which may include disposal or return\n\t\t\t\tof the product for disposal or other appropriate handling and other actions,\n\t\t\t\tsuch as retaining a sample of the product for further additional physical\n\t\t\t\texamination or laboratory analysis of the product by a manufacturer or\n\t\t\t\tregulatory or law enforcement agency.", "#text": "disposition"}, "#text": "The\n\t\t\t\tterm "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Disposition"}, "#text": "\n                ", "@id": "idda6e5010dba747a1b2d8ecdd06b68e3d"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or the dispensing of a product approved under ", "@entity-type": "act", "#text": "section\n\t\t\t\t503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, {"#tail": ".", "@entity-type": "act", "#text": "section 512(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:b"}], "term": [{"#tail": " or\n\t\t\t\t", "#text": "distribute"}, {"#tail": " means the sale, purchase, trade, delivery, handling,\n\t\t\t\tstorage, or receipt of a product, and does not include the dispensing of a\n\t\t\t\tproduct pursuant to a prescription executed in accordance with ", "#text": "distribution"}], "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Distribute or\n\t\t\t\tdistribution"}, "#text": "\n                ", "@id": "idfc8c6328ffab42028fe7be8dab64309d"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means the\n\t\t\t\twholesale distributor that directly purchased the product from the manufacturer\n\t\t\t\tand is the sole distributor of that manufacturer's product to a subsequent\n\t\t\t\trepackager, wholesale distributor, or dispenser.", "#text": "exclusive distributor"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Exclusive\n\t\t\t\tdistributor"}, "#text": "\n                ", "@id": "idA4556EC0B2CC41AF84B2BF988AE9948F"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a sealed case\n\t\t\t\tcontaining only product that has a single National Drug Code number belonging\n\t\t\t\tto a single lot.", "#text": "homogeneous case"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n                ", "#text": "Homogeneous\n\t\t\t\tcase"}, "#text": "\n                ", "@id": "idB8542D170FD443EBBF73DC6D6E5D0930"}, {"#tail": "\n              ", "@id": "idcc29be85d8fb47eca661045e3e5c492a", "enum": {"#tail": "\n                ", "#text": "(7)"}, "header": {"#tail": "\n                ", "#text": "Illegitimate\n\t\t\t\tproduct"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means a\n\t\t\t\tproduct for which credible evidence shows that the product\u2014", "#text": "illegitimate product"}, "#text": "The term "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is counterfeit, diverted,\n\t\t\t\tor stolen;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idbdc9e75337b5485bb65e6274b048cade", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is intentionally\n\t\t\t\tadulterated such that the product would result in serious adverse health\n\t\t\t\tconsequences or death to humans;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idd54d466db0474169b9ccb4de2f0e0bef", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is the subject of a\n\t\t\t\tfraudulent transaction; or"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id67376b7d3cc540598383ede303182493", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "appears otherwise unfit\n\t\t\t\tfor distribution such that the product could result in serious adverse health\n\t\t\t\tconsequence or death to humans."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "idb832a731104e4ee9904253db2236efa5", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "idb7b0012b4a0f452a87274ee277cced57", "enum": {"#tail": "\n                ", "#text": "(8)"}, "header": {"#tail": "\n                ", "#text": "Licensed"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "licensed"}, "#text": "The\n\t\t\t\tterm "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tor ", "@entity-type": "act", "#text": "section 503(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e"}, {"#tail": ", as applicable;", "@entity-type": "act", "#text": "section 582(a)(6)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:6", "@proposed": "true"}], "#text": "in the case of a\n\t\t\t\twholesale distributor, having a valid license in accordance with "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "ida8901217a7554e20bc566672ddf65844", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "section 584(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:a", "@proposed": "true"}, {"#tail": ", as applicable; and", "@entity-type": "act", "#text": "section 582(a)(7)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:7", "@proposed": "true"}], "#text": "in the case of a\n\t\t\t\tthird-party logistics provider, having a valid license in accordance with\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id8342cdba6825407eacd88c81de0a8e23", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\tdispenser, having a valid license under State law."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id8da2ce2d40f24370874be6bc0cf7188c", "#text": "\n                  "}]}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or a license issued\n\t\t\t\tunder ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " for such product, or if such\n\t\t\t\tproduct is not the subject of an approved application or license, the person\n\t\t\t\twho manufactured the product;", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "#text": "a\n\t\t\t\tperson that holds an application approved under "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id1978b386d1d04192967f4ad8e8517513", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " that obtains the product directly from a\n\t\t\t\tperson described in this clause or ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:9/sp:A/cl:i", "@proposed": "true"}, {"#tail": " or ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:9/sp:A/cl:i", "@proposed": "true"}, {"#tail": "; or", "@entity-type": "act", "#text": "(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:9/sp:A/cl:iii", "@proposed": "true"}], "#text": "a co-licensed partner of\n\t\t\t\tthe person described in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id05f65ef9ea6e476a91c8c2ac150c3ad2", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:9/sp:A/cl:i", "@proposed": "true"}, {"#tail": " that receives the product directly from\n\t\t\t\ta person described in this clause or ", "@entity-type": "act", "#text": "(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:9/sp:A/cl:ii", "@proposed": "true"}, {"#tail": " or ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:9/sp:A/cl:i", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:9/sp:A/cl:ii", "@proposed": "true"}], "#text": "an affiliate of a\n\t\t\t\tperson described in "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id3268b5f273094db6aa7a4be5e495209a", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": {"#tail": " means, with respect to\n\t\t\t\ta product\u2014", "#text": "manufacturer"}, "#text": "The term "}, "#text": "\n                  ", "@id": "id72745956D4AB4382BA6DD09567D01742"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or a member of a group of corporations that would constitute an\n\t\t\t\taffiliated group, as so defined, but for the fact that one or more members of\n\t\t\t\tthe group is a corporation described in ", "@entity-type": "act", "#text": "section 1504(a) of the Internal\n\t\t\t\tRevenue Code", "@value": "Internal Revenue Code/s:1504/ss:a"}, {"#tail": ".", "@entity-type": "act", "#text": "section 1504(b)(3) of the Internal\n\t\t\t\tRevenue Code", "@value": "Internal Revenue Code/s:1504/ss:b/p:3"}], "term": {"#tail": " means a member of\n\t\t\t\tan affiliated group, as that term is defined in ", "#text": "affiliate"}, "#text": "For\n\t\t\t\tpurposes of this paragraph, the term "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Affiliate"}, "#text": "\n                  ", "@id": "id4131D0517CDE4E97936D6BB7483B4B2E"}], "enum": {"#tail": "\n                ", "#text": "(9)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Manufacturer"}, "#text": "\n                ", "@id": "idc2ba4fef09cd4a559c553eb6d5c67a4b"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means the smallest\n\t\t\t\tindividual saleable unit of product for distribution by a manufacturer or\n\t\t\t\trepackager that is intended by the manufacturer for ultimate sale to the\n\t\t\t\tdispenser of such product.", "#text": "package"}, "#text": "The term "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "id103EE59DEDC041A792BA89C1798770C5"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " is the smallest container of product introduced into commerce by\n\t\t\t\tthe manufacturer or repackager that is intended by the manufacturer or\n\t\t\t\trepackager for individual sale to a dispenser.", "#text": "individual saleable\n\t\t\t\tunit"}, "#text": "For purposes of this paragraph, an "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Individual saleable\n\t\t\t\tunit"}, "#text": "\n                  ", "@id": "id191B8FE881A74B9790C10F1FCABEEAB6"}], "enum": {"#tail": "\n                ", "#text": "(10)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Package"}, "#text": "\n                ", "@id": "idbebe001ab3a74f3e8df7ad497703bcb1"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "term": {"#tail": " means a drug for\n\t\t\t\thuman use subject to ", "#text": "prescription drug"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(11)"}, "header": {"#tail": "\n                ", "#text": "Prescription\n\t\t\t\tdrug"}, "#text": "\n                ", "@id": "id279715e6549647d093eaa2da91dbbb9d"}, {"#tail": "\n              ", "text": {"{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", does not include blood or blood components intended\n\t\t\t\tfor transfusion, radioactive drugs or radioactive biological products (as\n\t\t\t\tdefined in ", "@entity-type": "act", "#text": "section 582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582"}, {"#tail": " or by a State pursuant to an\n\t\t\t\tagreement with such Commission under ", "@entity-type": "federal-body", "#text": "Nuclear Regulatory Commission", "@entity-id": "3100"}, {"#tail": ", ", "@entity-type": "act", "#text": "clause xiv", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:23/sp:B/cl:xiv", "@proposed": "true"}, {"#tail": ", or\n\t\t\t\t", "@entity-type": "act", "#text": "xv", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:23/sp:B/cl:xv", "@proposed": "true"}, {"#tail": ", any medical gas (as defined in ", "@entity-type": "act", "#text": "xvi of paragraph (23)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:23/sp:B/cl:xvi", "@proposed": "true"}, {"#tail": "), or a drug\n\t\t\t\tcompounded in compliance with ", "@entity-type": "act", "#text": "section 575", "@value": "Federal Food, Drug, and Cosmetic Act/s:575"}, {"#tail": ".", "@entity-type": "act", "#text": "section 503A", "@value": "Federal Food, Drug, and Cosmetic Act/s:503A", "@proposed": "true"}], "term": {"#tail": " means a prescription drug in a finished dosage form\n\t\t\t\tfor administration to a patient without substantial further manufacturing (such\n\t\t\t\tas capsules, tablets, and lyophilized products before reconstitution), but for\n\t\t\t\tpurposes of ", "#text": "product"}, "#tail": "\n\t\t\t\t\t\t\t", "external-xref": {"#tail": " of title 21, Code of Federal Regulations) that are\n\t\t\t\tregulated by the ", "@parsable-cite": "cfr/21/600.3", "#text": "section 600.3(ee)", "@legal-doc": "regulation"}, "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", an intravenous product described in ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 274 of the Atomic Energy Act of\n\t\t\t\t1954", "@value": "Atomic Energy Act of 1954/s:274"}, "@entity-type": "law-citation", "#text": "\n                    ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "uscode", "#text": "42 U.S.C. 2021", "@value": "usc/42/2021"}, "@parsable-cite": "usc/42/2021", "#text": "\n                      ", "@legal-doc": "usc"}}, "#text": "The\n\t\t\t\tterm "}, "enum": {"#tail": "\n                ", "#text": "(12)"}, "header": {"#tail": "\n                ", "#text": "Product"}, "#text": "\n                ", "@id": "idf4eb5ac4cf4a4935abddcc3412b41714"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a\n\t\t\t\tstandardized graphic that includes, in both human-readable form and on a\n\t\t\t\tmachine-readable data carrier that conforms to the standards developed by a\n\t\t\t\twidely-recognized international standards development organization, the\n\t\t\t\tstandardized numerical identifier, lot number, and expiration date of the\n\t\t\t\tproduct.", "#text": "product identifier"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(13)"}, "header": {"#tail": "\n                ", "#text": "Product\n\t\t\t\tidentifier"}, "#text": "\n                ", "@id": "id1372100e9d964a47a5e04237ca567317"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means the storage or identification of a product,\n\t\t\t\tto prevent distribution or transfer of the product, in a physically separate\n\t\t\t\tarea clearly identified for such use or through other procedures.", "#text": "quarantine"}, "#text": "The\n\t\t\t\tterm "}, "enum": {"#tail": "\n                ", "#text": "(14)"}, "header": {"#tail": "\n                ", "#text": "Quarantine"}, "#text": "\n                ", "@id": "idD8B19FBC402A4FA6A8C459D61FFF297D"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a person who owns or operates an\n\t\t\t\testablishment that repacks and relabels a product or package for further\n\t\t\t\tsale.", "#text": "repackager"}, "#text": "The\n\t\t\t\tterm "}, "enum": {"#tail": "\n                ", "#text": "(15)"}, "header": {"#tail": "\n                ", "#text": "Repackager"}, "#text": "\n                ", "@id": "idfc1ae01e2a3e4b76b7d87951fdcf77f8"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means providing product to the authorized immediate\n\t\t\t\ttrading partner from which such product was purchased, or to a returns\n\t\t\t\tprocessor or reverse logistics provider for handling of such product.", "#text": "return"}, "#text": "The\n\t\t\t\tterm "}, "enum": {"#tail": "\n                ", "#text": "(16)"}, "header": {"#tail": "\n                ", "#text": "Return"}, "#text": "\n                ", "@id": "id6e1ecf8ad846456ead6533e801b1a612"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": [{"#tail": " or ", "#text": "returns\n\t\t\t\tprocessor"}, {"#tail": " means a person who\n\t\t\t\towns or operates an establishment that dispositions or otherwise processes\n\t\t\t\tsaleable or nonsaleable product received from an authorized trading partner\n\t\t\t\tsuch that the product may be processed for credit to the purchaser,\n\t\t\t\tmanufacturer, or seller or disposed of for no further distribution.", "#text": "reverse logistics provider"}], "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(17)"}, "header": {"#tail": "\n                ", "#text": "Returns processor or\n\t\t\t\treverse logistics provider"}, "#text": "\n                ", "@id": "id59513d18bd0a4ab4b7e19a68fe88cd80"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " refers to the\n\t\t\t\ttransfer of a product from one pharmacy to another to fill a prescription for\n\t\t\t\tan identified patient. Such term does not include the transfer of a product\n\t\t\t\tfrom one pharmacy to another for the purpose of increasing or replenishing\n\t\t\t\tstock in anticipation of a potential need.", "#text": "specific patient need"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(18)"}, "header": {"#tail": "\n                ", "#text": "Specific patient\n\t\t\t\tneed"}, "#text": "\n                ", "@id": "ide2d7a0e74f584e609bfa1f628932608f"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a set of numbers or characters used to uniquely\n\t\t\t\tidentify each package or homogenous case that is composed of the National Drug\n\t\t\t\tCode that corresponds to the specific product (including the particular package\n\t\t\t\tconfiguration) combined with a unique alphanumeric serial number of up to 20\n\t\t\t\tcharacters.", "#text": "standardized numerical\n\t\t\t\tidentifier"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(19)"}, "header": {"#tail": "\n                ", "#text": "Standardized numerical\n\t\t\t\tidentifier"}, "#text": "\n                ", "@id": "id8b5cbdca10e24f7aa100de541ac01038"}, {"#tail": "\n              ", "@id": "id7a5be6ac9c594085ab9feab1952f47a5", "enum": {"#tail": "\n                ", "#text": "(20)"}, "header": {"#tail": "\n                ", "#text": "Suspect\n\t\t\t\tproduct"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means a product for\n\t\t\t\twhich there is reason to believe that such product\u2014", "#text": "suspect product"}, "#text": "The term "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is potentially\n\t\t\t\tcounterfeit, diverted, or stolen;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id7e6716ca3f6748d4ac3ada3b0b802e3b", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is potentially\n\t\t\t\tintentionally adulterated such that the product would result in serious adverse\n\t\t\t\thealth consequences or death to humans;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id052cc2f672554e99bd71077b78088f5c", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is potentially the\n\t\t\t\tsubject of a fraudulent transaction; or"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "idfcfd88f1ce4945c09267b7de46142712", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "appears otherwise unfit\n\t\t\t\tfor distribution such that the product would result in serious adverse health\n\t\t\t\tconsequences or death to humans."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id96e183e271b947669efec9532068d5de", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": "\n\t\t\t\tmeans an entity that provides or coordinates warehousing, or other logistics\n\t\t\t\tservices of a product in interstate commerce on behalf of a manufacturer,\n\t\t\t\twholesale distributor, or dispenser of a product, but does not take ownership\n\t\t\t\tof the product, nor have responsibility to direct the sale or disposition of\n\t\t\t\tthe product.", "#text": "third-party logistics provider"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(21)"}, "header": {"#tail": "\n                ", "#text": "Third-party logistics\n\t\t\t\tprovider"}, "#text": "\n                ", "@id": "idad2a332b6e7b4d368be38907b0939cf0"}, {"#tail": "\n              ", "@id": "id20902c8261dd4b4b855f6743136f34b7", "enum": {"#tail": "\n                ", "#text": "(22)"}, "header": {"#tail": "\n                ", "#text": "Trading\n\t\t\t\tpartner"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "trading partner"}, "#text": "The term "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "a manufacturer,\n\t\t\t\trepackager, wholesale distributor, or dispenser from whom a manufacturer,\n\t\t\t\trepackager, wholesale distributor, or dispenser accepts direct ownership of a\n\t\t\t\tproduct or to whom a manufacturer, repackager, wholesale distributor, or\n\t\t\t\tdispenser transfers direct ownership of a product; or"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id75928a1a6dd748ac8fb9ea81e21491fd", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "a third-party logistics\n\t\t\t\tprovider from whom a manufacturer, repackager, wholesale distributor, or\n\t\t\t\tdispenser accepts direct possession of a product or to whom a manufacturer,\n\t\t\t\trepackager, wholesale distributor, or dispenser transfers direct possession of\n\t\t\t\ta product."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id1fb7169c63574c21afb9a8bd314338cb", "#text": "\n                  "}]}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means the transfer of\n\t\t\t\tproduct between persons in which a change of ownership occurs.", "#text": "transaction"}, "#text": "The term "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "id85e1fa0df95e4fdfa8cf504c40502c8a"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ") or within a manufacturer;", "@entity-type": "act", "#text": "section\n\t\t\t\t1504(a) of the Internal Revenue Code of 1986", "@value": "Internal Revenue Code of 1986/s:1504/ss:a"}, "#text": "intracompany distribution\n\t\t\t\tof any product between members of an affiliated group (as defined in "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id2ef68d4493674ec9938b2695ba9a1bc6", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tproduct among hospitals or other health care entities that are under common\n\t\t\t\tcontrol;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "ide2c942b3b82a4893b51633a7513ca608", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", except that a drug shortage not caused by a public health\n\t\t\t\temergency shall not constitute an emergency medical reason;", "@entity-type": "act", "#text": "section 319 of the Public Health\n\t\t\t\tService Act", "@value": "Public Health Service Act/s:319"}, "#text": "the\n\t\t\t\tdistribution of a product for emergency medical reasons including a public\n\t\t\t\thealth emergency declaration pursuant to "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id276e3165050941f28309435d6e25dc44", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "#text": "the dispensing\n\t\t\t\tof a product pursuant to a valid prescription executed in accordance with\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "@id": "idfb8d47894a554d0d926e2b0a26d0440d", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 503(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:d"}, "#text": "the distribution\n\t\t\t\tof product samples by a manufacturer or a licensed wholesale distributor in\n\t\t\t\taccordance with "}, "enum": {"#tail": "\n                    ", "#text": "(v)"}, "@id": "id4dad1453ca81467481f6587e20bb18a5", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the distribution of\n\t\t\t\tblood or blood components intended for transfusion;"}, "enum": {"#tail": "\n                    ", "#text": "(vi)"}, "@id": "idec7611c0f765471485047fc0ba58336e", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the distribution of\n\t\t\t\tminimal quantities of product by a licensed retail pharmacy to a licensed\n\t\t\t\tpractitioner for office use;"}, "enum": {"#tail": "\n                    ", "#text": "(vii)"}, "@id": "id3a415585c57d40f39f49ff11d8f7b69d", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to a nonprofit affiliate of the organization to the extent\n\t\t\t\totherwise permitted by law;", "@entity-type": "act", "#text": "section 501(c)(3) of the Internal\n\t\t\t\tRevenue Code of 1954", "@value": "Internal Revenue Code of 1954/s:501/ss:c/p:3"}, "#text": "the sale,\n\t\t\t\tpurchase, or trade of a drug or an offer to sell, purchase, or trade a drug by\n\t\t\t\ta charitable organization described in "}, "enum": {"#tail": "\n                    ", "#text": "(viii)"}, "@id": "id529815ee76ff4d7082e14d52fd73e4d5", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tproduct pursuant to the sale or merger of a pharmacy or pharmacies or a\n\t\t\t\twholesale distributor or wholesale distributors, except that any records\n\t\t\t\trequired to be maintained for the product shall be transferred to the new owner\n\t\t\t\tof the pharmacy or pharmacies or wholesale distributor or wholesale\n\t\t\t\tdistributors;"}, "enum": {"#tail": "\n                    ", "#text": "(ix)"}, "@id": "ida15ad14a23864e7995409f4a74798dd9", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 512(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:b"}, "#text": "the dispensing of\n\t\t\t\ta product approved under "}, "enum": {"#tail": "\n                    ", "#text": "(x)"}, "@id": "id4e6a280bfd364451b255337948958c55", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " or\n\t\t\t\tby a State pursuant to an agreement with such Commission under ", "@entity-type": "federal-body", "#text": "Nuclear Regulatory Commission", "@entity-id": "3100"}, "#text": "products transferred to\n\t\t\t\tor from any facility that is licensed by the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 274 of\n\t\t\t\tthe Atomic Energy Act of 1954", "@value": "Atomic Energy Act of 1954/s:274"}, "@entity-type": "law-citation", "#text": "\n                        ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                        ", "@entity-type": "uscode", "#text": "42 U.S.C. 2021", "@value": "usc/42/2021"}, "@parsable-cite": "usc/42/2021", "#text": "\n                          ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n                    ", "#text": "(xi)"}, "@id": "idecf8e564a4c7441e89c3c3340a8bc58b", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "a combination product\n\t\t\t\tthat is\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(xii)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "a product comprised of a\n\t\t\t\tdevice and 1 or more other regulated components (such as a drug/device,\n\t\t\t\tbiologic/device, or drug/device/biologic) that are physically, chemically, or\n\t\t\t\totherwise combined or mixed and produced as a single entity;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "id856de6da470943959c08797305f7ab70", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "2 or more separate\n\t\t\t\tproducts packaged together in a single package or as a unit and comprised of a\n\t\t\t\tdrug and device or device and biological product; or"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "ide5c89ee4654d40a0aae823beb98e7628", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "quote": {"#tail": " as described in ", "#text": "medical convenience\n\t\t\t\tkit"}, "#text": "2 or more\n\t\t\t\tfinished medical devices plus one or more drug or biological products which are\n\t\t\t\tpackaged together in what is referred to as a ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "clause (xiii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:23/sp:B/cl:xiii", "@proposed": "true"}}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "idad73efd1cadb4a2f8be5e7f2926a6e1e", "#text": "\n                      "}], "#text": "\n                    ", "@id": "idf7f949528f51402884ea9424109fc14a"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "quote": {"#tail": ")\n\t\t\t\tif\u2014", "#text": "medical convenience kit"}, "#text": "the distribution of a\n\t\t\t\tcollection of finished medical devices or a collection of finished drug or\n\t\t\t\tbiological products assembled in kit form strictly for the convenience of the\n\t\t\t\tpurchaser or user (to be known as a "}, "enum": {"#tail": "\n                    ", "#text": "(xiii)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as a device manufacturer in accordance with ", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}, {"#tail": ";", "@entity-type": "act", "#text": "section\n\t\t\t\t510(b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:510/ss:b/p:2"}], "#text": "the medical convenience\n\t\t\t\tkit is assembled in an establishment that is registered with the "}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "id6f29a6f1b784436cba2b3894d209d21f", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the person who\n\t\t\t\tmanufacturers a medical convenience kit purchased the product contained in the\n\t\t\t\tmedical convenience kit directly from the pharmaceutical manufacturer or from a\n\t\t\t\twholesale distributor that purchased the product directly from the\n\t\t\t\tpharmaceutical manufacturer;"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "id21c3831654fb4067b0d6f408c19ab0e2", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the person who\n\t\t\t\tmanufacturers a medical convenience kit does not alter the primary container or\n\t\t\t\tlabel of the product as purchased from the manufacturer or wholesale\n\t\t\t\tdistributor;"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "id50074e2e76a14725bbf37b6cb1f13c61", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "Comprehensive Drug Abuse Prevention and Control Act\n\t\t\t\tof 1970", "@value": "Comprehensive Drug Abuse Prevention and Control Act of 1970"}, "#text": "the medical\n\t\t\t\tconvenience kit does not contain a controlled substance that appears in a\n\t\t\t\tschedule contained in the "}, "enum": {"#tail": "\n                      ", "#text": "(IV)"}, "@id": "id2f76cb38f136405ba964b848b6e0e257", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "the products contained in\n\t\t\t\tthe medical convenience kit are\u2014"}, "enum": {"#tail": "\n                      ", "#text": "(V)"}, "item": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "intravenous solutions\n\t\t\t\tintended for the replenishment of fluids and electrolytes;"}, "enum": {"#tail": "\n                        ", "#text": "(aa)"}, "#text": "\n                        ", "@id": "id9946b07719bd491a882bc04a701012c6", "@commented": "no"}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "products intended to\n\t\t\t\tmaintain the equilibrium of water and minerals in the body;"}, "enum": {"#tail": "\n                        ", "#text": "(bb)"}, "#text": "\n                        ", "@id": "id83169e7b0dc34d0d9112dcd733481958", "@commented": "no"}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "products intended for\n\t\t\t\tirrigation or reconstitution;"}, "enum": {"#tail": "\n                        ", "#text": "(cc)"}, "#text": "\n                        ", "@id": "ida8a7001d46c84fd48501fbb7545b0ddf", "@commented": "no"}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "anesthetics;"}, "enum": {"#tail": "\n                        ", "#text": "(dd)"}, "#text": "\n                        ", "@id": "id447a00837bde47fcbf3b19d7dae01d8d", "@commented": "no"}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "anticoagulants;"}, "enum": {"#tail": "\n                        ", "#text": "(ee)"}, "#text": "\n                        ", "@id": "id4f31ae30b6c54ccfa81fb2f8829e29b8", "@commented": "no"}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "vasopressors; or"}, "enum": {"#tail": "\n                        ", "#text": "(ff)"}, "#text": "\n                        ", "@id": "id415e5434fcfe423aa0a2e65787aca2ca", "@commented": "no"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "sympathicomimetics;"}, "enum": {"#tail": "\n                        ", "#text": "(gg)"}, "#text": "\n                        ", "@id": "idee2eb92470f94d32ac022d92f7f81ca1", "@commented": "no"}], "#text": "\n                      ", "@id": "id67cc18d501304120956f2a1ae44e2730", "@commented": "no"}], "#text": "\n                    ", "@id": "idc093ab22cec54016b0dc290e53ea8c9f"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the distribution of an\n\t\t\t\tintravenous product that, by its formulation, is intended for the replenishment\n\t\t\t\tof fluids and electrolytes (such as sodium, chloride, and potassium) or\n\t\t\t\tcalories (such as dextrose and amino acids);"}, "enum": {"#tail": "\n                    ", "#text": "(xiv)"}, "@id": "id69f27ef9ecb64b11adc6793ee07484d8", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the distribution of an\n\t\t\t\tintravenous product used to maintain the equilibrium of water and minerals in\n\t\t\t\tthe body, such as dialysis solutions;"}, "enum": {"#tail": "\n                    ", "#text": "(xv)"}, "@id": "id12530294cc164d36821772622fc376d8", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tproduct that is intended for irrigation or reconstitution, or sterile water,\n\t\t\t\twhether intended for such purposes or for injection;"}, "enum": {"#tail": "\n                    ", "#text": "(xvi)"}, "@id": "id70cce742ef304264894a443073c30383", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "); or", "@entity-type": "act", "#text": "section 575", "@value": "Comprehensive Drug Abuse Prevention and Control Act of 1970/s:575"}, "#text": "the distribution of a\n\t\t\t\tmedical gas (as defined in "}, "enum": {"#tail": "\n                    ", "#text": "(xvii)"}, "@id": "idf127af1045fe4ae6be819ee48bdee7f7", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " that meets the definition of a device under ", "@entity-type": "act", "#text": "section 351 of the Public\n\t\t\t\tHealth Service Act", "@value": "Public Health Service Act/s:351"}, {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t201(h)", "@value": "Federal Food, Drug, and Cosmetic Act/s:201/ss:h"}], "#text": "the\n\t\t\t\tdistribution or sale of any licensed product under "}, "enum": {"#tail": "\n                    ", "#text": "(xviii)"}, "@id": "idA050B63788504E278CB043049EBD6BEE", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Exemptions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "term": {"#tail": " does not include\u2014", "#text": "transaction"}, "#text": "The\n\t\t\t\tterm "}, "#text": "\n                  ", "@id": "id59e38a9fcd4a4d6985d67b634959974e"}], "enum": {"#tail": "\n                ", "#text": "(23)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Transaction"}, "#text": "\n                ", "@id": "idc351f735afc24d65bf79a47cacc7d6b5"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a\n\t\t\t\tstatement in paper or electronic form, including the transaction information\n\t\t\t\tfor each prior transaction going back to the manufacturer of the\n\t\t\t\tproduct.", "#text": "transaction history"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(24)"}, "header": {"#tail": "\n                ", "#text": "Transaction\n\t\t\t\thistory"}, "#text": "\n                ", "@id": "id8f6a79e496e74f0a95882c4c19f97a52"}, {"#tail": "\n              ", "@id": "idaa900461f34c40eb9fc14b16e596cadd", "enum": {"#tail": "\n                ", "#text": "(25)"}, "header": {"#tail": "\n                ", "#text": "Transaction\n\t\t\t\tinformation"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": "\n\t\t\t\tmeans\u2014", "#text": "transaction information"}, "#text": "The term "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the proprietary or\n\t\t\t\testablished name or names of the product;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idca98550e56a645c7b098fe9278326569", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the strength and dosage\n\t\t\t\tform of the product;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id386a30da80c0403880676fa3c3e4c469", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the National Drug Code\n\t\t\t\tnumber of the product;"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id7615f0999be64861956cf8426c3e698d", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the container\n\t\t\t\tsize;"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id0a077f0485af4fd6993f8de504062c45", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the number of\n\t\t\t\tcontainers;"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "ide94175caa17e44ce9c9c272738f14f1b", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the lot number of the\n\t\t\t\tproduct;"}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@id": "id82a3c8680b2b44cfacd679c332d9af65", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the date of the\n\t\t\t\ttransaction;"}, "enum": {"#tail": "\n                  ", "#text": "(G)"}, "@id": "id7efd3f6ccf5545ae834fd657660d584c", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the date of the shipment,\n\t\t\t\tif different from the date of the transaction;"}, "enum": {"#tail": "\n                  ", "#text": "(H)"}, "@id": "id27b76abda7c1484f98ff846bc709591f", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the business name and\n\t\t\t\taddress of the person from whom ownership is being transferred; and"}, "enum": {"#tail": "\n                  ", "#text": "(I)"}, "@id": "ide58569b4c2914634a89d62d17b7992ca", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the business name and\n\t\t\t\taddress of the person to whom ownership is being transferred."}, "enum": {"#tail": "\n                  ", "#text": "(J)"}, "@id": "id85c9627775484111bd479714c4ae17fb", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "id356d828b4997401b934b2a5e59241792", "enum": {"#tail": "\n                ", "#text": "(26)"}, "header": {"#tail": "\n                ", "#text": "Transaction\n\t\t\t\tstatement"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " is a statement,\n\t\t\t\tin paper or electronic form, that the entity transferring ownership in a\n\t\t\t\ttransaction\u2014", "#text": "transaction statement"}, "#text": "The "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"short-title": {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is authorized as required\n\t\t\t\tunder the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id18a4efa686ad445f85b79cc6c4f80097", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "received the product from\n\t\t\t\ta person that is authorized as required under the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id67a0a2fb0bb14a4a9b6ffcadb77d469a", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}, "#text": "received\n\t\t\t\ttransaction information and a transaction statement from the prior owner of the\n\t\t\t\tproduct, as required under "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id02781730D561448CB810679D29C5D390", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "did not knowingly ship a\n\t\t\t\tsuspect or illegitimate product;"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "idcac2d913ce84400db604f862b410483c", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section\n\t\t\t\t582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}, "#text": "had systems and\n\t\t\t\tprocesses in place to comply with verification requirements under "}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "idCDA67D75D0CF4EA4A7B1B2B5539EA460", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "did not knowingly provide\n\t\t\t\tfalse transaction information; and"}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@id": "idea18980e94fb47b7b3a8c9f801099fbf", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "did not knowingly alter\n\t\t\t\tthe transaction history."}, "enum": {"#tail": "\n                  ", "#text": "(G)"}, "@id": "id821bbce9d3ae4cfa969060d6c124b999", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "quote": {"#tail": " means determining whether the product identifier affixed\n\t\t\t\tto, or imprinted upon, a package or homogeneous case corresponds to the\n\t\t\t\tstandardized numerical identifier or lot number and expiration date assigned to\n\t\t\t\tthe product by the manufacturer or the repackager, as applicable in accordance\n\t\t\t\twith ", "#text": "verify"}, "term": {"#tail": " or\n\t\t\t\t", "#text": "verification"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}}, "enum": {"#tail": "\n                ", "#text": "(27)"}, "header": {"#tail": "\n                ", "#text": "Verification or\n\t\t\t\tverify"}, "#text": "\n                ", "@id": "id0fb40f67e3b04906a5268574b4d63b0b"}, {"#tail": "\n            ", "text": {"short-title": {"#tail": ").", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                    "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", as amended by the\n\t\t\t\t", "@entity-type": "act", "#text": "section 503(e)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:4", "@proposed": "true"}, "term": {"#tail": " means a\n\t\t\t\tperson (other than a manufacturer, a manufacturer's co-licensed partner, a\n\t\t\t\tthird-party logistics provider, or repackager) engaged in wholesale\n\t\t\t\tdistribution (as defined in ", "#text": "wholesale distributor"}, "#tail": "\n\t\t\t\t\t\t\t", "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(28)"}, "header": {"#tail": "\n                ", "#text": "Wholesale\n\t\t\t\tdistributor"}, "#text": "\n                ", "@id": "id1a6ab3c16a3341fbae288693e0fd2a42", "@commented": "no"}], "#text": "\n              ", "@id": "id3a18d9b0d1dd4088a70189c2cc31802e"}, {"#tail": "\n          ", "enum": {"#tail": "\n              ", "#text": "582."}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Requirements"}, "subsection": [{"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "In general"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Each manufacturer, repackager, wholesale distributor,\n\t\t\t\tthird-party logistics provider, and dispenser shall comply with the\n\t\t\t\trequirements set forth in this section with respect to the role of such\n\t\t\t\tmanufacturer, repackager, wholesale distributor, third-party logistics\n\t\t\t\tprovider, or dispenser in a transaction involving product. If an entity meets\n\t\t\t\tthe definition of more than one of the entities listed in the preceding\n\t\t\t\tsentence, such entity shall comply with all applicable requirements in this\n\t\t\t\tsection, but shall not be required to duplicate requirements."}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "Other\n\t\t\t\tactivities"}, "#text": "\n                  ", "@id": "idcad420f79ecc427da64d5d4f201df2f3"}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:b", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c", "@proposed": "true"}, {"#tail": ",\n\t\t\t\t", "@entity-type": "act", "#text": "(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e", "@proposed": "true"}, {"#tail": ". In establishing such standards, the Secretary shall consider the\n\t\t\t\tfeasibility of establishing standardized documentation to be used by members of\n\t\t\t\tthe pharmaceutical distribution supply chain to convey the transaction\n\t\t\t\tinformation, transaction history, and transaction statement to the subsequent\n\t\t\t\tpurchaser of a product and to facilitate the exchange of lot level data. The\n\t\t\t\tstandards established under this paragraph shall take into consideration the\n\t\t\t\tstandards established under section 505D and shall comply with a form and\n\t\t\t\tformat developed by a widely recognized international standards development\n\t\t\t\torganization.", "@entity-type": "act", "#text": "(f)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f", "@proposed": "true"}], "#text": "The Secretary shall, in consultation with other\n\t\t\t\tappropriate Federal officials, manufacturers, repackagers, wholesale\n\t\t\t\tdistributors, third-party logistics providers, dispensers, and other\n\t\t\t\tpharmaceutical distribution supply chain stakeholders, issue a draft guidance\n\t\t\t\tdocument that establishes standards for the interoperable exchange of\n\t\t\t\ttransaction information, transaction history, and transaction statements, in\n\t\t\t\tpaper or electronic format, for compliance with "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "idD874702E61B34786BA69B2EA8177F5AF"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t\tthe ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:2/sp:A", "@proposed": "true"}, {"#tail": " shall gather comments and information from stakeholders and\n\t\t\t\tmaintain such comments and information in a public docket for at least 60 days\n\t\t\t\tprior to issuing such guidance.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Prior to issuing the draft guidance under "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Public\n\t\t\t\tinput"}, "#text": "\n                    ", "@id": "id74B3639C825C49B5A31BD50BB211E381"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " not\n\t\t\t\tlater than 1 year after the date of enactment of the\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:2/sp:A", "@proposed": "true"}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tSecretary shall publish the standards established under "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Publication"}, "#text": "\n                    ", "@id": "id834853DFD1374AE0B59897AB12CD3B59"}], "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Initial\n\t\t\t\tstandards"}, "#text": "\n                  ", "@id": "id37f83c884ab54f1ab1fb5e22d634fd5f"}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " determines that such requirements would result in\n\t\t\t\tan undue economic hardship or for emergency medical reasons, including a public\n\t\t\t\thealth emergency declaration pursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ";", "@entity-type": "act", "#text": "section 319 of the Public Health\n\t\t\t\tService Act", "@value": "Public Health Service Act/s:319"}], "#text": "establish a\n\t\t\t\tprocess by which an authorized manufacturer, repackager, wholesale distributor,\n\t\t\t\tor dispenser may request a waiver from any of the requirements set forth in\n\t\t\t\tthis section if the "}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "id046aa406c23a458fb0e4f933f4c59e03", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines exceptions, and a process through\n\t\t\t\twhich a manufacturer or repackager may request such an exception, to the\n\t\t\t\trequirements relating to product identifiers if a product is packaged in a\n\t\t\t\tcontainer too small or otherwise unable to accommodate a label with sufficient\n\t\t\t\tspace to bear the information required for compliance with this section;\n\t\t\t\tand", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "establish a\n\t\t\t\tprocess by which the "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id0c0475ac0bdf4d13b6f461fbbff7ec5e", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may determine other products or transactions\n\t\t\t\tthat shall be exempt from the requirements of this section.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "establish a\n\t\t\t\tprocess by which the "}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "idd6f921d9e6cd486c963d2ee9c9b599a2", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"short-title": {"#tail": ",\n\t\t\t\tthe ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall, by guidance\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Not later than 2 years after the date of enactment of the\n\t\t\t\t"}, "#text": "\n                    ", "@id": "idb4be36e379a34b86bfdfb4acd69f670e"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall include a process for the biennial\n\t\t\t\treview and renewal of such waivers, exceptions, and exemptions, as\n\t\t\t\tapplicable.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:3/sp:A", "@proposed": "true"}, "#text": "The\n\t\t\t\tguidance issued under "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Content"}, "#text": "\n                    ", "@id": "idfaceb20ff9fa402585c406c5e3cf8053"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall provide an\n\t\t\t\teffective date that is not later than 180 days prior to the date on which\n\t\t\t\tmanufacturers are required to affix or imprint a product identifier to each\n\t\t\t\tpackage and homogenous case of product intended to be introduced in a\n\t\t\t\ttransaction into commerce consistent with this section.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "In\n\t\t\t\tissuing the guidance under this paragraph, the "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Process"}, "#text": "\n                    ", "@id": "idEAF57E4A3C194DF6858F8502752DE6AA", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Waivers, exceptions,\n\t\t\t\tand exemptions"}, "#text": "\n                  ", "@id": "id52847607be7f4567b1224facddbf1115"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Except where otherwise specified, the requirements\n\t\t\t\tof this section may be enforced without further regulations or guidance from\n\t\t\t\tthe "}, "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Self-executing\n\t\t\t\trequirements"}, "#text": "\n                  ", "@id": "id5e1f761a44c44712a4d5159f322481c2", "@commented": "no"}, {"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "text": {"short-title": {"#tail": ", the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall finalize guidance specifying whether and\n\t\t\t\tunder what circumstances product that is not labeled with a product identifier\n\t\t\t\tand that is in the pharmaceutical distribution supply chain at the time of the\n\t\t\t\teffective date of the requirements of this section shall be exempted from the\n\t\t\t\trequirements of this section.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Not later than 2 years after the date of enactment of\n\t\t\t\tthe "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "Product\n\t\t\t\tidentifier"}, "#text": "\n                    ", "@id": "id4852fe7bb9a649b3b30e516a0cd2ff63"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (b)(1)(A)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:1/sp:A/cl:i", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(c)(1)(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii", "@proposed": "true"}, {"#tail": ", and\n\t\t\t\t", "@entity-type": "act", "#text": "(d)(1)(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:1/sp:A/cl:ii", "@proposed": "true"}, {"#tail": ";", "@entity-type": "act", "#text": "(e)(1)(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:1/sp:A/cl:ii", "@proposed": "true"}], "#text": "authorized trading\n\t\t\t\tpartners shall be exempt from providing transaction information as required\n\t\t\t\tunder "}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "id834761bfd4c2437eb733525f32c897d0", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "transaction history\n\t\t\t\trequired under this section shall begin with the owner of such product on such\n\t\t\t\tdate; and"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id08de44577164496388838409419e73de", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the owners of such\n\t\t\t\tproduct on such date shall be exempt from asserting receipt of transaction\n\t\t\t\tinformation and transaction statement from the prior owner as required under\n\t\t\t\tthis section."}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "id5c92353bdc27481598bcb8e51f402dbe", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Tracing"}, "text": {"short-title": {"#tail": "\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "For\n\t\t\t\ta product that entered the pharmaceutical distribution supply chain prior to\n\t\t\t\tthe date that is 1 year after the date of enactment of the\n\t\t\t\t"}, "#text": "\n                    ", "@id": "id83b96e7662564d708bdc0ee29e6e253c"}], "enum": {"#tail": "\n                  ", "#text": "(5)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Grandfathering\n\t\t\t\tproduct"}, "#text": "\n                  ", "@id": "id73e72de97f104e46a3fe6e56a012c75b"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", until the effective\n\t\t\t\tdate of the wholesale distributor licensing regulations under ", "@entity-type": "act", "#text": "section 581(8)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:8/sp:A", "@proposed": "true"}, {"#tail": ", the\n\t\t\t\tterm ", "@entity-type": "act", "#text": "section 583", "@value": "Federal Food, Drug, and Cosmetic Act/s:583", "@proposed": "true"}], "term": [{"#tail": " or ", "#text": "licensed"}, {"#tail": ", as it relates to a\n\t\t\t\twholesale distributor with respect to prescription drugs, shall mean a\n\t\t\t\twholesale distributor with a valid license under State law.", "#text": "authorized"}], "#text": "Notwithstanding "}, "enum": {"#tail": "\n                  ", "#text": "(6)"}, "header": {"#tail": "\n                  ", "#text": "Wholesale distributor\n\t\t\t\tlicenses"}, "#text": "\n                  ", "@id": "idf1685d0360bc4f89a6eb496387e301ae"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", a third-party\n\t\t\t\tlogistics provider shall be considered ", "@entity-type": "act", "#text": "section 584", "@value": "Federal Food, Drug, and Cosmetic Act/s:584", "@proposed": "true"}, {"#tail": " unless the ", "@entity-type": "act", "#text": "section\n\t\t\t\t581(8)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:8/sp:A", "@proposed": "true"}, {"#tail": " has made a finding that the third-party\n\t\t\t\tlogistics provider does not utilize good handling and distribution practices\n\t\t\t\tand publishes notice thereof.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "term": {"#tail": " under ", "#text": "licensed"}, "#text": "Until the effective date of the third-party\n\t\t\t\tlogistics provider licensing regulations under "}, "enum": {"#tail": "\n                  ", "#text": "(7)"}, "header": {"#tail": "\n                  ", "#text": "Third-party logistics\n\t\t\t\tprovider licenses"}, "#text": "\n                  ", "@id": "id8258bd50035549d59bed3326d55cec29"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in the annual report of an\n\t\t\t\testablishment, in accordance with section 314.70(d) of chapter 21, Code of\n\t\t\t\tFederal Regulations (or any successor regulation).", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Changes made to package labels solely to incorporate the\n\t\t\t\tproduct identifier may be submitted to the "}, "enum": {"#tail": "\n                  ", "#text": "(8)"}, "header": {"#tail": "\n                  ", "#text": "Label\n\t\t\t\tchanges"}, "#text": "\n                  ", "@id": "ida561b5660ce642bc97de9c1982459ce6"}, {"#tail": "\n              ", "@id": "idAFDA258E0050423DB77A637A2D87141B", "enum": {"#tail": "\n                  ", "#text": "(9)"}, "header": {"#tail": "\n                  ", "#text": "Product\n\t\t\t\tidentifiers"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "With respect to any requirement relating to product\n\t\t\t\tidentifiers under this subchapter\u2014"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " allows, through guidance, the use of other technologies for data\n\t\t\t\tinstead of or in addition to the technologies described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and\n\t\t\t\t", "@entity-type": "act", "#text": "clauses (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:9/sp:A/cl:i", "@proposed": "true"}, {"#tail": ", the applicable data\u2014", "@entity-type": "act", "#text": "(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:9/sp:A/cl:ii", "@proposed": "true"}], "#text": "unless the\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "shall be included in a\n\t\t\t\t2-dimensional data matrix barcode when affixed to, or imprinted upon, a\n\t\t\t\tpackage; and"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "idF7130F0239B747A5B0EC19BCE899AAA2", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "shall be included in a\n\t\t\t\tlinear or 2-dimensional data matrix barcode when affixed to, or imprinted upon,\n\t\t\t\ta homogeneous case; and"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id14EB58A5C8EB486DB8422EE6B2CA09EA", "#text": "\n                      "}], "#text": "\n                    ", "@id": "id41C32D7747534196A40C2C7C33E23807"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "verification of the\n\t\t\t\tproduct identifier may occur by using human-readable or machine-readable\n\t\t\t\tmethods."}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "idF27288400FD640368827999A6BDF61CC", "#text": "\n                    "}]}], "#text": "\n                ", "@id": "idc9e4612b030e4b1980d0f0db2666aabb"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Manufacturer\n\t\t\t\trequirements"}, "paragraph": [{"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "prior to, or at the time\n\t\t\t\tof, each transaction in which such manufacturer transfers\u2014"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "ownership of a product,\n\t\t\t\tprovide the subsequent recipient with transaction history, transaction\n\t\t\t\tinformation, and a transaction statement, in a single document in an electronic\n\t\t\t\tor paper format; or"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "idF5662C317DEA463DBD2ACC4B3DA7A61A", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "possession of a product\n\t\t\t\tto a third-party logistics provider for the purpose of transferring ownership\n\t\t\t\tas part of a transaction to a subsequent recipient, provide to the third-party\n\t\t\t\tlogistics provider the transaction history, transaction information, and a\n\t\t\t\ttransaction statement for such transaction to a subsequent recipient;\n\t\t\t\tand"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "idF980054B524D4D8A9A969FD2A059EA20", "#text": "\n                        "}], "#text": "\n                      ", "@id": "id9e261d132f1d4b3c930003ab9b27a6dc"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "maintain the transaction\n\t\t\t\tinformation, transaction history, and transaction statement for each\n\t\t\t\ttransaction for not less than 6 years after the date of the transaction."}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id3afc991548c148dca90a0351ec16f825", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"short-title": {"#tail": ", a manufacturer shall\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 1 year after the date of\n\t\t\t\tenactment of the "}, "#text": "\n                    ", "@id": "idcf0caf84a81e432b974673aa173a68e2"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or other appropriate\n\t\t\t\tFederal or State official, in the event of a recall or for the purpose of\n\t\t\t\tinvestigating a suspect product or an illegitimate product, a manufacturer\n\t\t\t\tshall, not later than 24 hours after receiving the request or in other such\n\t\t\t\treasonable time as determined by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", based on the circumstances of\n\t\t\t\tthe request, provide the applicable transaction information, transaction\n\t\t\t\thistory, and transaction statement for the product.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon a request by the "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Requests for\n\t\t\t\tinformation"}, "#text": "\n                    ", "@id": "id3de29356dea54f05af5a8c31833eef14"}], "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Product\n\t\t\t\ttracing"}, "#text": "\n                  ", "@id": "id91fc923ed7e648498b928e6c0b49d7ce"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ", a manufacturer shall affix or imprint a product identifier\n\t\t\t\tto each package and homogenous case of a product intended to be introduced in a\n\t\t\t\ttransaction into commerce. Such manufacturer shall maintain the product\n\t\t\t\tidentifier information for such product for not less than 6 years after the\n\t\t\t\tdate of the transaction.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 4 years after the date of\n\t\t\t\tenactment of the "}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Product\n\t\t\t\tidentifier"}, "#text": "\n                  ", "@id": "id0991a0019e78419d9db94f0592982e54"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ", the trading partners of a manufacturer may be only\n\t\t\t\tauthorized trading partners.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 1 year after the date of\n\t\t\t\tenactment of the "}, "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Authorized trading\n\t\t\t\tpartners"}, "#text": "\n                  ", "@id": "id4c503ff6b1554e29bad33aa8f71512cc"}, {"#tail": "\n              ", "@id": "ida135ec28306d410986c839ace0c9dac8", "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Verification"}, "text": {"short-title": {"#tail": ",\n\t\t\t\ta manufacturer shall have systems in place to enable the manufacturer to comply\n\t\t\t\twith the following requirements:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning\n\t\t\t\tnot later than 1 year after the date of enactment of the\n\t\t\t\t"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such product\n\t\t\t\twithin the possession or control of the manufacturer from product intended for\n\t\t\t\tdistribution until such product is cleared or dispositioned; and"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "idc52df06835c747ba9c5dbefc239a18cb", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"short-title": {"#tail": ", verifying the product at the package level,\n\t\t\t\tincluding the standardized numerical identifier.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                          ", "@entity-type": "act", "#text": "Drug Supply\n\t\t\t\tChain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                            "}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "promptly conduct an\n\t\t\t\tinvestigation in coordination with trading partners, as applicable, to\n\t\t\t\tdetermine whether the product is an illegitimate product, which shall include\n\t\t\t\tvalidating any applicable transaction history and transaction information in\n\t\t\t\tthe possession of the manufacturer and otherwise investigating to determine\n\t\t\t\twhether the product is an illegitimate product, and, beginning 4 years after\n\t\t\t\tthe date of enactment of the "}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "idcd6164f025f04a789daa9a21c3aa98ea", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that has made a\n\t\t\t\tdetermination that a product within the possession or control of a manufacturer\n\t\t\t\tis a suspect product, a manufacturer shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon making a determination that a product in the\n\t\t\t\tpossession or control of the manufacturer is a suspect product, or upon\n\t\t\t\treceiving a request for verification from the "}, "#text": "\n                      ", "@id": "id97540dee73fd4ba6b63bc45d731ed7a2"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", if applicable, of such determination and such product may\n\t\t\t\tbe further distributed.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "If the manufacturer makes the determination that a\n\t\t\t\tsuspect product is not an illegitimate product, the manufacturer shall promptly\n\t\t\t\tnotify the "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Cleared\n\t\t\t\tproduct"}, "#text": "\n                      ", "@id": "id4ac0a4b3da8f4f1ab95bad0736a31bce"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\tmanufacturer shall keep records of the investigation of a suspect product for\n\t\t\t\tnot less than 6 years after the conclusion of the investigation."}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Records"}, "#text": "\n                      ", "@id": "id8d0dc3cc676242339204f009bbb45641"}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Suspect\n\t\t\t\tproduct"}, "#text": "\n                    ", "@id": "ide4ad32a0131c45268049a3f603d722d4"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such product\n\t\t\t\twithin the possession or control of the manufacturer from product intended for\n\t\t\t\tdistribution until such product is dispositioned;"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id64b0b7d268474605a465e170691fc54c", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "disposition the\n\t\t\t\tillegitimate product within the possession or control of the\n\t\t\t\tmanufacturer;"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "idd7e05f9dee2d489d91c8086cb7004fbe", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "take reasonable and\n\t\t\t\tappropriate steps to assist a trading partner to disposition an illegitimate\n\t\t\t\tproduct not in the possession or control of the manufacturer; and"}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@id": "id1e4945baf7a248568cf7f9198fd16199", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (or other appropriate Federal or State\n\t\t\t\tofficial) upon request by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " (or other appropriate Federal or State\n\t\t\t\tofficial), as necessary and appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "retain a sample\n\t\t\t\tof the product for further physical examination or laboratory analysis of the\n\t\t\t\tproduct by the manufacturer or "}, "enum": {"#tail": "\n                        ", "#text": "(IV)"}, "@id": "idC60A629998314534871225BAA7F01C81", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "Upon determining that a product in the possession or\n\t\t\t\tcontrol of a manufacturer is an illegitimate product, the manufacturer shall,\n\t\t\t\tin a manner consistent with the systems and processes of such\n\t\t\t\tmanufacturer\u2014"}, "#text": "\n                      ", "@id": "idf7b725a1c7674924a67743b1c6c5d344"}, {"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and all immediate trading partners that the manufacturer\n\t\t\t\thas reason to believe may have received such illegitimate product of such\n\t\t\t\tdetermination not later than 24 hours after making such determination.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon determining that a product in the possession or\n\t\t\t\tcontrol of the manufacturer is an illegitimate product, the manufacturer shall\n\t\t\t\tnotify the "}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "header": {"#tail": "\n                        ", "#text": "Illegitimate\n\t\t\t\tproduct"}, "#text": "\n                        ", "@id": "idb8c5c5991bd2411298893e2736c84152"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and\n\t\t\t\timmediate trading partners that the manufacturer has reason to believe may have\n\t\t\t\tin the trading partner\u2019s possession a product manufactured by, or purported to\n\t\t\t\tbe a product manufactured by, the manufacturer not later than 24 hours after\n\t\t\t\tdetermining or being notified by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " or a trading partner that there\n\t\t\t\tis a high risk that such product is an illegitimate product. For purposes of\n\t\t\t\tthis subclause, a ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in guidance pursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i", "@proposed": "true"}], "#text": "A manufacturer shall notify the ", "quote": {"#tail": " may include a specific high-risk\n\t\t\t\tthat could increase the likelihood that illegitimate product will enter the\n\t\t\t\tpharmaceutical distribution supply chain and other high risks as determined by\n\t\t\t\tthe ", "#text": "high risk"}}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "header": {"#tail": "\n                        ", "#text": "High risk of\n\t\t\t\tillegitimacy"}, "#text": "\n                        ", "@id": "idba3b3158b0034818b19ceeb7ba05491f"}], "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "Making a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "idc715e2ffe9ce41cd8ce57354ce19c4da"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or a trading partner that a determination has been made that a\n\t\t\t\tproduct is an illegitimate product, a manufacturer shall identify all\n\t\t\t\tillegitimate product subject to such notification that is in the possession or\n\t\t\t\tcontrol of the manufacturer, including any product that is subsequently\n\t\t\t\treceived, and shall perform the activities described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:4/sp:A", "@proposed": "true"}], "#text": "Upon the receipt of a notification from the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Responding to a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "id401f856c33254aa6b8f1610eac275006"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", that a notification is no longer necessary, a manufacturer shall\n\t\t\t\tpromptly notify immediate trading partners that the manufacturer notified\n\t\t\t\tpursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " that such notification has been terminated.", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:4/sp:B/cl:ii", "@proposed": "true"}], "#text": "Upon making a determination, in consultation with\n\t\t\t\tthe "}, "enum": {"#tail": "\n                      ", "#text": "(iv)"}, "header": {"#tail": "\n                      ", "#text": "Terminating a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "idF374CE6063C54F4885382FBD4295A95F"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\tmanufacturer shall keep records of the disposition of an illegitimate product\n\t\t\t\tfor not less than 6 years after the conclusion of the disposition."}, "enum": {"#tail": "\n                      ", "#text": "(v)"}, "header": {"#tail": "\n                      ", "#text": "Records"}, "#text": "\n                      ", "@id": "id5206f276e6bc4122921a1e33e101954b"}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Illegitimate\n\t\t\t\tproduct"}, "#text": "\n                    ", "@id": "idcf29cf9c3db041639c11f20ee933c0b8"}, {"#tail": "\n                  ", "text": {"short-title": {"#tail": ",\n\t\t\t\tupon receiving a request for verification from an authorized repackager,\n\t\t\t\twholesale distributor, or dispenser that is in possession or control of a\n\t\t\t\tproduct such person believes to be manufactured by such manufacturer, a\n\t\t\t\tmanufacturer shall, not later than 24 hours after receiving the verification\n\t\t\t\trequest or in other such reasonable time as determined by the Secretary, based\n\t\t\t\ton the circumstances of the request, notify the person making the request\n\t\t\t\twhether the product identifier, including the standardized numerical\n\t\t\t\tidentifier, that is the subject of the request corresponds to the product\n\t\t\t\tidentifier affixed or imprinted by the manufacturer. If a manufacturer\n\t\t\t\tresponding to a verification request identifies a product identifier that does\n\t\t\t\tnot correspond to that affixed or imprinted by the manufacturer, the\n\t\t\t\tmanufacturer shall treat such product as suspect product and conduct an\n\t\t\t\tinvestigation as described in ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ". If the manufacturer has reason\n\t\t\t\tto believe the product is an illegitimate product, the manufacturer shall\n\t\t\t\tadvise the person making the request of such belief at the time such\n\t\t\t\tmanufacturer responds to the verification request.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:4/sp:A", "@proposed": "true"}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning 4 years after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Requests for\n\t\t\t\tverification"}, "#text": "\n                    ", "@id": "idd67bae2948704c99a2907228a0dd8dad"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A manufacturer may satisfy the requirements of this\n\t\t\t\tparagraph by developing a secure electronic database or utilizing a secure\n\t\t\t\telectronic database developed or operated by another entity. The owner of such\n\t\t\t\tdatabase shall establish the requirements and processes to respond to requests\n\t\t\t\tand may provide for data access to other members of the pharmaceutical\n\t\t\t\tdistribution supply chain, as appropriate. The development and operation of\n\t\t\t\tsuch a database shall not relieve a manufacturer of the requirement under this\n\t\t\t\tparagraph to respond to a verification request submitted by means other than a\n\t\t\t\tsecure electronic database."}, "enum": {"#tail": "\n                    ", "#text": "(D)"}, "header": {"#tail": "\n                    ", "#text": "Electronic\n\t\t\t\tdatabase"}, "#text": "\n                    ", "@id": "id0a9ae00875004171b5c5805eecd72591"}, {"#tail": "\n                  ", "text": {"short-title": {"#tail": "\n\t\t\t\t(except as provided pursuant to ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "), upon receipt of a returned\n\t\t\t\tproduct that the manufacturer intends to further distribute, before further\n\t\t\t\tdistributing such product, the manufacturer shall verify the product\n\t\t\t\tidentifier, including the standardized numerical identifier, for each sealed\n\t\t\t\thomogeneous case of such product or, if such product is not in a sealed\n\t\t\t\thomogeneous case, verify the product identifier, including the standardized\n\t\t\t\tnumerical identifier, on each package.", "@entity-type": "act", "#text": "subsection (a)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5", "@proposed": "true"}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning 4 years after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(E)"}, "header": {"#tail": "\n                    ", "#text": "Saleable returned\n\t\t\t\tproduct"}, "#text": "\n                    ", "@id": "id1c2885b9c2804acb871a07b1c9c066eb"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(1)(A)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:1/sp:A/cl:i", "@proposed": "true"}, "#text": "A manufacturer may return a nonsaleable product to the\n\t\t\t\tmanufacturer or repackager, to the wholesale distributor from whom such product\n\t\t\t\twas purchased, or to a person acting on behalf of such a person, including a\n\t\t\t\treturns processor, without providing the information described in "}, "enum": {"#tail": "\n                    ", "#text": "(F)"}, "header": {"#tail": "\n                    ", "#text": "Nonsaleable returned\n\t\t\t\tproduct"}, "#text": "\n                    ", "@id": "id0ADFF47B968D485088AB7ED1B907E8B5"}]}], "#text": "\n                ", "@id": "id553feec93e3b45b3b3734a3340de56fc"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Wholesale distributor\n\t\t\t\trequirements"}, "paragraph": [{"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "A wholesale distributor\n\t\t\t\tshall not accept ownership of a product unless the previous owner prior to, or\n\t\t\t\tat the time of, the transaction provides the transaction history, transaction\n\t\t\t\tinformation, and a transaction statement for the product, as applicable under\n\t\t\t\tthis subparagraph."}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "ida209f5a1826141bd9258aed1a349fa1d", "#text": "\n                      "}, {"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "enum": {"#tail": "\n                        ", "#text": "(I)"}, "item": [{"#tail": "\n                        ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "If the wholesale\n\t\t\t\tdistributor purchased a product directly from the manufacturer, the exclusive\n\t\t\t\tdistributor of the manufacturer, or a repackager that purchased directly from\n\t\t\t\tthe manufacturer, then prior to, or at the time of, each transaction in which\n\t\t\t\tthe wholesale distributor transfers ownership of a product, the wholesale\n\t\t\t\tdistributor shall provide to the subsequent purchaser\u2014"}, "enum": {"#tail": "\n                          ", "#text": "(aa)"}, "subitem": [{"@committee-id": "SSHR00", "@changed": "added", "@indent": "up2", "#tail": "\n                          ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "a transaction statement,\n\t\t\t\twhich shall state that such wholesale distributor, or a member of the\n\t\t\t\taffiliated group of such wholesale distributor, purchased the product directly\n\t\t\t\tfrom the manufacturer, exclusive distributor of the manufacturer, or repackager\n\t\t\t\tthat purchased directly from the manufacturer; and"}, "enum": {"#tail": "\n                            ", "#text": "(AA)"}, "@reported-display-style": "italic", "#text": "\n                            ", "@id": "id144DA66C00EE42E58717A25048998D12"}, {"@committee-id": "SSHR00", "@changed": "added", "@indent": "up2", "#tail": "\n                        ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the\n\t\t\t\ttransaction history and transaction information.", "@entity-type": "act", "#text": "subclause (II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii/scl:II", "@proposed": "true"}, "#text": "subject to "}, "enum": {"#tail": "\n                            ", "#text": "(BB)"}, "@reported-display-style": "italic", "#text": "\n                            ", "@id": "id65F2E50E265A45CFB606944619B29E19"}], "@display-inline": "yes-display-inline", "#text": "\n                          ", "@id": "idA8678C37A34943248C98237F61AED7F6", "@commented": "no"}, {"@committee-id": "SSHR00", "@changed": "added", "@indent": "up2", "#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "item (aa)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii/scl:I/i:aa", "@proposed": "true"}, "#text": "The wholesale distributor shall provide\n\t\t\t\tthe transaction history, transaction information, and transaction statement\n\t\t\t\tunder "}, "enum": {"#tail": "\n                          ", "#text": "(bb)"}, "subitem": [{"@indent": "down1", "#tail": "\n                          ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "if provided to a\n\t\t\t\tdispenser, on a single document in an electronic or paper format; and"}, "enum": {"#tail": "\n                            ", "#text": "(AA)"}, "#text": "\n                            ", "@id": "idD64E034E0C534CAA8DEFA493037BE425"}, {"@indent": "down1", "#tail": "\n                        ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t\t\t", "#text": "if provided to a\n\t\t\t\twholesale distributor, through any combination of self-generated paper,\n\t\t\t\telectronic data, or manufacturer-provided information on the product\n\t\t\t\tpackage."}, "enum": {"#tail": "\n                            ", "#text": "(BB)"}, "#text": "\n                            ", "@id": "id08F0F60688304FFFBB5A670F16CF10AA"}], "@reported-display-style": "italic", "#text": "\n                          ", "@id": "id7360D4E892B54DA1B697C75FC7E9BBEF"}], "@display-inline": "yes-display-inline", "#text": "\n                        ", "@id": "idB1E29F596E504969BC8B59DEA5F0120D", "@commented": "no"}, {"@committee-id": "SSHR00", "@changed": "added", "@indent": "up1", "#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", transaction history and transaction\n\t\t\t\tinformation shall not be required to include the lot number of the product, the\n\t\t\t\tinitial transaction date, or the initial shipment date from the manufacturer\n\t\t\t\t(as defined in ", "@entity-type": "act", "#text": "subclause (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii/scl:I", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "subparagraphs (F)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:25/sp:F", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(G)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:25/sp:G", "@proposed": "true"}, {"#tail": ").", "@entity-type": "act", "#text": "(H) of section 581(25)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:25/sp:H", "@proposed": "true"}], "#text": "For purposes of\n\t\t\t\ttransactions described in "}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@reported-display-style": "italic", "#text": "\n                        ", "@id": "id639C6E5F42BF4976AEFDB972584953B3"}], "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "idec6c3f21f4ca4387b01700ab772537a6", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", then prior to, or\n\t\t\t\tat the time of, each transaction or subsequent transaction, the wholesale\n\t\t\t\tdistributor shall provide to the subsequent purchaser a transaction statement,\n\t\t\t\ttransaction history, and transaction information, in a paper or electronic\n\t\t\t\tformat that complies with the guidance document issued under ", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:2", "@proposed": "true"}], "#text": "If the wholesale\n\t\t\t\tdistributor did not purchase a product directly from the manufacturer, the\n\t\t\t\texclusive distributor of the manufacturer, or a repackager that purchased\n\t\t\t\tdirectly from the manufacturer, as described in "}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "id78906204a8674bb49c0c41d7c7f96d94", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the transaction history supplied shall begin only with the\n\t\t\t\twholesale distributor described in ", "@entity-type": "act", "#text": "clause (iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:iii", "@proposed": "true"}, {"#tail": ", but the wholesale\n\t\t\t\tdistributor described in ", "@entity-type": "act", "#text": "clause (ii)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii/scl:I", "@proposed": "true"}, {"#tail": " shall inform the subsequent purchaser\n\t\t\t\tthat such wholesale distributor received a direct purchase statement from a\n\t\t\t\twholesale distributor described in ", "@entity-type": "act", "#text": "clause (iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:iii", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "clause (ii)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:iii", "@proposed": "true"}], "#text": "For the purposes of\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(iv)"}, "@id": "idD8DF9EFF33E6440DA7B9BABF279D58F2", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "clauses\n\t\t\t\t(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:i", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii", "@proposed": "true"}, {"#tail": " for not less than 6 years after the date of the\n\t\t\t\ttransaction.", "@entity-type": "act", "#text": "(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:iii", "@proposed": "true"}], "#text": "A\n\t\t\t\twholesale distributor shall maintain the transaction information, transaction\n\t\t\t\thistory, and transaction statement for each transaction described in "}, "enum": {"#tail": "\n                      ", "#text": "(v)"}, "@id": "id51717FED6206478590FEF87F9816ED11", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"short-title": {"#tail": ", the following requirements shall apply to wholesale\n\t\t\t\tdistributors:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 1 year after the date of\n\t\t\t\tenactment of the "}, "#text": "\n                    ", "@id": "iddec051a0ab3742b3af89477300dc20b4"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"short-title": {"#tail": "\n\t\t\t\t(except as provided pursuant to ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                        ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                          "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "), a wholesale distributor may\n\t\t\t\taccept returned product from a dispenser pursuant to the terms and conditions\n\t\t\t\tof any agreement between the parties, and, notwithstanding ", "@entity-type": "act", "#text": "subsection (a)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5", "@proposed": "true"}, {"#tail": ", may distribute such returned product without providing the transaction\n\t\t\t\thistory. For transactions subsequent to the return, the transaction history of\n\t\t\t\tsuch product shall begin with the wholesale distributor that accepted the\n\t\t\t\treturned product, consistent with the requirements of this subsection.", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii", "@proposed": "true"}], "#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "Until\n\t\t\t\tthe date that is 6 years after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "header": {"#tail": "\n                        ", "#text": "Requirements"}, "#text": "\n                        ", "@id": "id348999e394224b68ab28fb707a64da05"}, {"#tail": "\n                    ", "text": {"short-title": {"#tail": "\n\t\t\t\t(except as provided pursuant to ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                        ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                          "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "), a wholesale distributor may\n\t\t\t\taccept returned product from a dispenser only if the wholesale distributor can\n\t\t\t\tassociate returned product with the transaction information and transaction\n\t\t\t\tstatement associated with that product. For all transactions after such date,\n\t\t\t\tthe transaction history, as applicable, of such product shall begin with the\n\t\t\t\twholesale distributor that accepted and verified the returned product. For\n\t\t\t\tpurposes of this subparagraph, the transaction information and transaction\n\t\t\t\thistory, as applicable, need not include transaction dates if it is not\n\t\t\t\treasonably practicable to obtain such dates.", "@entity-type": "act", "#text": "subsection (a)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5", "@proposed": "true"}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "Beginning 6 years after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "header": {"#tail": "\n                        ", "#text": "Enhanced\n\t\t\t\trequirements"}, "#text": "\n                        ", "@id": "id96dc345e92be455da7a8704f6b5bb3f5"}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "Saleable\n\t\t\t\treturns"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the following shall\n\t\t\t\tapply:", "@entity-type": "act", "#text": "subparagraph (A)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:i", "@proposed": "true"}, "#text": "Notwithstanding "}, "#text": "\n                      ", "@id": "id669faaa71d4f4613842062294613bdf2"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:i", "@proposed": "true"}, "#text": "A wholesale distributor may return a nonsaleable\n\t\t\t\tprescription drug to the manufacturer or repackager, to the wholesale\n\t\t\t\tdistributor from whom such prescription drug was purchased, or to a person\n\t\t\t\tacting on behalf of such a person, including a returns processor, without\n\t\t\t\tproviding the information required under "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Nonsaleable\n\t\t\t\treturns"}, "#text": "\n                      ", "@id": "id69d05d5e8da443feae2276d6c5df9beb"}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Returns"}, "#text": "\n                    ", "@id": "id132c7a783e6d4227ba458a2251e4d509"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or other appropriate\n\t\t\t\tFederal or State official, in the event of a recall or for the purpose of\n\t\t\t\tinvestigating a suspect product or an illegitimate product a wholesale\n\t\t\t\tdistributor shall, not later than 24 hours after receiving the request or in\n\t\t\t\tother such reasonable time as determined by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", based on the\n\t\t\t\tcircumstances of the request, provide the applicable transaction information,\n\t\t\t\ttransaction history, and transaction statement for the product.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon a request by the "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Requests for\n\t\t\t\tinformation"}, "#text": "\n                    ", "@id": "idbe801327dfd54f958da4d668f45aa0d2"}], "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Product\n\t\t\t\ttracing"}, "#text": "\n                  ", "@id": "id43c44392ea4b442ba974a2c534ef6edd"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ",\n\t\t\t\ta wholesale distributor may engage in transactions involving a product only if\n\t\t\t\tsuch product is encoded with a product identifier (except as provided pursuant\n\t\t\t\tto ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ").", "@entity-type": "act", "#text": "subsection (a)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5", "@proposed": "true"}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning 6 years after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Product\n\t\t\t\tidentifier"}, "#text": "\n                  ", "@id": "iddc2b9ec5d1ff4e53ad6a111a41154633"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ", the trading partners of a wholesale distributor may be only\n\t\t\t\tauthorized trading partners.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 1 year after the date of\n\t\t\t\tenactment of the "}, "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Authorized trading\n\t\t\t\tpartners"}, "#text": "\n                  ", "@id": "id1ded1eddae5b4119ac1981427f023678"}, {"#tail": "\n              ", "@id": "id15f43b513bdd4a52a0382293ee8a06be", "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Verification"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": ",\n\t\t\t\ta wholesale distributor shall have systems in place to enable the wholesale\n\t\t\t\tdistributor to comply with the following requirements:", "@entity-type": "act", "@value": "Drug Supply Chain Security Act", "short-title": {"#tail": "\n                    ", "#text": "Drug Supply Chain Security Act"}, "#text": "\n                      "}, "#text": "Beginning\n\t\t\t\tnot later than 1 year after the date of enactment of the\n\t\t\t\t"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such product\n\t\t\t\twithin the possession or control of the wholesale distributor from product\n\t\t\t\tintended for distribution until such product is cleared or dispositioned;\n\t\t\t\tand"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "idfce32860949b4ce59d36fd270c0f9f34", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " (except as provided pursuant to\n\t\t\t\t", "@entity-type": "act", "@value": "Drug Supply Chain Security Act", "short-title": {"#tail": "\n                          ", "#text": "Drug\n\t\t\t\tSupply Chain Security Act"}, "#text": "\n                            "}, {"#tail": "), verifying the product at the package level, including the\n\t\t\t\tstandardized numerical identifier.", "@entity-type": "act", "#text": "subsection (a)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5", "@proposed": "true"}], "#text": "promptly conduct an\n\t\t\t\tinvestigation in coordination with trading partners, as applicable, to\n\t\t\t\tdetermine whether the product is an illegitimate product, which shall include\n\t\t\t\tvalidating any applicable transaction history and transaction information in\n\t\t\t\tthe possession of the wholesale distributor and otherwise investigating to\n\t\t\t\tdetermine whether the product is an illegitimate product, and, beginning 6\n\t\t\t\tyears after the date of enactment of the "}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id9573d2f936214817bdddc9fd16c6c64d", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that has made a\n\t\t\t\tdetermination that a product within the possession or control of a wholesale\n\t\t\t\tdistributor is a suspect product, a wholesale distributor shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon making a determination that a product in the\n\t\t\t\tpossession or control of the wholesale distributor is a suspect product, or\n\t\t\t\tupon receiving a request for verification from the "}, "#text": "\n                      ", "@id": "id2235aa7f6a2e48948c9b52d21dad0825"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", if applicable, of such determination and such\n\t\t\t\tproduct may be further distributed.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "If the wholesale distributor determines that a suspect\n\t\t\t\tproduct is not an illegitimate product, the wholesale distributor shall\n\t\t\t\tpromptly notify the "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Cleared\n\t\t\t\tproduct"}, "#text": "\n                      ", "@id": "idaf0676b070f94ccf9a3fd176851ec1be"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\twholesale distributor shall keep records of the investigation of a suspect\n\t\t\t\tproduct for not less than 6 years after the conclusion of the\n\t\t\t\tinvestigation."}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Records"}, "#text": "\n                      ", "@id": "id3658897282b6454c9fbd90fc472d85e4"}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Suspect\n\t\t\t\tproduct"}, "#text": "\n                    ", "@id": "idebd2595aacfb4b25b96ae8941449ac29"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such product\n\t\t\t\twithin the possession or control of the wholesale distributor from product\n\t\t\t\tintended for distribution until such product is dispositioned;"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "ida3aa78caf8174688afeb6f93c663c48d", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "disposition the\n\t\t\t\tillegitimate product within the possession or control of the wholesale\n\t\t\t\tdistributor;"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "idde02722ffc2d4c08a4e52519d4569c63", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "take reasonable and\n\t\t\t\tappropriate steps to assist a trading partner to disposition an illegitimate\n\t\t\t\tproduct not in the possession or control of the wholesale distributor;\n\t\t\t\tand"}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@id": "idf44cad8df77b4e6f884252b96149cf4b", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (or other appropriate Federal or State\n\t\t\t\tofficial) upon request by the manufacturer or Secretary (or other appropriate\n\t\t\t\tFederal or State official), as necessary and appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "retain a sample of the\n\t\t\t\tproduct for further physical examination or laboratory analysis of the product\n\t\t\t\tby the manufacturer or "}, "enum": {"#tail": "\n                        ", "#text": "(IV)"}, "@id": "id763C99D2FF5A4FC698A09CE63901D343", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "Upon determining, in coordination with the manufacturer,\n\t\t\t\tthat a product in the possession or control of a wholesale distributor is an\n\t\t\t\tillegitimate product, the wholesale distributor shall, in a manner that is\n\t\t\t\tconsistent with the systems and processes of such wholesale distributor\u2014"}, "#text": "\n                      ", "@id": "id64a1cf8458514a6786ff0fef01735c18"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and all immediate trading partners that\n\t\t\t\tthe wholesale distributor has reason to believe may have received such\n\t\t\t\tillegitimate product of such determination not later than 24 hours after making\n\t\t\t\tsuch determination.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon determining that a product in the possession or\n\t\t\t\tcontrol of the wholesale distributor is an illegitimate product, the wholesale\n\t\t\t\tdistributor shall notify the "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Making a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "iddad1db1fc75e457aaca41dc6398879a0"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or a trading partner that a determination has been made that a\n\t\t\t\tproduct is an illegitimate product, a wholesale distributor shall identify all\n\t\t\t\tillegitimate product subject to such notification that is in the possession or\n\t\t\t\tcontrol of the wholesale distributor, including any product that is\n\t\t\t\tsubsequently received, and shall perform the activities described in\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:4/sp:A", "@proposed": "true"}], "#text": "Upon the receipt of a notification from the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Responding to a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "id6ac7aef27c3041988054b5e5408c8e7c"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", that a notification is no longer necessary, a wholesale distributor\n\t\t\t\tshall promptly notify immediate trading partners that the wholesale distributor\n\t\t\t\tnotified pursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " that such notification has been\n\t\t\t\tterminated.", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:4/sp:B/cl:ii", "@proposed": "true"}], "#text": "Upon a determination, in consultation with the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(iv)"}, "header": {"#tail": "\n                      ", "#text": "Terminating a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "id5F1AED23A637482D9A01FB2590AD01ED"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\twholesale distributor shall keep records of the disposition of an illegitimate\n\t\t\t\tproduct for not less than 6 years after the conclusion of the\n\t\t\t\tdisposition."}, "enum": {"#tail": "\n                      ", "#text": "(v)"}, "header": {"#tail": "\n                      ", "#text": "Records"}, "#text": "\n                      ", "@id": "idd3b792bae90d4f928a6e47ac62e9e626"}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Illegitimate\n\t\t\t\tproduct"}, "#text": "\n                    ", "@id": "id67df907e0b834a04859800ce55488aa8"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A wholesale distributor may satisfy the requirements of\n\t\t\t\tthis paragraph by developing a secure electronic database or utilizing a secure\n\t\t\t\telectronic database developed or operated by another entity. The owner of such\n\t\t\t\tdatabase shall establish the requirements and processes to respond to requests\n\t\t\t\tand may provide for data access to other members of the pharmaceutical\n\t\t\t\tdistribution supply chain, as appropriate. The development and operation of\n\t\t\t\tsuch a database shall not relieve a wholesale distributor of the requirement\n\t\t\t\tunder this paragraph to respond to a verification request submitted by means\n\t\t\t\tother than a secure electronic database."}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Electronic\n\t\t\t\tdatabase"}, "#text": "\n                    ", "@id": "id6e71015b977f4af0b3bee4637a6b317d"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ", upon receipt of a returned product that the wholesale\n\t\t\t\tdistributor intends to further distribute, before further distributing such\n\t\t\t\tproduct, the wholesale distributor shall verify the product identifier,\n\t\t\t\tincluding the standardized numerical identifier, for each sealed homogeneous\n\t\t\t\tcase of such product or, if such product is not in a sealed homogeneous case,\n\t\t\t\tverify the product identifier, including the standardized numerical identifier,\n\t\t\t\ton each package.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning 6 years after the date of\n\t\t\t\tenactment of the "}, "enum": {"#tail": "\n                    ", "#text": "(D)"}, "header": {"#tail": "\n                    ", "#text": "Verification of\n\t\t\t\tsaleable returned product"}, "#text": "\n                    ", "@id": "idcd9421d35fcb43f8b08e8a07052627dd"}]}], "#text": "\n                ", "@id": "id515e8624724141b3a829ef3727d673bc"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Dispenser\n\t\t\t\trequirements"}, "paragraph": [{"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "shall not accept\n\t\t\t\townership of a product, unless the previous owner prior to, or at the time of,\n\t\t\t\tthe transaction, provides transaction history, transaction information, and a\n\t\t\t\ttransaction statement;"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "id1ccba8b3b5de4cc2a910252fd58b248f", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "prior to, or at the time\n\t\t\t\tof, each transaction in which the dispenser transfers ownership of a product\n\t\t\t\t(but not including dispensing to a patient or returns) shall provide the\n\t\t\t\tsubsequent owner with transaction history, transaction information, and a\n\t\t\t\ttransaction statement for the product, except that the requirements of this\n\t\t\t\tclause shall not apply to sales by a dispenser to another dispenser to fulfill\n\t\t\t\ta specific patient need; and"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id2539a94040ca4446a49d19f18daaea37", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "shall maintain\n\t\t\t\ttransaction information, transaction history, and transaction statements, as\n\t\t\t\tnecessary to investigate a suspect product, for not less than 6 years after the\n\t\t\t\ttransaction."}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "idc6cea9bc94114ba5b955506261430749", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"short-title": {"#tail": ",\n\t\t\t\ta dispenser\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Beginning 1 year after the date of enactment of the\n\t\t\t\t"}, "#text": "\n                    ", "@id": "id327026c77d7e40caa7a3eed97c1c132b"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A dispenser may enter into a written agreement with a\n\t\t\t\tthird party, including an authorized wholesale distributor, under which the\n\t\t\t\tthird party confidentially maintains the transaction information, transaction\n\t\t\t\thistory, and transaction statements required to be maintained under this\n\t\t\t\tsubsection on behalf of the dispenser. If a dispenser enters into such an\n\t\t\t\tagreement, the dispenser shall maintain a copy of the written agreement and\n\t\t\t\tshall not be relieved of the obligations of the dispenser under this\n\t\t\t\tsubsection."}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Agreements with third\n\t\t\t\tparties"}, "#text": "\n                    ", "@id": "ida801182fdf8f414882033510b30ec31f"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:1/sp:A", "@proposed": "true"}, "#text": "A dispenser may return product to the trading partner\n\t\t\t\tfrom which the dispenser obtained the product without providing the information\n\t\t\t\trequired under "}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "Saleable\n\t\t\t\treturns"}, "#text": "\n                      ", "@id": "idaedba11005a24e8c8980d14160413784"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:1/sp:A/cl:i", "@proposed": "true"}, "#text": "A dispenser may return a nonsaleable product to the\n\t\t\t\tmanufacturer or repackager, to the wholesale distributor from whom such product\n\t\t\t\twas purchased, to a returns processor, or to a person acting on behalf of such\n\t\t\t\ta person without providing the information required under "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Nonsaleable\n\t\t\t\treturns"}, "#text": "\n                      ", "@id": "idfb0aa4e9e7174adb80d895e636d12532"}], "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Returns"}, "#text": "\n                    ", "@id": "idddbcd6d87a6642a3bf24e3ce912f5ce7"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " or other appropriate\n\t\t\t\tFederal or State official, in the event of a recall or for the purpose of\n\t\t\t\tinvestigating a suspect or an illegitimate product, a dispenser shall, not\n\t\t\t\tlater than 2 business days after receiving the request or in another such\n\t\t\t\treasonable time as determined by the Secretary, based on the circumstances of\n\t\t\t\tthe request, provide the applicable transaction information, transaction\n\t\t\t\tstatement, and transaction history which the dispenser received from the\n\t\t\t\tprevious owner, which shall not include the lot number of the product, the\n\t\t\t\tinitial transaction date, or the initial shipment date from the manufacturer\n\t\t\t\tunless such information was included in the transaction information,\n\t\t\t\ttransaction statement, and transaction history provided by the manufacturer or\n\t\t\t\twholesale distributor to the dispenser. The dispenser may respond to the\n\t\t\t\trequest by providing the applicable information in either paper or electronic\n\t\t\t\tformat.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon a request by the "}, "enum": {"#tail": "\n                    ", "#text": "(D)"}, "header": {"#tail": "\n                    ", "#text": "Requests for\n\t\t\t\tinformation"}, "#text": "\n                    ", "@id": "id678c802e3067489b8b5598989d57bbe3"}], "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Product\n\t\t\t\ttracing"}, "#text": "\n                  ", "@id": "id73543783008a4d09a69e44fec590d07b"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ", a dispenser may engage in transactions involving a product\n\t\t\t\tonly if such product is encoded with a product identifier (except as provided\n\t\t\t\tpursuant to ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ").", "@entity-type": "act", "#text": "subsection (a)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5", "@proposed": "true"}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 7 years after the date of\n\t\t\t\tenactment of the "}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Product\n\t\t\t\tidentifier"}, "#text": "\n                  ", "@id": "id938da59b96a14b9e811d205b3244aaaa"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ", the trading partners of a dispenser may be only authorized\n\t\t\t\ttrading partners.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 1 year after the date of\n\t\t\t\tenactment of the "}, "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Authorized trading\n\t\t\t\tpartners"}, "#text": "\n                  ", "@id": "id2ad3a5f0820c4d3c9755cac5a12e3bb3"}, {"#tail": "\n              ", "@id": "id852cd707db164252b4f3c44ac483604c", "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Verification"}, "text": {"short-title": {"#tail": ",\n\t\t\t\ta dispenser shall have systems in place to enable the dispenser to comply with\n\t\t\t\tthe following requirements:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning\n\t\t\t\tnot later than 1 year after the date of enactment of the\n\t\t\t\t"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such product\n\t\t\t\twithin the possession or control of the dispenser from product intended for\n\t\t\t\tdistribution until such product is cleared or dispositioned; and"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "idb042373d629d402e94501e5efdc3606d", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "promptly conduct an\n\t\t\t\tinvestigation in coordination with trading partners, as applicable, to\n\t\t\t\tdetermine whether the product is an illegitimate product."}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "iddb65ce0d80a54810b519bf785709a317", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that has made a determination\n\t\t\t\tthat a product within the possession or control of a dispenser is a suspect\n\t\t\t\tproduct, a dispenser shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon making a determination that a product in the\n\t\t\t\tpossession or control of the dispenser is a suspect product, or upon receiving\n\t\t\t\ta request for verification from the "}, "#text": "\n                      ", "@id": "idd429fb01992d4d5db52116dcbc4a67d9"}, {"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"short-title": {"#tail": ", verifying whether the lot number of a suspect\n\t\t\t\tproduct corresponds with the lot number for such product;", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                          ", "@entity-type": "act", "#text": "Drug Supply\n\t\t\t\tChain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                            "}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "beginning 7 years after\n\t\t\t\tthe date of enactment of the "}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "idfd2c2c0dc94d48eab41d9f7d0cdb9b29", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "beginning 7 years after\n\t\t\t\tthe date of enactment of such Act, verifying that the product identifier,\n\t\t\t\tincluding the standardized numerical identifier, of at least 3 packages or 10\n\t\t\t\tpercent of such suspect product, whichever is greater, or all packages, if\n\t\t\t\tthere are fewer than 3, corresponds with the product identifier for such\n\t\t\t\tproduct;"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id3fee2eeb998544e78e4fee520534ccfc", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "validating any\n\t\t\t\tapplicable transaction history and transaction information in the possession of\n\t\t\t\tthe dispenser; and"}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@id": "id84fa568e382e4b5494ae3c7712042eac", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "otherwise investigating\n\t\t\t\tto determine whether the product is an illegitimate product."}, "enum": {"#tail": "\n                        ", "#text": "(IV)"}, "@id": "idb00129d26377473494a394182aea23c2", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Investigation"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall include\u2014", "@entity-type": "act", "#text": "clause (i)(II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:4/sp:A/cl:i/scl:II", "@proposed": "true"}, "#text": "An\n\t\t\t\tinvestigation conducted under "}, "#text": "\n                      ", "@id": "id132C92A4C06444C489593AABDCD99625"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", if applicable, of such determination and such product may be further\n\t\t\t\tdistributed or dispensed.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "If the dispenser makes the determination that a suspect\n\t\t\t\tproduct is not an illegitimate product, the dispenser shall promptly notify the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Cleared\n\t\t\t\tproduct"}, "#text": "\n                      ", "@id": "id6b15e40f5f534f709156ad42621eb3c7"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\tdispenser shall keep records of the investigation of a suspect product for not\n\t\t\t\tless than 6 years after the conclusion of the investigation."}, "enum": {"#tail": "\n                      ", "#text": "(iv)"}, "header": {"#tail": "\n                      ", "#text": "Records"}, "#text": "\n                      ", "@id": "idf09176bdaad94a948e90192fad79060f"}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Suspect\n\t\t\t\tproduct"}, "#text": "\n                    ", "@id": "id32e298f707e24001997103b5c7105c38"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "disposition the\n\t\t\t\tillegitimate product within the possession or control of the dispenser;"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "idf118465e15de4f3a87ea1b4bb31e6f20", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "take reasonable and\n\t\t\t\tappropriate steps to assist a trading partner to disposition an illegitimate\n\t\t\t\tproduct not in the possession or control of the dispenser; and"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "ide4d26696fca840ffb513d61e8e48999e", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "retain a sample of the\n\t\t\t\tproduct for further physical examination or laboratory analysis of the product\n\t\t\t\tby the manufacturer or Secretary (or other appropriate Federal or State\n\t\t\t\tofficial) upon request by the manufacturer or Secretary (or other appropriate\n\t\t\t\tFederal or State official), as necessary and appropriate."}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@id": "idD83E49DA7F9C4DF38593D9EA6F61114C", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "Upon determining, in coordination with the manufacturer,\n\t\t\t\tthat a product in the possession or control of a dispenser is an illegitimate\n\t\t\t\tproduct, the dispenser shall\u2014"}, "#text": "\n                      ", "@id": "id1b5fcd8a4ed040de86153a2492e5bea3"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and all immediate trading partners that the dispenser has reason\n\t\t\t\tto believe may have received such illegitimate product of such determination\n\t\t\t\tnot later than 24 hours after making such determination.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon determining that a product in the possession or\n\t\t\t\tcontrol of the dispenser is an illegitimate product, the dispenser shall notify\n\t\t\t\tthe "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Making a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "id68a7b2ac302a41a3bbda0b9c7c0dec85"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or a trading partner that a determination has been made that a\n\t\t\t\tproduct is an illegitimate product, a dispenser shall identify all illegitimate\n\t\t\t\tproduct subject to such notification that is in the possession or control of\n\t\t\t\tthe dispenser, including any product that is subsequently received, and shall\n\t\t\t\tperform the activities described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:4/sp:A", "@proposed": "true"}], "#text": "Upon the receipt of a notification from the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Responding to a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "iddab89879fd6f43dda911d1b03502654c"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", that a notification is no longer necessary, a dispenser shall\n\t\t\t\tpromptly notify immediate trading partners that the dispenser notified pursuant\n\t\t\t\tto ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " that such notification has been terminated.", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:4/sp:B/cl:ii", "@proposed": "true"}], "#text": "Upon making a determination, in consultation with\n\t\t\t\tthe "}, "enum": {"#tail": "\n                      ", "#text": "(iv)"}, "header": {"#tail": "\n                      ", "#text": "Terminating a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "id37792e7da08340a0880ab74e4063d70e"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\tdispenser shall keep records of the disposition of an illegitimate product for\n\t\t\t\tnot less than 6 years after the conclusion of the disposition."}, "enum": {"#tail": "\n                      ", "#text": "(v)"}, "header": {"#tail": "\n                      ", "#text": "Records"}, "#text": "\n                      ", "@id": "idAEB7D96C7A614D6EB6BEA54D9F44BE60"}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Illegitimate\n\t\t\t\tproduct"}, "#text": "\n                    ", "@id": "id68643f492d834cf49d0c289a88f8326c"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A dispenser may satisfy the requirements of this\n\t\t\t\tparagraph by developing a secure electronic database or utilizing a secure\n\t\t\t\telectronic database developed or operated by another entity."}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Electronic\n\t\t\t\tdatabase"}, "#text": "\n                    ", "@id": "idd3799f408f6c477688c62adc19fd2bbf"}]}], "#text": "\n                ", "@id": "ida57260e705a744548a196a6d29561ac7"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Repackager\n\t\t\t\trequirements"}, "paragraph": [{"#tail": "\n                ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "not accept ownership of a\n\t\t\t\tproduct unless the previous owner, prior to, or at the time of, the\n\t\t\t\ttransaction, provides transaction history, transaction information, and a\n\t\t\t\ttransaction statement for the product;"}, "enum": {"#tail": "\n                      ", "#text": "(i)"}, "@id": "ida26c87e5c5fd480ebd2aecc13f5fe88f", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "prior to, or at the time\n\t\t\t\tof, each transaction in which the repackager transfers ownership of a product,\n\t\t\t\tor transfers possession of a product to a third-party logistics provider,\n\t\t\t\tprovide the subsequent owner with transaction history, transaction information,\n\t\t\t\tand a transaction statement; and"}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "@id": "id59261e54eac2429ebd5909e58b8672ad", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "clauses (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:1/sp:A/cl:i", "@proposed": "true"}, {"#tail": " for not less than 6 years\n\t\t\t\tafter the transaction.", "@entity-type": "act", "#text": "(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:1/sp:A/cl:ii", "@proposed": "true"}], "#text": "maintain the\n\t\t\t\ttransaction information, transaction history, and transaction statement for\n\t\t\t\teach transaction described in "}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "@id": "idaf3774e04e1347a7bfaa1cc92d82e91e", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"short-title": {"#tail": ", a repackager shall\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 1 year after the date of\n\t\t\t\tenactment of the "}, "#text": "\n                    ", "@id": "idbae7a878bab649929a4eed9833e738d6"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:1/sp:A/cl:ii", "@proposed": "true"}, "#text": "A repackager may return a nonsaleable product to the\n\t\t\t\tmanufacturer or repackager, or to the wholesale distributor from whom such\n\t\t\t\tproduct was purchased, or to a person acting on behalf of such a person,\n\t\t\t\tincluding a returns processor, without providing the information required under\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n                    ", "#text": "Nonsaleable\n\t\t\t\treturns"}, "#text": "\n                    ", "@id": "idfaeddf0a81b84c81a726fa6eecd231bb"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or other appropriate\n\t\t\t\tFederal or State official, in the event of a recall or for the purpose of\n\t\t\t\tinvestigating a suspect product or an illegitimate product, a repackager shall,\n\t\t\t\tnot later than 24 hours after receiving the request or in other such reasonable\n\t\t\t\ttime as determined by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", based on the circumstances of the request,\n\t\t\t\tprovide the applicable transaction information, transaction history and\n\t\t\t\ttransaction statement for the product.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon a request by the "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Requests for\n\t\t\t\tinformation"}, "#text": "\n                    ", "@id": "idb20f9d692bea4927b8f634d1c3b79de6"}], "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Product\n\t\t\t\ttracing"}, "#text": "\n                  ", "@id": "id763126f5ed6f41a0ba0ba536ba084bef"}, {"#tail": "\n                ", "@id": "idba23fc623f2149a690645ac22e9dfced", "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Product\n\t\t\t\tidentifier"}, "text": {"short-title": {"#tail": ", a repackager\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 5 years after the date of\n\t\t\t\tenactment of the "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "shall affix or imprint a\n\t\t\t\tproduct identifier to each package and homogenous case of product intended to\n\t\t\t\tbe introduced in a transaction in commerce;"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "id6817cfe581244e73966464b8c4c567fa", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "shall maintain the\n\t\t\t\tproduct identifier information for such product for not less than 6 years after\n\t\t\t\tthe date of the transaction;"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "id8042B3A76DCF47138390E8E86B60CCD0", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "); and", "@entity-type": "act", "#text": "subsection (a)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5", "@proposed": "true"}, "#text": "may engage in\n\t\t\t\ttransactions involving a product only if such product is encoded with a product\n\t\t\t\tidentifier (except as provided pursuant to "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "idf668b681ea954b6fb4aadca632f65dca", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "maintain records for not\n\t\t\t\tless than 6 years to allow the repackager to associate the product identifier\n\t\t\t\tthe repackager affixes or imprints with the product identifier assigned by the\n\t\t\t\toriginal manufacturer of the product."}, "enum": {"#tail": "\n                    ", "#text": "(D)"}, "@id": "iddacde1bfa5ab4a868c13e663441e8c6d", "#text": "\n                    "}]}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ",\n\t\t\t\tthe trading partners of a repackager may be only authorized trading\n\t\t\t\tpartners.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning 1 year after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Authorized trading\n\t\t\t\tpartners"}, "#text": "\n                  ", "@id": "id8b108646ae574d5faba5091ab3dcee5f"}, {"#tail": "\n              ", "@id": "idf96a8e24df5d49ee8a6c2df44c9e65c7", "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Verification"}, "text": {"short-title": {"#tail": ",\n\t\t\t\ta repackager shall have systems in place to enable the repackager to comply\n\t\t\t\twith the following requirements:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning\n\t\t\t\tnot later than 1 year after the date of enactment of the\n\t\t\t\t"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such product\n\t\t\t\twithin the possession or control of the repackager from product intended for\n\t\t\t\tdistribution until such product is cleared or dispositioned; and"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id02d1196d2174420d9aefee00b499c025", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " (except as provided pursuant to ", "@entity-type": "act", "@value": "Drug Supply Chain Security Act", "short-title": {"#tail": "\n                          ", "#text": "Drug Supply\n\t\t\t\tChain Security Act"}, "#text": "\n                            "}, {"#tail": "), verifying the product at the package level, including the standardized\n\t\t\t\tnumerical identifier.", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(a)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5", "@proposed": "true"}], "#text": "promptly conduct an\n\t\t\t\tinvestigation in coordination with trading partners, as applicable, to\n\t\t\t\tdetermine whether the product is an illegitimate product, which shall include\n\t\t\t\tvalidating any applicable transaction history and transaction information in\n\t\t\t\tthe possession of the repackager and otherwise investigating to determine\n\t\t\t\twhether the product is an illegitimate product, and, beginning 5 years after\n\t\t\t\tthe date of enactment of the "}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id69bb8fa2cd424e27b49478878043fe38", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that has made a determination\n\t\t\t\tthat a product within the possession or control of a repackager is a suspect\n\t\t\t\tproduct, a repackager shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon making a determination that a product in the\n\t\t\t\tpossession or control of the repackager is a suspect product, or upon receiving\n\t\t\t\ta request for verification from the "}, "#text": "\n                      ", "@id": "id0a232a49484c430c86bdf27f55c919ef"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", if applicable, of such determination and such product may be\n\t\t\t\tfurther distributed.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "If the repackager makes the determination that a suspect\n\t\t\t\tproduct is not an illegitimate product, the repackager shall promptly notify\n\t\t\t\tthe "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Cleared\n\t\t\t\tproduct"}, "#text": "\n                      ", "@id": "id2db72b73c07542df99cb486c06411687"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\trepackager shall keep records of the investigation of a suspect product for not\n\t\t\t\tless than 6 years after the conclusion of the investigation."}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Records"}, "#text": "\n                      ", "@id": "id9e23bbf0d5ef46978c3c479f2514aece"}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Suspect\n\t\t\t\tproduct"}, "#text": "\n                    ", "@id": "idab7a652119ae44c3b9cd29312461f772"}, {"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such product\n\t\t\t\twithin the possession or control of the repackager from product intended for\n\t\t\t\tdistribution until such product is dispositioned;"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id6050a2cfcfde471b960373cc6300e22b", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "disposition the\n\t\t\t\tillegitimate product within the possession or control of the repackager;"}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id1D54FDA248A74DB7A7789ECF7F44B600", "#text": "\n                        "}, {"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "take reasonable and\n\t\t\t\tappropriate steps to assist a trading partner to disposition an illegitimate\n\t\t\t\tproduct not in the possession or control of the repackager; and"}, "enum": {"#tail": "\n                        ", "#text": "(III)"}, "@id": "id730f085fe8764cb99a2817a85c0a90a4", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "retain a sample of the\n\t\t\t\tproduct for further physical examination or laboratory analysis of the product\n\t\t\t\tby the manufacturer or Secretary (or other appropriate Federal or State\n\t\t\t\tofficial) upon request by the manufacturer or Secretary (or other appropriate\n\t\t\t\tFederal or State official), as necessary and appropriate."}, "enum": {"#tail": "\n                        ", "#text": "(IV)"}, "@id": "id9C628FE8E956491384CA6D293B00AECE", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "Upon determining, in coordination with the manufacturer,\n\t\t\t\tthat a product in the possession or control of a repackager is an illegitimate\n\t\t\t\tproduct, the repackager shall, in a manner that is consistent with the systems\n\t\t\t\tand processes of such repackager\u2014"}, "#text": "\n                      ", "@id": "id41878dc0ded34ca5988cafac6bafcff1"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and all immediate trading partners that the repackager has\n\t\t\t\treason to believe may have received the illegitimate product of such\n\t\t\t\tdetermination not later than 24 hours after making such determination.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon determining that a product in the possession or\n\t\t\t\tcontrol of the repackager is an illegitimate product, the repackager shall\n\t\t\t\tnotify the "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Making a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "id28d794a2dcf444ada3395d992d614a0d"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or a trading partner, a repackager shall identify all illegitimate\n\t\t\t\tproduct subject to such notification that is in the possession or control of\n\t\t\t\tthe repackager, including any product that is subsequently received, and shall\n\t\t\t\tperform the activities described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4/sp:A", "@proposed": "true"}], "#text": "Upon the receipt of a notification from the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Responding to a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "id760720e2df0c4bc89adff1b862da8cf2"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", that a notification is no longer necessary, a repackager shall\n\t\t\t\tpromptly notify immediate trading partners that the repackager notified\n\t\t\t\tpursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " that such notification has been terminated.", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4/sp:B/cl:ii", "@proposed": "true"}], "#text": "Upon a determination, in consultation with the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(iv)"}, "header": {"#tail": "\n                      ", "#text": "Terminating a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "ida599d7364a4e4327b33d51324e2a9042"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\trepackager shall keep records of the disposition of an illegitimate product for\n\t\t\t\tnot less than 6 years after the conclusion of the disposition."}, "enum": {"#tail": "\n                      ", "#text": "(v)"}, "header": {"#tail": "\n                      ", "#text": "Records"}, "#text": "\n                      ", "@id": "id806B72414F144A4CAD04BF3F71EB9975"}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Illegitimate\n\t\t\t\tproduct"}, "#text": "\n                    ", "@id": "id3f8fb743710d43b9a161bff3994a6b73"}, {"#tail": "\n                  ", "text": {"short-title": {"#tail": ",\n\t\t\t\tupon receiving a request for verification from an authorized manufacturer,\n\t\t\t\twholesale distributor, or dispenser that is in possession or control of a\n\t\t\t\tproduct they believe to be repackaged by such repackager, a repackager shall,\n\t\t\t\tnot later than 24 hours after receiving the verification request or in other\n\t\t\t\tsuch reasonable time as determined by the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", based on the circumstances\n\t\t\t\tof the request, notify the person making the request whether the product\n\t\t\t\tidentifier, including the standardized numerical identifier, that is the\n\t\t\t\tsubject of the request corresponds to the product identifier affixed or\n\t\t\t\timprinted by the repackager. If a repackager responding to a verification\n\t\t\t\trequest identifies a product identifier that does not correspond to that\n\t\t\t\taffixed or imprinted by the repackager, the repackager shall treat such product\n\t\t\t\tas suspect product and conduct an investigation as described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". If the repackager has reason to believe the product is an illegitimate\n\t\t\t\tproduct, the repackager shall advise the person making the request of such\n\t\t\t\tbelief at the time such manufacturer responds to the verification\n\t\t\t\trequest.", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4/sp:A", "@proposed": "true"}], "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning 5 years after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "header": {"#tail": "\n                    ", "#text": "Requests for\n\t\t\t\tverification"}, "#text": "\n                    ", "@id": "ide4820ac802f64985838c89e206211e68"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " by developing a secure electronic database or utilizing a secure electronic\n\t\t\t\tdatabase developed or operated by another entity. The owner of such database\n\t\t\t\tshall establish the requirements and processes to respond to requests and may\n\t\t\t\tprovide for data access to other members of the pharmaceutical distribution\n\t\t\t\tsupply chain, as appropriate. The development and operation of such a database\n\t\t\t\tshall not relieve a repackager of the requirement under ", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4", "@proposed": "true"}, {"#tail": " to\n\t\t\t\trespond to a verification request submitted by means other than a secure\n\t\t\t\telectronic database.", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4/sp:C", "@proposed": "true"}], "#text": "A repackager may satisfy the requirements of "}, "enum": {"#tail": "\n                    ", "#text": "(D)"}, "header": {"#tail": "\n                    ", "#text": "Electronic\n\t\t\t\tdatabase"}, "#text": "\n                    ", "@id": "idf0150b18226146198a59f5de1e43517e"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ", upon receipt of a returned product that the repackager\n\t\t\t\tintends to further distribute, before further distributing such product, the\n\t\t\t\trepackager shall verify the product identifier for each sealed homogeneous case\n\t\t\t\tof such product or, if such product is not in a sealed homogeneous case, verify\n\t\t\t\tthe product identifier on each package.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                        "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning 5 years after the date of\n\t\t\t\tenactment of the "}, "enum": {"#tail": "\n                    ", "#text": "(E)"}, "header": {"#tail": "\n                    ", "#text": "Verification of\n\t\t\t\tsaleable returned product"}, "#text": "\n                    ", "@id": "id4234272c8c554b15ae1ac2d830bdcc11"}]}], "#text": "\n                ", "@id": "id3d0d4b915f48401f8a0d31bee2ebdf84"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Third-party logistics\n\t\t\t\tprovider requirements"}, "paragraph": [{"#tail": "\n                ", "@id": "id27e979a8240045358ab1c2bd684a9be3", "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"short-title": {"#tail": ", a third-party logistics provider shall\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 1 year after the date of\n\t\t\t\tenactment of the "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "not accept possession of\n\t\t\t\ta product unless the owner of the product provides the transaction history,\n\t\t\t\ttransaction information, and a transaction statement for the product;"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "id1ec32f7931294f85a97669b7dafd19d1", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for not less than 6 years\n\t\t\t\tafter the transfer of possession; and", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:1/sp:A", "@proposed": "true"}, "#text": "maintain a copy\n\t\t\t\tof the information described in "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "ida1cc5d39a7404fbab6e9bccff3b5e904", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or other appropriate Federal or State official, in the event of a\n\t\t\t\trecall or for the purpose of investigating a suspect product or an illegitimate\n\t\t\t\tproduct, not later than 24 hours after receiving the request or in other such\n\t\t\t\treasonable time as determined by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " based on the circumstances of\n\t\t\t\tthe request, provide the applicable transaction information, transaction\n\t\t\t\thistory, and transaction statement for the product.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "upon a request by\n\t\t\t\tthe "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "id12C59C70851E4852BDBF4552103F67BB", "#text": "\n                    "}], "@commented": "no"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ", a third-party logistics provider may accept possession of\n\t\t\t\tproduct only if such product is encoded with a product identifier (except as\n\t\t\t\tprovided pursuant to ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ").", "@entity-type": "act", "#text": "subsection (a)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:5", "@proposed": "true"}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 6 years after the date of\n\t\t\t\tenactment of the "}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Product\n\t\t\t\ttracing"}, "#text": "\n                  ", "@id": "id0c8d363eb35c40d68b29f43ef76ef060"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ",\n\t\t\t\tthe trading partners of a third-party logistics provider may be only authorized\n\t\t\t\ttrading partners.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning 1 year after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Authorized trading\n\t\t\t\tpartners"}, "#text": "\n                  ", "@id": "id1f6080e38c444bbc9af385f4f0e7f9aa"}, {"#tail": "\n              ", "@id": "idc80806f9a88e49e5a361ee8378bc2931", "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Verification"}, "text": {"short-title": {"#tail": ",\n\t\t\t\ta third-party logistics provider shall have systems in place to enable the\n\t\t\t\tthird-party logistics provider to comply with the following\n\t\t\t\trequirements:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning\n\t\t\t\tnot later than 1 year after the date of enactment of the\n\t\t\t\t"}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such product\n\t\t\t\twithin the possession or control of the third-party logistics provider from\n\t\t\t\tproduct intended for distribution until such product is cleared or transferred\n\t\t\t\tto the owner of such product for disposition of the product; and"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "idebb64ace18cc433e8d70ae721022fd74", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "promptly notify the\n\t\t\t\towner of such product of the need to conduct an investigation to determine\n\t\t\t\twhether the product is an illegitimate product."}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "idf15fdf29328640b7bf283380c829de75", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "Upon making a determination that a product in the\n\t\t\t\tpossession or control of a third-party logistics provider is a suspect product,\n\t\t\t\ta third-party logistics provider shall\u2014"}, "#text": "\n                      ", "@id": "id3603b838fee940e1a9edce77dee7a828"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "If the owner of the product notifies the third-party\n\t\t\t\tlogistics provider of the determination that a suspect product is not an\n\t\t\t\tillegitimate product, such product may be further distributed."}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Cleared\n\t\t\t\tproduct"}, "#text": "\n                      ", "@id": "id13d87833b00f43cd96a684cfe98653ff"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subclauses (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:4/sp:A/cl:i/scl:I", "@proposed": "true"}, {"#tail": ", as such subclauses relate to a\n\t\t\t\tsuspect product, for not less than 6 years after the conclusion of the\n\t\t\t\tinvestigation.", "@entity-type": "act", "#text": "(II) of clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:4/sp:A/cl:i/scl:II", "@proposed": "true"}], "#text": "A\n\t\t\t\tthird-party logistics provider shall keep records of the activities described\n\t\t\t\tin "}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Records"}, "#text": "\n                      ", "@id": "idab3bc8c1548448f39a99df3c8a144d90"}], "enum": {"#tail": "\n                    ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Suspect\n\t\t\t\tproduct"}, "#text": "\n                    ", "@id": "idf62ceacbfa7e44a5814990b6c8e5feb0"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                    ", "subclause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "promptly notify the owner\n\t\t\t\tof such product of the need to disposition such product; and"}, "enum": {"#tail": "\n                        ", "#text": "(I)"}, "@id": "id6961fe83646e43ab887210b0c29943cf", "#text": "\n                        "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "promptly transfer\n\t\t\t\tpossession of the product to the owner of such product to disposition the\n\t\t\t\tproduct."}, "enum": {"#tail": "\n                        ", "#text": "(II)"}, "@id": "id5fa2160095354280bae515276971c81b", "#text": "\n                        "}], "enum": {"#tail": "\n                      ", "#text": "(i)"}, "header": {"#tail": "\n                      ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "Upon determining, in coordination with the manufacturer,\n\t\t\t\tthat a product in the possession or control of a third-party logistics provider\n\t\t\t\tis an illegitimate product, the third-party logistics provider shall\u2014"}, "#text": "\n                      ", "@id": "id388659b378ab4c458275b3e38e424f63"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " not later than 24\n\t\t\t\thours after making such determination.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon determining that a product in the possession or\n\t\t\t\tcontrol of the third-party logistics provider is an illegitimate product, the\n\t\t\t\tthird-party logistics provider shall notify the "}, "enum": {"#tail": "\n                      ", "#text": "(ii)"}, "header": {"#tail": "\n                      ", "#text": "Making a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "id57e786d2abe442af985937c0b78d8e84"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", a third-party logistics provider shall identify all illegitimate\n\t\t\t\tproduct subject to such notification that is in the possession or control of\n\t\t\t\tthe third-party logistics provider, including any product that is subsequently\n\t\t\t\treceived, and shall perform the activities described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:4/sp:A", "@proposed": "true"}], "#text": "Upon the receipt of a notification from the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(iii)"}, "header": {"#tail": "\n                      ", "#text": "Responding to a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "id4e98d1b0b4c94888802d9a6e80f97b13"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and the owner of such product, that a notification is no longer\n\t\t\t\tnecessary, a third-party logistics provider shall promptly terminate such\n\t\t\t\tnotification.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon making a determination, in consultation with\n\t\t\t\tthe "}, "enum": {"#tail": "\n                      ", "#text": "(iv)"}, "header": {"#tail": "\n                      ", "#text": "Terminating a\n\t\t\t\tnotification"}, "#text": "\n                      ", "@id": "ideb96820a56ff4cb39ccf3208d7d4a760"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subclauses (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:4/sp:A/cl:i/scl:I", "@proposed": "true"}, {"#tail": " as such subclauses relate to an\n\t\t\t\tillegitimate product for not less than 6 years after the conclusion of the\n\t\t\t\tdisposition.", "@entity-type": "act", "#text": "(II) of clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:4/sp:A/cl:i/scl:II", "@proposed": "true"}], "#text": "A\n\t\t\t\tthird-party logistics provider shall keep records of the activities described\n\t\t\t\tin "}, "enum": {"#tail": "\n                      ", "#text": "(v)"}, "header": {"#tail": "\n                      ", "#text": "Records"}, "#text": "\n                      ", "@id": "idB8557A8FF924417CBE3037ED15D696E1"}], "enum": {"#tail": "\n                    ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Illegitimate\n\t\t\t\tproduct"}, "#text": "\n                    ", "@id": "id6f2ffcaf4bf0405685304411704d1b2e"}]}], "#text": "\n                ", "@id": "id0c227a1b27574be8ac8411e9f2ea9694"}, {"#tail": "\n            ", "enum": {"#tail": "\n                ", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Drop shipments"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "), ", "@entity-type": "act", "#text": "clauses (ii", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:4/sp:B/cl:ii", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:4/sp:B/cl:iii", "@proposed": "true"}, {"#tail": ", provided that the manufacturer, repackager, or other wholesale\n\t\t\t\tdistributor that distributes the product to the dispenser by means of drop\n\t\t\t\tshipment for such wholesale distributor includes on the transaction information\n\t\t\t\tand transaction history to the dispenser the contact information of such\n\t\t\t\twholesale distributor and provides the transaction information, transaction\n\t\t\t\thistory, and transaction statement directly to the dispenser.", "@entity-type": "act", "#text": "(iv) of subsection\n\t\t\t\t(c)(4)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:4/sp:B/cl:iv", "@proposed": "true"}], "#text": "A wholesale distributor that does not physically handle\n\t\t\t\tor store product shall be exempt from the provisions of this section, except\n\t\t\t\tthe notification requirements under "}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "ida82ff6a43bbd4a41be3f660595c916f8"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "For\n\t\t\t\tpurposes of this subsection, providing administrative services, including\n\t\t\t\tprocessing of orders and payments, shall not by itself, be construed as being\n\t\t\t\tinvolved in the handling, distribution, or storage of a\n\t\t\t\tproduct."}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Clarification"}, "#text": "\n                  ", "@id": "id2FEB5669BC4344E381845B6977AA21FD"}], "#text": "\n                ", "@id": "id4a17635c488f4ba7b15ebf394bbca3b3"}], "#text": "\n              ", "@id": "id0e96c13b1e944d0283468014a8ff4603"}], "enum": {"#tail": "\n            ", "#text": "H"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Pharmaceutical\n\t\t\t\tdistribution supply chain"}, "#text": "\n            ", "@id": "idd8202d6f2a164af786469a74f7d1d26c"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id5bdb07e4de4041be82c5abe03118f8b3"}, "#text": "\n        ", "@id": "id152ccba45d2d4c529aa71d3141e42f5d"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as added by ", "@entity-type": "act", "#text": "Section\n\t\t\t 582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}, {"#tail": ", is amended by adding at the end the\n\t\t\t following:", "@entity-type": "act", "#text": "section 202", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:202", "@proposed": "true"}], "#text": "\n          ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "203."}, "header": {"#tail": "\n        ", "#text": "Enhanced drug\n\t\t\t distribution security"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "@reported-display-style": "italic", "subsection": [{"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(h)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Enhanced drug\n\t\t\t\tdistribution security"}, "paragraph": [{"#tail": "\n            ", "@id": "id08dca4b9ec8149499795c59ea0bcae5a", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"short-title": {"#tail": ", the following interoperable, electronic tracing of product\n\t\t\t\tat the package level requirements shall go into effect:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                  "}, "#tail": "\n\t\t\t\t\t\t\t", "#text": "On the date that is 10 years after the date of enactment\n\t\t\t\tof the "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tand ", "@entity-type": "act", "#text": "paragraphs (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:3", "@proposed": "true"}, {"#tail": ", including any revision of such guidance issued in\n\t\t\t\taccordance with ", "@entity-type": "act", "#text": "(4) of subsection (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:4", "@proposed": "true"}, {"#tail": " of such subsection.", "@entity-type": "act", "#text": "paragraph (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:5", "@proposed": "true"}], "#text": "The transaction\n\t\t\t\tinformation and the transaction statements as required under this section shall\n\t\t\t\tbe exchanged in a secure, interoperable, electronic manner in accordance with\n\t\t\t\tthe standards established under the guidance issued pursuant to "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "ide440bf6050e141e3b4dafd2fe94ecb62", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The transaction\n\t\t\t\tinformation required under this section shall include the product identifier at\n\t\t\t\tthe package level for each package included in the transaction."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "id7a6f1d3e7254443d8e92edd0a16a4d62", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and the\n\t\t\t\tguidances issued pursuant to ", "@entity-type": "act", "#text": "subsection (a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:2", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "paragraphs (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:2", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:3", "@proposed": "true"}, {"#tail": ",\n\t\t\t\tincluding any revision of such guidances issued in accordance with ", "@entity-type": "act", "#text": "(4) of subsection (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:4", "@proposed": "true"}, {"#tail": ", which may include the use of aggregation and inference\n\t\t\t\tas necessary.", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(5) of such subsection", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:5", "@proposed": "true"}], "#text": "Systems and processes for\n\t\t\t\tverification of product at the package level, including the standardized\n\t\t\t\tnumerical identifier, shall be required in accordance with the standards\n\t\t\t\testablished under the guidance issued pursuant to "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "id6e54d5038e1b4769a88b573d3ee667e3", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (or other\n\t\t\t\tappropriate Federal or State official) in the event of a recall or for the\n\t\t\t\tpurposes of investigating a suspect product or an illegitimate product shall be\n\t\t\t\trequired.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The systems and\n\t\t\t\tprocesses necessary to promptly respond with the transaction information and\n\t\t\t\ttransaction statement for a product upon a request by the "}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "id76ad7d97f89e48ec93e179d68166ac70", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The systems and processes\n\t\t\t\tnecessary to promptly facilitate gathering the information necessary to produce\n\t\t\t\tthe transaction information for each transaction going back to the\n\t\t\t\tmanufacturer, as applicable, shall be required\u2014"}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (or other appropriate Federal or State official), on\n\t\t\t\taccount of a recall or for the purposes of investigating a suspect product or\n\t\t\t\tan illegitimate product; or", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "in the event of a\n\t\t\t\trequest by the "}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "id2710315DC397425494812E51F4FD02AE", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (or\n\t\t\t\tother appropriate Federal or State official) with a request described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "clause\n\t\t\t\t(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:1/sp:E/cl:i", "@proposed": "true"}], "#text": "in the event of\n\t\t\t\ta request by an authorized trading partner, in a secure manner that ensures the\n\t\t\t\tprotection of confidential commercial information and trade secrets, for\n\t\t\t\tpurposes of investigating a suspect product or assisting the "}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "id350C7F7FEC8D4FE699ADD919E4E89EA2", "#text": "\n                  "}], "#text": "\n                ", "@id": "id6f8d8c5d7de44124a5dd3e82dcf981ac"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Each person accepting a\n\t\t\t\tsaleable return shall have systems and processes in place to allow acceptance\n\t\t\t\tof such product and may accept saleable returns only if such person can\n\t\t\t\tassociate the saleable return product with the transaction information and\n\t\t\t\ttransaction statement associated with that product."}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "id8d04fa00a38242fab1858f96da188978", "#text": "\n                "}]}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "A dispenser may enter into a written agreement with a\n\t\t\t\tthird party, including an authorized wholesale distributor, under which the\n\t\t\t\tthird party shall confidentially maintain any information and statements\n\t\t\t\trequired to be maintained under this section. If a dispenser enters into such\n\t\t\t\tan agreement, the dispenser shall maintain a copy of the written agreement and\n\t\t\t\tshall not be relieved of the obligations of the dispenser under this\n\t\t\t\tsubsection."}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "Information maintenance\n\t\t\t\tagreement"}, "#text": "\n                ", "@id": "id9b1077ae3109408d9030e441c74fafbc"}, {"#tail": "\n            ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " is not met, if the ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3", "@proposed": "true"}, {"#tail": " determines that\n\t\t\t\tsuch requirements under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " would result in undue economic hardship;\n\t\t\t\tand", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:1", "@proposed": "true"}], "#text": "establishing timelines\n\t\t\t\tfor compliance by small businesses (including small business dispensers with 25\n\t\t\t\tor fewer full time employees) with such requirements, in order to ensure that\n\t\t\t\tsuch requirements do not impose undue economic hardship for small businesses,\n\t\t\t\tincluding small business dispensers for whom the criteria set forth in the\n\t\t\t\tassessment under "}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "id44bb2774b3c9441caec8a491986dd0a3", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " if the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:1", "@proposed": "true"}, {"#tail": " determines that such requirements\n\t\t\t\twould result in an undue economic hardship, which shall include a process for\n\t\t\t\tthe biennial review and renewal of any such waiver.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "establishing a\n\t\t\t\tprocess by which a dispenser may request a waiver from any of the requirements\n\t\t\t\tset forth in "}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "ida4416b70070a4a9090fc4913ad8d5bfa", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Alternative\n\t\t\t\tmethods"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", taking into consideration the assessment\n\t\t\t\tconducted under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall provide for alternative methods of\n\t\t\t\tcompliance with any of the requirements set forth in ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3", "@proposed": "true"}, {"#tail": ",\n\t\t\t\tincluding\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:1", "@proposed": "true"}], "#text": "The "}, "#text": "\n                ", "@id": "id4d2220111ab34a6ca02e50455b10f7e7"}], "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Compliance"}, "#text": "\n              ", "@id": "ida792bc0703d44fbeae6ed2579d0537b2"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "text": {"short-title": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                    "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " issues the final guidance required under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", the\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i", "@proposed": "true"}, {"#tail": " shall enter into contract with a private, independent consulting firm\n\t\t\t\twith expertise to conduct a technology and software assessment that looks at\n\t\t\t\tthe feasibility of dispensers with 25 or fewer full-time employees conducting\n\t\t\t\tinteroperable, electronic tracing of products at the package level. In no case\n\t\t\t\tmay such assessment commence later than 7\u00bd years after the date of enactment of\n\t\t\t\tthe ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#tail": "\n\t\t\t\t\t\t\t", "#text": "Not later than the date that is 18 months after the\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "idedb3e3e9b1c24735a89cd2851b7bc001"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the private,\n\t\t\t\tindependent consulting firm shall agree to consult with dispensers with 25 or\n\t\t\t\tfewer full-time employees when conducting the assessment under such\n\t\t\t\tsubparagraph.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3/sp:A", "@proposed": "true"}, "#text": "As\n\t\t\t\ta condition of the award of the contract under "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Condition"}, "#text": "\n                ", "@id": "idAFEF47DD7337440BAB205F1175E77B97"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the necessary software\n\t\t\t\tand hardware is readily accessible to such dispensers;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "idf0cc61d562df4dbda9e070035fa0930d", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the necessary software\n\t\t\t\tand hardware is prohibitively expensive to obtain, install, and maintain for\n\t\t\t\tsuch dispensers; and"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "idf644f736b7804fd9ae31f611af38f431", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the necessary hardware\n\t\t\t\tand software can be integrated into business practices, such as\n\t\t\t\tinteroperability with wholesale distributors, for such dispensers."}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "id5e41e8847c0042ecbf2abab0e60db70c", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Content"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall assess whether\u2014", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3/sp:A", "@proposed": "true"}, "#text": "The\n\t\t\t\tassessment conducted under "}, "#text": "\n                ", "@id": "id6e98f4618f9440f49f52e39c44ce578a"}, {"#tail": "\n            ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for\n\t\t\t\tpublic comment prior to beginning the assessment;", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3/sp:A", "@proposed": "true"}, "#text": "publish the\n\t\t\t\tstatement of work for the assessment conducted under "}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "id80519817c10a4229b39cda39c08b66e2", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish the final\n\t\t\t\tassessment for public comment not later than 30 calendar days after receiving\n\t\t\t\tsuch assessment; and"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "iddc52ea6ea0024666bef8fe48fa301bc9", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "hold a public meeting\n\t\t\t\tnot later than 180 calendar days after receiving the final assessment at which\n\t\t\t\tpublic stakeholders may present their views on the assessment."}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "id9a02f0fde2c247d3b898f068ce527c35", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(D)"}, "header": {"#tail": "\n                ", "#text": "Publication"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The\n\t\t\t\t"}, "#text": "\n                ", "@id": "idba9a9bd282004f3ba69b9c5a13a1c154"}], "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Assessment"}, "#text": "\n              ", "@id": "idc116ed31a5b942fdafacfe142d47079b"}, {"#tail": "\n          ", "@id": "idbeb98a33f64d40caa7e73c41afc31ea6", "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Procedure"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "uscode", "#text": "\n                  ", "external-xref": {"#tail": " of title 5, United States Code", "@parsable-cite": "usc/5/553", "#text": "section 553", "@legal-doc": "usc"}, "@value": "usc/5/553"}, {"#tail": ", in promulgating any\n\t\t\t\tregulation pursuant to this section, shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Notwithstanding\n\t\t\t\t"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide appropriate\n\t\t\t\tflexibility by\u2014"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "not requiring the\n\t\t\t\tadoption of specific business systems for the maintenance and transmission of\n\t\t\t\tdata;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "idfb629951661b4ca587e5f37ecbe2bd66", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " or set forth in regulations implementing such requirements,\n\t\t\t\tincluding timelines\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:1", "@proposed": "true"}, "#text": "prescribing\n\t\t\t\talternative methods of compliance for any of the requirements set forth in\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " is not met), if the ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3", "@proposed": "true"}, {"#tail": "\n\t\t\t\tdetermines that such requirements would result in undue economic hardship;\n\t\t\t\tand", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "for small\n\t\t\t\tbusinesses to comply with the requirements set forth in the regulations in\n\t\t\t\torder to ensure that such requirements do not impose undue economic hardship\n\t\t\t\tfor small businesses (including small business dispensers for whom the criteria\n\t\t\t\tset forth in the assessment under "}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "id689b0a455432450a90e1152a96a72c00", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tdetermines that such requirements would result in an undue economic hardship;\n\t\t\t\tand", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "which shall\n\t\t\t\tinclude establishing a process by which a dispenser may request a waiver from\n\t\t\t\tany of the requirements set forth in such regulations if the "}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "id4aa1311e99d34973b83e3bf2dec1364b", "#text": "\n                    "}], "#text": "\n                  ", "@id": "idbdb50c04292641f9a6051a5ab3af2c7e"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "taking into\n\t\t\t\tconsideration\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the results of pilot\n\t\t\t\tprojects, including pilot projects pursuant to this section;"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "id9b201a779f694c889c3c1e64eb030706", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the public meetings held\n\t\t\t\tand related guidance documents issued under this section;"}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "id4fdbebc1a56d4cab963d943f5fcaaa59", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the public health\n\t\t\t\tbenefits of any additional regulations in comparison to the cost of compliance\n\t\t\t\twith such requirements, including on entities of varying sizes and\n\t\t\t\tcapabilities;"}, "enum": {"#tail": "\n                    ", "#text": "(III)"}, "@id": "id31e35c1ca7ce49ddb1f465fe428327d3", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the diversity of the\n\t\t\t\tpharmaceutical distribution supply chain by providing appropriate flexibility\n\t\t\t\tfor each sector, including both large and small businesses; and"}, "enum": {"#tail": "\n                    ", "#text": "(IV)"}, "@id": "id5ff76dce4d2243ddba522508aa0a1dc0", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to small business dispensers, including\n\t\t\t\trelated public comment and the public meeting, and requirements under this\n\t\t\t\tsection;", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:3", "@proposed": "true"}, "#text": "the assessment\n\t\t\t\tpursuant to "}, "enum": {"#tail": "\n                    ", "#text": "(V)"}, "@id": "idb0a779c890ed4bb7941bc5f5783219d0", "#text": "\n                    "}], "#text": "\n                  ", "@id": "ide5d93bd691534f3a8ba3409cdf4bb942"}], "#text": "\n                ", "@id": "id9729ac5b569a408fa21bd0d84e164352"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "issue a notice of\n\t\t\t\tproposed rulemaking that includes a copy of the proposed regulation;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "id7c10a31624b044f198f728156038162a", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "provide a period of not\n\t\t\t\tless than 60 days for comments on the proposed regulation; and"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "id6ca06c5183d74e5bbcabc0ef5ef9ef6c", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "publish the final\n\t\t\t\tregulation not less than 2 years prior to the effective date of the\n\t\t\t\tregulation."}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "id77a9e190274545749ad17e84a100c0bd", "#text": "\n                "}]}], "#text": "\n            ", "@id": "id1cad5ecabf194b0796eb75d91991a5a3"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Guidance\n\t\t\t\tdocuments"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall issue the guidance documents as provided for\n\t\t\t\tin this subsection.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "For the purposes of facilitating the successful and\n\t\t\t\tefficient adoption of secure, interoperable product tracing at the package\n\t\t\t\tlevel in order to enhance drug distribution security and further protect the\n\t\t\t\tpublic health, the "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n              ", "@id": "id29CA8E5838AB49DBA26AC0222B843105"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "identify specific\n\t\t\t\tscenarios that could significantly increase the risk of a suspect product\n\t\t\t\tentering the pharmaceutical distribution supply chain;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "id3bfbe26c01fa4ae4a3ef5298b73f3fa9", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide recommendation\n\t\t\t\ton how trading partners may identify such product and make a determination if\n\t\t\t\tthe product is a suspect product as soon as practicable; and"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "idd8f9962fe03745548aaa943c4e807910", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " regarding illegitimate product pursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", ", "@entity-type": "act", "#text": "subsections\n\t\t\t\t(b)(4)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:4/sp:B", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(c)(4)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:4/sp:B", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(d)(4)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:4/sp:B", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(e)(4)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4/sp:B", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(f)(4)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:4/sp:B", "@proposed": "true"}], "#text": "set forth the process\n\t\t\t\tby which manufacturers, repackagers, wholesale distributors, dispensers, and\n\t\t\t\tthird-party logistics providers shall terminate notifications in consultation\n\t\t\t\twith the "}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "idece122f8c2f14965a8ce454e98387d3b", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": ", the ", "@entity-type": "act", "@value": "Drug Supply Chain Security Act", "short-title": {"#tail": "\n                  ", "#text": "Drug Supply Chain Security\n\t\t\t\tAct"}, "#text": "\n                    "}, {"#tail": " shall issue a guidance document to aid trading\n\t\t\t\tpartners in the identification of a suspect product and notification\n\t\t\t\ttermination. Such guidance document shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Not later than 180 days after the date of enactment of\n\t\t\t\tthe "}, "#text": "\n                ", "@id": "id162068CC657541FEAE09F3A0659E6E00"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " revises the guidance issued under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:2/sp:A", "@proposed": "true"}, {"#tail": " shall follow the procedure set forth in\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:5", "@proposed": "true"}], "#text": "If the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Revised\n\t\t\t\tguidance"}, "#text": "\n                ", "@id": "id296C5DBC3AFF47EE825ED36658A2A547"}], "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Suspect and\n\t\t\t\tillegitimate product"}, "#text": "\n              ", "@id": "id98c9539f840340358d0b85e7665567f6"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "define the circumstances\n\t\t\t\tunder which the sectors within the pharmaceutical distribution supply chain\n\t\t\t\tmay, in the most efficient manner practicable, infer the contents of a case,\n\t\t\t\tpallet, tote, or other aggregate of individual packages or containers of\n\t\t\t\tproduct, from a product identifier associated with the case, pallet, tote, or\n\t\t\t\tother aggregate, without opening each case, pallet, tote, or other aggregate or\n\t\t\t\totherwise individually scanning each package;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "id8afb11903c994533b90e807404f33db5", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "identify methods and\n\t\t\t\tprocesses to enhance secure tracing of product at the package level, such as\n\t\t\t\tsecure processes to facilitate the use of inference, enhanced verification\n\t\t\t\tactivities, the use of aggregation and inference, processes that utilize the\n\t\t\t\tproduct identifiers to enhance tracing of product at the package level,\n\t\t\t\tincluding the standardized numerical identifier, or package security features;\n\t\t\t\tand"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "idf158a7f65ec94948a40d7afcd4662ab7", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "ensure the protection\n\t\t\t\tof confidential commercial information and trade secrets."}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "id47F253528FC9451A91B654F61A0BE459", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall issue a final guidance document\n\t\t\t\tthat outlines and makes recommendations with respect to the system attributes\n\t\t\t\tnecessary to enable secure tracing at the package level as required under the\n\t\t\t\trequirements established under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". Such guidance document\n\t\t\t\tshall\u2014", "@entity-type": "act", "#text": "subsection (h)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h", "@proposed": "true"}], "#text": "In order to enhance drug distribution security at the\n\t\t\t\tpackage level, not later than 18 months after conducting a public meeting on\n\t\t\t\tthe system attributes necessary to enable secure tracing of product at the\n\t\t\t\tpackage level, including allowing for the use of verification, inference, and\n\t\t\t\taggregation, as necessary, the "}, "#text": "\n                ", "@id": "id855CC5F333294F4EBE9F7FE81D40286A"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and in revising such guidance, if\n\t\t\t\tapplicable, the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:3/sp:A", "@proposed": "true"}, {"#tail": " shall follow the procedure set forth in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:5", "@proposed": "true"}], "#text": "In\n\t\t\t\tissuing the guidance under "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Procedure"}, "#text": "\n                ", "@id": "idC856CB9872C54F2482A5C2C884BF881D"}], "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Unit level\n\t\t\t\ttracing"}, "#text": "\n              ", "@id": "id65a18a369da44f19b36fbc79ff21f09a"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "identifies and makes\n\t\t\t\trecommendations with respect to the standards necessary for adoption in order\n\t\t\t\tto support the secure, interoperable electronic data exchange among the\n\t\t\t\tpharmaceutical distribution supply chain that comply with a form and format\n\t\t\t\tdeveloped by a widely recognized international standards development\n\t\t\t\torganization;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "idec032e434c27483b8aa77c51a38dc8bc", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subsection (a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:2", "@proposed": "true"}, {"#tail": ";", "@entity-type": "act", "#text": "section\n\t\t\t\t505D", "@value": "Federal Food, Drug, and Cosmetic Act/s:505D"}], "#text": "takes into\n\t\t\t\tconsideration standards established pursuant to "}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "id774b670f020b407cbdf671c36a70e72c", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "facilitates the\n\t\t\t\tcreation of a uniform process or methodology for product tracing; and"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "idf10e1522eb1b4296834d814eb8cdb412", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "ensures the protection\n\t\t\t\tof confidential commercial information and trade secrets."}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "@id": "id7c368bfa92fd4939b0251ab9374fd639", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", not later than 18 months after conducting a\n\t\t\t\tpublic meeting on the interoperable standards necessary to enhance the security\n\t\t\t\tof the pharmaceutical distribution supply chain, shall update the guidance\n\t\t\t\tissued pursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", as necessary and appropriate, and\n\t\t\t\tfinalize such guidance document so that the guidance document\u2014", "@entity-type": "act", "#text": "subsection (a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:2", "@proposed": "true"}], "#text": "In order to enhance secure tracing of a product at the\n\t\t\t\tpackage level, the "}, "#text": "\n                ", "@id": "id00C847C7AEC64014BA496C59C494F570"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and in revising such guidance, if\n\t\t\t\tapplicable, the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:4/sp:A", "@proposed": "true"}, {"#tail": " shall follow the procedure set forth in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:5", "@proposed": "true"}], "#text": "In\n\t\t\t\tissuing the guidance under "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Procedure"}, "#text": "\n                ", "@id": "id36A572DFC43C4353B233CFE18AD6F027"}], "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Standards for\n\t\t\t\tinteroperable data exchange"}, "#text": "\n              ", "@id": "id9515753a3c3b4ad0b7c79f9c35adee52"}, {"#tail": "\n          ", "@id": "id1D45A921BB7A40768F2AC70F5E71316A", "enum": {"#tail": "\n              ", "#text": "(5)"}, "header": {"#tail": "\n              ", "#text": "Procedure"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", except the initial guidance issued under ", "@entity-type": "act", "#text": "subsection (h)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h", "@proposed": "true"}, {"#tail": ", the\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph (2)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:2/sp:A", "@proposed": "true"}, {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In\n\t\t\t\tissuing or revising any guidance issued pursuant to this subsection or\n\t\t\t\t"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "publish a notice in the\n\t\t\t\tFederal Register for a period not less than 30 days announcing that the draft\n\t\t\t\tor revised draft guidance is available;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "id7fd9c754f0e24dbe98159ecd92932598", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tand make such draft guidance document available in hard copy;", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "post the draft\n\t\t\t\tguidance document on the Internet Web site of the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "id62de2e5bf670443f8a64c8fc43f051f4", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "provide an opportunity\n\t\t\t\tfor comment and review and take into consideration any comments\n\t\t\t\treceived;"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "idbd9338595cca4ebb9da25eb30345b5ae", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "revise the draft\n\t\t\t\tguidance, as appropriate;"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "id50c46d0db007425ba3d6d81e05c4ed08", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "publish a notice in the\n\t\t\t\tFederal Register for a period not less than 30 days announcing that the final\n\t\t\t\tguidance or final revised guidance is available;"}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "id660384bc78c84ba38bb384865abc3788", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "post the final guidance\n\t\t\t\tdocument on the Internet Website of the Food and Drug Administration and make\n\t\t\t\tsuch final guidance document available in hard copy; and"}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "id4c543ed1bd2544c88c065e83fb40f9e2", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "provide for an effective\n\t\t\t\tdate of not earlier than 1 year after such guidance becomes final."}, "enum": {"#tail": "\n                ", "#text": "(G)"}, "@id": "id9dc9093e057e445fb408af36cb888cce", "#text": "\n                "}]}], "#text": "\n            ", "@id": "ideaac9677f4734df39a94fb252fc48e34"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(j)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Public\n\t\t\t\tmeetings"}, "paragraph": [{"#tail": "\n            ", "@id": "id79021d74220c4ac6a0f5397aec1ee2f3", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"short-title": {"#tail": ".\n\t\t\t\tIn carrying out the public meetings described in this paragraph, the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                  "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall hold not less than 3 public meetings\n\t\t\t\tto enhance the safety and security of the pharmaceutical distribution supply\n\t\t\t\tchain and provide for comment. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may hold the first such public\n\t\t\t\tmeeting not earlier than 1 year after the date of enactment of the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tshall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#tail": "\n\t\t\t\t\t\t\t", "#text": "The "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tand ", "@entity-type": "act", "#text": "paragraphs (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:3", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "act", "#text": "(4) of subsection (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:4", "@proposed": "true"}], "#text": "prioritize topics\n\t\t\t\tnecessary to inform the issuance of the guidance described in "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "idb154d2a9cba640f8811b29ce1887d5db", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "take all measures\n\t\t\t\treasonable and practicable to ensure the protection of confidential commercial\n\t\t\t\tinformation and trade secrets."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "id76ffe7679d8349d6a9fd5333d2f5f01a", "#text": "\n                "}]}, {"#tail": "\n          ", "@id": "id2151a3ad36834631acc5d3c4665e50c5", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Content"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ":", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:j/p:1", "@proposed": "true"}, "#text": "Each\n\t\t\t\tof the following topics shall be addressed in at least one of the public\n\t\t\t\tmeetings described in "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to build capacity for a\n\t\t\t\tunit-level system, including the impact of the requirements of such subsections\n\t\t\t\ton\u2014", "@entity-type": "act", "#text": "subsections (b) through (f)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:b..f", "@proposed": "true"}, "#text": "An assessment of\n\t\t\t\tthe steps taken under "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the ability of the health\n\t\t\t\tcare system collectively to maintain patient access to medicines;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "id4e5fc9517aac4ff99049bbf69a32c2fc", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the scalability of such\n\t\t\t\trequirements, including as it relates to product lines; and"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "id634426b9c50040a983afed92e824982d", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the capability of\n\t\t\t\tdifferent sectors and subsectors, including both large and small businesses, to\n\t\t\t\taffix and utilize the product identifier."}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "id866640e2bb5243d6bceef37fedb2c717", "#text": "\n                  "}], "#text": "\n                ", "@id": "idc7235e5feec04bf6a2ed14e9dfc377ab"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", including the standards necessary for adoption in order to support the\n\t\t\t\tsecure, interoperable electronic data exchange among sectors within the\n\t\t\t\tpharmaceutical distribution supply chain.", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(h)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h", "@proposed": "true"}, "#text": "The system\n\t\t\t\tattributes necessary to support the requirements set forth under "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "idfb7f3fb8e5254b758b0f05e0f035c4a1", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Best practices in each of\n\t\t\t\tthe different sectors within the pharmaceutical distribution supply chain to\n\t\t\t\timplement the requirements of this section."}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "id66b9ec8eb372421bafe3735a13594475", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The costs and benefits of\n\t\t\t\tthe implementation of this section, including the impact on each pharmaceutical\n\t\t\t\tdistribution supply chain sector and on public health."}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "idf5f5d479e03d4c95b322b74def3f2a69", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Whether electronic\n\t\t\t\ttracing requirements, including tracing of product at the package level, are\n\t\t\t\tfeasible, cost-effective, and needed to protect the public health."}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "id06390ff276a5401a81124cfd477d73f7", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The systems and processes\n\t\t\t\tneeded to utilize the product identifiers to enhance tracing of product at the\n\t\t\t\tpackage level, including allowing for verification, aggregation, and inference,\n\t\t\t\tas necessary."}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "ida902ab4eb527488a84eba03a440c1a15", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The technical\n\t\t\t\tcapabilities and legal authorities, if any, needed to establish an\n\t\t\t\tinteroperable, electronic system that provides for tracing of product at the\n\t\t\t\tpackage level."}, "enum": {"#tail": "\n                ", "#text": "(G)"}, "@id": "idbd44303ab3504387b853ffa8cdd9a95a", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The impact that such\n\t\t\t\tadditional requirements would have on patient safety, the drug supply, cost and\n\t\t\t\tregulatory burden, and timely patient access to prescription drugs."}, "enum": {"#tail": "\n                ", "#text": "(H)"}, "@id": "id0f363b55aea343239a29ee07c7730294", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Other topics, as\n\t\t\t\tdetermined appropriate by the "}, "enum": {"#tail": "\n                ", "#text": "(I)"}, "@id": "idc409502a5ec643a983b5737d3b6192c7", "#text": "\n                "}]}], "#text": "\n            ", "@id": "id38121468d2b448efba1df9e6d5a83109"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(k)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Pilot projects"}, "paragraph": [{"#tail": "\n            ", "text": {"short-title": {"#tail": ", to enhance the safety and security of\n\t\t\t\tthe pharmaceutical distribution supply chain, take into consideration any pilot\n\t\t\t\tprojects conducted prior to such date of enactment, and inform the draft and\n\t\t\t\tfinal guidance under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "Drug\n\t\t\t\tSupply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                  "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish 1 or more pilot projects,\n\t\t\t\tin coordination with authorized manufacturers, repackagers, wholesale\n\t\t\t\tdistributors, third-party logistics providers, and dispensers, to explore and\n\t\t\t\tevaluate methods to enhance the safety and security of the pharmaceutical\n\t\t\t\tdistribution supply chain. Such projects shall build upon efforts, in existence\n\t\t\t\tas of the date of enactment of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "paragraphs (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:3", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(4) of subsection (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:i/p:4", "@proposed": "true"}], "#tail": "\n\t\t\t\t\t\t", "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n              ", "@id": "id30a3fb82bf61462da7f199441cc50fb5"}, {"#tail": "\n          ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall ensure that the pilot projects under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " reflect the diversity of the pharmaceutical distribution supply\n\t\t\t\tchain and that the pilot projects, when taken as a whole, include participants\n\t\t\t\trepresentative of every sector, including both large and small\n\t\t\t\tbusinesses.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:k/p:1", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "id9d5be24ee59b40d9a6b4a52e3412db6d"}, {"#tail": "\n            ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "utilize the product\n\t\t\t\tidentifier for tracing of a product, which may include verification of the\n\t\t\t\tproduct identifier of a product, including the use of aggregation and\n\t\t\t\tinference;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "id578530bca2e54955b06bbf87a29dda82", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "improve the technical\n\t\t\t\tcapabilities of each sector and subsector to comply with systems and processes\n\t\t\t\tneeded to utilize the product identifiers to enhance tracing of a\n\t\t\t\tproduct;"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "id55cfb481af6844fc8abb146631ff2d7a", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "identify system\n\t\t\t\tattributes that are necessary to implement the requirements established under\n\t\t\t\tthis section; and"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "idd3261d28fb5344edb342c5d1b7681ced", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "complete other\n\t\t\t\tactivities as determined by the "}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "@id": "id2f4688908a8f46f6a6b17f99658deb7a", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Project\n\t\t\t\tdesign"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be designed\n\t\t\t\tto\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:k/p:1", "@proposed": "true"}, "#text": "The pilot projects under "}, "#text": "\n                ", "@id": "id2de13569c5a1440b84553e674fd1e23f"}], "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Content"}, "#text": "\n              ", "@id": "id22b17c10577444deb230af1c3e7fb92d"}], "#text": "\n            ", "@id": "idd08923eb52834771be96461a551833cb"}, {"#tail": "\n          ", "text": {"short-title": {"#tail": ":", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                "}, "#tail": "\n\t\t\t\t\t\t", "#text": "The\n\t\t\t\tfollowing requirements shall have no force or effect beginning on the date that\n\t\t\t\tis 10 years after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n            ", "#text": "(l)"}, "header": {"#tail": "\n            ", "#text": "Sunset"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The provision and receipt\n\t\t\t\tof transaction history under this section."}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "id3123aa85b6b7416c8926eef466d5cfd7", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (b)(4)(E)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:4/sp:E", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(c)(1)(B)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:B/cl:i", "@proposed": "true"}, {"#tail": ", and\n\t\t\t\t", "@entity-type": "act", "#text": "(d)(1)(C)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:1/sp:B/cl:i", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(e)(4)(E)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4/sp:E", "@proposed": "true"}], "#text": "The requirements set\n\t\t\t\tforth for returns under "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "id2b6e7824e0c64b6d8c4e24d59b5d252c", "#text": "\n              "}], "#text": "\n            ", "@id": "idc05159ec574444c581a497ee9fe7ba1d"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t\t", "@entity-type": "act", "#text": "subsections (h)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h/p:4", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:j", "@proposed": "true"}, {"#tail": " shall not be construed as a condition, prohibition, or precedent\n\t\t\t\tfor precluding or delaying the provisions becoming effective pursuant to\n\t\t\t\t", "@entity-type": "act", "#text": "(k)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:k", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(h)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:h", "@proposed": "true"}], "#text": "The requirements set forth in "}, "enum": {"#tail": "\n            ", "#text": "(m)"}, "header": {"#tail": "\n            ", "#text": "Rule of\n\t\t\t\tconstruction"}, "#text": "\n            ", "@id": "idfd9de69cdb82416382686911558ef781"}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id59969741af6e427a9f1cb2699dcabf62"}, "#text": "\n        ", "@id": "id78139f99bfa44fd6bfe76849e3b3d206"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "204."}, "header": {"#tail": "\n\t\t\t\t", "#text": "National licensure\n\t\t\t standards for prescription drug wholesale distributors"}, "subsection": [{"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Amendments"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "paragraphs (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:2"}, {"#tail": " and inserting the following:", "@entity-type": "act", "#text": "(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:3"}], "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by\n\t\t\t striking ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 503(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "uscode", "#text": "21 U.S.C. 353(e)", "@value": "usc/21/353/e"}, "@parsable-cite": "usc/21/353", "#text": "\n                  ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "header": {"#tail": "\n            ", "#text": "License\n\t\t\t requirement"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n\t\t\t\t\t", "@reported-display-style": "italic", "paragraph": [{"#tail": "\n              ", "@id": "id1f9b9420c75a410d84d4a15ee04215b9", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "License\n\t\t\t\trequirement"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ":", "@entity-type": "act", "#text": "section 583", "@value": "Federal Food, Drug, and Cosmetic Act/s:583", "@proposed": "true"}, "#text": "Subject to "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "is licensed by the\n\t\t\t\tState from which the drug is distributed; or"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                      ", "@id": "id18E884A392924D38AF01B9C692083F05", "@commented": "no"}, {"@committee-id": "SSHR00", "@changed": "added", "@indent": "up1", "#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "if the State from which the drug\n\t\t\t\tdistributed has not established a licensure requirement, is licensed by the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@reported-display-style": "italic", "#text": "\n                      ", "@id": "id720C82711F8042E48DAD17BAE5DE3BA2"}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id19980E335D834395B7DA67CA87AFB525", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "if the drug is\n\t\t\t\tdistributed interstate, is licensed by the State into which the drug is\n\t\t\t\tdistributed if the State into which the drug is distributed requires the\n\t\t\t\tlicensure of a person that distributes drugs into the State."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id4B20BB6AF09F40479E936EFACF05A47B", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in any State unless such person\u2014", "@entity-type": "act", "#text": "subsection (b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "#text": "No person may engage in wholesale distribution of a drug\n\t\t\t\tsubject to "}, "#text": "\n                  ", "@id": "id94C04F772A5F4C3194709FA7A3629F9C"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall meet the standards, terms, and conditions established by\n\t\t\t\tthe ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1/sp:A", "@proposed": "true"}, {"#tail": " under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "section 583", "@value": "Federal Food, Drug, and Cosmetic Act/s:583", "@proposed": "true"}], "#text": "Each Federal and State license described in\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "License\n\t\t\t\tstandards"}, "#text": "\n                  ", "@id": "id703C3BAC78C54122A834F2D51A05E904"}]}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "each State by which the\n\t\t\t\tperson is licensed and the appropriate identification number of each such\n\t\t\t\tlicense; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "idd24ce812c0f74aa3bfeb566978714857", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the name, address, and\n\t\t\t\tcontact information of each facility at which, and all trade names under which,\n\t\t\t\tthe person conducts business."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "idbde6c4431ca740c9acff78918171b271", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Licensure\n\t\t\t\treporting"}, "text": {"short-title": {"#tail": ",\n\t\t\t\tany person who owns or operates an establishment that engages in wholesale\n\t\t\t\tdistribution shall report to the Secretary, on an annual basis pursuant to a\n\t\t\t\tschedule determined by the Secretary\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning 1 year after the date of enactment of the\n\t\t\t\t"}, "#text": "\n                  ", "@id": "id817CB5D3D91245D195821750EF6072C2"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "identify each wholesale\n\t\t\t\tdistributor by name, contact information, and each State where such wholesale\n\t\t\t\tdistributor is appropriately licensed to engage in wholesale\n\t\t\t\tdistribution;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id01499591fc1c41cca33f1a2c2e6110ae", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";\n\t\t\t\tand", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "be available to\n\t\t\t\tthe public on the Internet Web site of the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "ida913b40d8b254decbf1baac6dcc1a6b4", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "be regularly\n\t\t\t\tupdated on a schedule determined by the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id2e64041c8a6846389028dd1d0e4cba5b", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Database"}, "text": {"short-title": {"#tail": ",\n\t\t\t\tthe ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall establish a database of licensed wholesale distributors.\n\t\t\t\tSuch database shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Not\n\t\t\t\tlater than 1 year after the date of enactment of the\n\t\t\t\t"}, "#text": "\n                  ", "@id": "idef744454ee784b509ecb8b22df336ca8"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Licensure reporting and\n\t\t\t\tdatabase"}, "#text": "\n                ", "@id": "id226da65c15e74cb6aa56baf3b5cac42c"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b"}, {"#tail": " shall license a person engaged in\n\t\t\t\twholesale distribution located in such State and may collect a reasonable fee\n\t\t\t\tin such amount necessary to reimburse the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " for costs associated with\n\t\t\t\testablishing and administering the licensure program and conducting periodic\n\t\t\t\tinspections under this section. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall adjust fee rates as needed\n\t\t\t\ton an annual basis to generate only the amount of revenue needed to perform\n\t\t\t\tthis service. Fees authorized under this paragraph shall be collected and\n\t\t\t\tavailable for obligation only to the extent and in the amount provided in\n\t\t\t\tadvance in appropriations Acts. Such fees are authorized to remain available\n\t\t\t\tuntil expended.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If a State does not establish a\n\t\t\t\tlicensing program for persons engaged in the wholesale distribution of a drug\n\t\t\t\tsubject to "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Authorized licensure\n\t\t\t\tfees of secretary"}, "#text": "\n                  ", "@id": "id34610194be604e30b19e7422402a3f1b"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Nothing in this Act shall prohibit States from collecting\n\t\t\t\tfees from wholesale distributors in connection with State licensing of such\n\t\t\t\tdistributors."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "State licensing\n\t\t\t\tfees"}, "#text": "\n                  ", "@id": "id06e5fed979c84b34902fd983939bf7f6"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Costs"}, "#text": "\n                ", "@id": "id51c6f01400a64b11af086c037a589bd5"}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t\t", "@id": "idE59F80AE41874797A7084BC21C70C1F4"}, "#text": "\n            ", "@id": "idE65EFFEF2DCF4771AE87AE5BD0B752E3"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is further amended by adding at the end the following:", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:204/ss:a/p:1", "@proposed": "true"}, "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as amended by\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 503(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "uscode", "#text": "21 U.S.C. 353(e)", "@value": "usc/21/353/e"}, "@parsable-cite": "usc/21/353", "#text": "\n                  ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "header": {"#tail": "\n            ", "#text": "Wholesale\n\t\t\t distribution"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n\t\t\t\t\t", "@reported-display-style": "italic", "paragraph": {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the term ", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:d"}, {"#tail": "\n\t\t\t\tto a person other than a consumer or patient, or receipt of a drug subject to\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b"}, {"#tail": " by a person other than the consumer or patient, but does not\n\t\t\t\tinclude\u2014", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b"}], "term": {"#tail": " means the distribution of a drug subject to ", "#text": "wholesale\n\t\t\t\tdistribution"}, "#text": "For the purposes\n\t\t\t\tof this subsection and "}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "#text": "\n                ", "@id": "ida478ee3d2d034bac932d45cbc6f159aa", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ") or within a manufacturer;", "@entity-type": "act", "#text": "section\n\t\t\t\t1504(a) of the Internal Revenue Code of 1986", "@value": "Internal Revenue Code of 1986/s:1504/ss:a"}, "#text": "intracompany distribution\n\t\t\t\tof any drug between members of an affiliated group (as defined in "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idc79eccaff24c473a99e23975a1473af3", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tdrug, or an offer to distribute a drug among hospitals or other health care\n\t\t\t\tentities which are under common control;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id3a39e320bef9462aafafb44b452925ce", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", except that, for purposes of this paragraph, a drug\n\t\t\t\tshortage not caused by a public health emergency shall not constitute an\n\t\t\t\temergency medical reason;", "@entity-type": "act", "#text": "section 319 of the Public\n\t\t\t\tHealth Service Act", "@value": "Public Health Service Act/s:319"}, "#text": "the distribution of a\n\t\t\t\tdrug or an offer to distribute a drug for emergency medical reasons, including\n\t\t\t\ta public health emergency declaration pursuant to "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "ida591e644579c405fb92add0a6ea75b05", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section\n\t\t\t\t503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "#text": "the dispensing of\n\t\t\t\ta drug pursuant to a valid prescription executed in accordance with "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "ide13af1043ccf436d8e0ede916a13e3a2", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of\n\t\t\t\tminimal quantities of drug by a licensed retail pharmacy to a licensed\n\t\t\t\tpractitioner for office use;"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "id3f82d5d180134a93943f0db938f9824b", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tdrug or an offer to distribute a drug by a charitable organization to a\n\t\t\t\tnonprofit affiliate of the organization to the extent otherwise permitted by\n\t\t\t\tlaw;"}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@id": "idd24555e2bc024c638a9dd97427b12bbb", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the purchase or other\n\t\t\t\tacquisition by a dispenser, hospital, or other health care entity of a drug for\n\t\t\t\tuse by such dispenser, hospital, or other health care entity;"}, "enum": {"#tail": "\n                  ", "#text": "(G)"}, "@id": "idbb2dab14f3ca4800be5dd09daf6ed2a2", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tdrug by the manufacturer of such drug;"}, "enum": {"#tail": "\n                  ", "#text": "(H)"}, "@id": "ida081e584f3054b3ba2c048d29a499cc1", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the receipt or transfer\n\t\t\t\tof a drug by an authorized third-party logistics provider provided that such\n\t\t\t\tthird-party logistics provider does not take ownership of the drug;"}, "enum": {"#tail": "\n                  ", "#text": "(I)"}, "@id": "id8cee228766d34455b12a16972238a725", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "a common carrier that\n\t\t\t\ttransports a drug, provided that the common carrier does not take ownership of\n\t\t\t\tthe drug;"}, "enum": {"#tail": "\n                  ", "#text": "(J)"}, "@id": "id5d98b8ca500d4e748a54fb7c0c06ae6b", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 582(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e", "@proposed": "true"}, "#text": "the distribution\n\t\t\t\tof a drug, or an offer to distribute a drug by an authorized repackager that\n\t\t\t\thas taken ownership or possession of the drug and repacks it in accordance with\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(K)"}, "@id": "id683e519ecf1d41179ecbf8bdb7286ce5", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "salable drug returns when\n\t\t\t\tconducted by a dispenser;"}, "enum": {"#tail": "\n                  ", "#text": "(L)"}, "@id": "ide3877406299043c9b84a3112f49c81b2", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tmedical convenience kit which is a collection of finished medical devices or a\n\t\t\t\tcollection of drug or biologic products assembled in kit form strictly for the\n\t\t\t\tconvenience of the purchaser or user if\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(M)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as a device manufacturer in accordance with ", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}, {"#tail": ";", "@entity-type": "act", "#text": "section\n\t\t\t\t510(b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:510/ss:b/p:2"}], "#text": "the medical convenience\n\t\t\t\tkit is assembled in an establishment that is registered with the "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id2efebdd7fe4c4c998b4375b2c8398913", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the person who\n\t\t\t\tmanufacturers the medical convenience kit purchased the finished drug or\n\t\t\t\tbiologic product contained in the medical convenience kit directly from the\n\t\t\t\tpharmaceutical manufacturer or from a wholesale distributor that purchased the\n\t\t\t\tproduct directly from the pharmaceutical manufacturer;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id437594fc280e484399e8324e9008cffa", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the person who\n\t\t\t\tmanufacturers a medical convenience kit does not alter the primary container or\n\t\t\t\tlabel of the product as purchased from the manufacturer or wholesale\n\t\t\t\tdistributor;"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "id4e2a19b0e92c4e41ad429d3a548eae98", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the medical convenience\n\t\t\t\tkit does not contain a controlled substance that appears in a schedule\n\t\t\t\tcontained in the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\t(", "@entity-type": "act", "#text": "Comprehensive Drug Abuse Prevention and Control Act of 1970", "@value": "Comprehensive Drug Abuse Prevention and Control Act of 1970"}, {"#tail": ")", "@entity-type": "uscode", "#text": "\n                          ", "external-xref": {"#tail": ", et seq", "@parsable-cite": "usc/21/801", "#text": "21 U.S.C. 801", "@legal-doc": "usc"}, "@value": "usc/21/801/etseq"}], "@entity-type": "law-citation", "#text": "\n                        "}}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "@id": "idf4a4d3140a21413f87d08f938789c2ad", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the products contained in\n\t\t\t\tthe medical convenience kit are\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(v)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "intravenous solutions\n\t\t\t\tintended for the replenishment of fluids and electrolytes;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "#text": "\n                      ", "@id": "id2872581e13b74c19acf04cef0614597b", "@commented": "no"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "drugs intended to\n\t\t\t\tmaintain the equilibrium of water and minerals in the body;"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "#text": "\n                      ", "@id": "idb2b849902aaf4b64ad56cac36c26e1fc", "@commented": "no"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "drugs intended for\n\t\t\t\tirrigation or reconstitution;"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "#text": "\n                      ", "@id": "id671a02180b43452db2d06448ab53d143", "@commented": "no"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "anesthetics;"}, "enum": {"#tail": "\n                      ", "#text": "(IV)"}, "#text": "\n                      ", "@id": "id79fa8a19b3a74d7f91d579112a116fae", "@commented": "no"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "anticoagulants;"}, "enum": {"#tail": "\n                      ", "#text": "(V)"}, "#text": "\n                      ", "@id": "ida72d9cdd449248ebb076a9b815688da4", "@commented": "no"}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "vasopressors; or"}, "enum": {"#tail": "\n                      ", "#text": "(VI)"}, "#text": "\n                      ", "@id": "iddaee9f8b38ce41d48ff2284062e4c285", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "sympathicomimetics;"}, "enum": {"#tail": "\n                      ", "#text": "(VII)"}, "#text": "\n                      ", "@id": "id35ad17f23d81430d8f57e502c64109df", "@commented": "no"}], "#text": "\n                    ", "@id": "id60b2b24f94fa449c8d79559c07de7633", "@commented": "no"}], "#text": "\n                  ", "@id": "id11d483b11ba940538d350dc24667b70a"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of an\n\t\t\t\tintravenous drug that, by its formulation, is intended for the replenishment of\n\t\t\t\tfluids and electrolytes (such as sodium, chloride, and potassium) or calories\n\t\t\t\t(such as dextrose and amino acids);"}, "enum": {"#tail": "\n                  ", "#text": "(N)"}, "@id": "ide517608bc6584d4d8031582487c0b19b", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of an\n\t\t\t\tintravenous drug used to maintain the equilibrium of water and minerals in the\n\t\t\t\tbody, such as dialysis solutions;"}, "enum": {"#tail": "\n                  ", "#text": "(O)"}, "@id": "idf63e9d00cf4049dead2dc378940f8aa4", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tdrug that is intended for irrigation or reconstitution, or sterile water,\n\t\t\t\twhether intended for such purposes or for injection;"}, "enum": {"#tail": "\n                  ", "#text": "(P)"}, "@id": "idd0860c0bac4347a4bf9969f3ae619c39", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 575", "@value": "Federal Food, Drug, and Cosmetic Act/s:575"}, "#text": "the distribution of\n\t\t\t\tmedical gas, as defined in "}, "enum": {"#tail": "\n                  ", "#text": "(Q)"}, "@id": "id4c5ffb8b688a44768d3f2d816ad36212", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "facilitating the\n\t\t\t\tdistribution of a product by providing solely administrative services,\n\t\t\t\tincluding processing of orders and payments; or"}, "enum": {"#tail": "\n                  ", "#text": "(R)"}, "@id": "idc431b65261d040d88ce649191943bd06", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for the purpose of repackaging the drug for use by that\n\t\t\t\thospital, or other health care entity and other health care entities that are\n\t\t\t\tunder common control, if ownership of the drug remains with the hospital or\n\t\t\t\tother health care entity at all\n\t\t\t\ttimes.", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, "#text": "the transfer of a\n\t\t\t\tproduct by a hospital or other health care entity to a repackager registered\n\t\t\t\tunder "}, "enum": {"#tail": "\n                  ", "#text": "(S)"}, "@id": "idd779fc7ae9d5451eb816c8ebdeb83895", "#text": "\n                  "}]}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t\t", "@id": "idf7f32e3dc5684e008752f21a112ceeaf"}, "#text": "\n            ", "@id": "id11009d86cc2446b78c2b292000c4eb56"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is further amended by adding at the end the following:", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:2"}, "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as amended by\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "(", "@entity-type": "act", "#text": "Section 503(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "uscode", "#text": "21 U.S.C. 353(e)", "@value": "usc/21/353/e"}, "@parsable-cite": "usc/21/353", "#text": "\n                  ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n            ", "#text": "(3)"}, "header": {"#tail": "\n            ", "#text": "Third-party logistics\n\t\t\t providers"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n\t\t\t\t\t", "@reported-display-style": "italic", "paragraph": {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", each entity\n\t\t\t\tthat meets the definition of a third-party logistics provider under ", "@entity-type": "act", "#text": "paragraphs (1) through (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1..4"}, {"#tail": " shall obtain a license as a third-party logistics provider as described\n\t\t\t\tin ", "@entity-type": "act", "#text": "section\n\t\t\t\t581(21)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:21", "@proposed": "true"}, {"#tail": " and is not required to obtain a license as a wholesale\n\t\t\t\tdistributor if the entity never assumes an ownership interest in the product it\n\t\t\t\thandles.", "@entity-type": "act", "#text": "section 584(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:a"}], "#text": "Notwithstanding "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Third-party logistics\n\t\t\t\tproviders"}, "#text": "\n                ", "@id": "id1800c5d7a9d54898bc802568ddef8c8e"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t\t", "@id": "id1D5792219B93429E902772B8023A4176"}, "#text": "\n            ", "@id": "idcf5d8069c9c945e6bd30c70728fc2ee8"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is\n\t\t\t amended by adding at the end the following:", "@entity-type": "act", "#text": "section 202", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:202", "@proposed": "true"}, "#text": "Subchapter H of chapter V, as added by "}, "enum": {"#tail": "\n            ", "#text": "(4)"}, "header": {"#tail": "\n            ", "#text": "Licensure\n\t\t\t standards"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n\t\t\t\t\t", "section": {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "583."}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "National licensure\n\t\t\t\tstandards for prescription drug wholesale distributors"}, "subsection": [{"#tail": "\n                ", "text": {"short-title": [{"#tail": ", establish by regulation minimum standards, terms,\n\t\t\t\tand conditions for the licensing of persons under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain\n\t\t\t\tSecurity Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, {"#tail": "), including the revocation, reissuance, and renewal of such\n\t\t\t\tlicense.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}], "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall, not later than 2 years after the\n\t\t\t\tdate of enactment of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " (as amended\n\t\t\t\tby the ", "@entity-type": "act", "#text": "section 503(e)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1"}], "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(a)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "id60d28eeab53c4b9aa9dcbfa88bc35ebd", "@commented": "no"}, {"#tail": "\n                ", "text": {"short-title": {"#tail": ")\n\t\t\t\tand shall prescribe minimum requirements for the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall apply to all State and Federal\n\t\t\t\tlicenses described under ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:a", "@proposed": "true"}, {"#tail": " (as amended by the\n\t\t\t\t", "@entity-type": "act", "#text": "section 503(e)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1"}], "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\tstandards established under "}, "enum": {"#tail": "\n                  ", "#text": "(b)"}, "header": {"#tail": "\n                  ", "#text": "Content"}, "paragraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The storage and handling\n\t\t\t\tof such drugs, including facility requirements."}, "enum": {"#tail": "\n                    ", "#text": "(1)"}, "@id": "idc529fa56de3e49fe90858c657fbfd58d", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The establishment and\n\t\t\t\tmaintenance of records of the distributions of such drugs."}, "enum": {"#tail": "\n                    ", "#text": "(2)"}, "@id": "idd02f48899cd047f19f45d4c3bab90e61", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "The furnishing of a bond\n\t\t\t\tor other equivalent means of security, as follows:"}, "enum": {"#tail": "\n                    ", "#text": "(3)"}, "#text": "\n                    ", "@id": "id46c9dfed5c1b42479b6bd92a0d3475cd", "subparagraph": [{"#tail": "\n                    ", "clause": [{"#tail": "\n                      ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "#text": "For the issuance or\n\t\t\t\trenewal of a wholesale distributor license, an applicant that is not a\n\t\t\t\tgovernment owned and operated wholesale distributor shall submit a surety bond\n\t\t\t\tof $100,000 or other equivalent means of security acceptable to the\n\t\t\t\tState."}, "enum": {"#tail": "\n                        ", "#text": "(i)"}, "@display-inline": "yes-display-inline", "#text": "\n                        ", "@id": "idD515B6DB957F4D1D8E4B76796B4287F0", "@commented": "no"}, {"@committee-id": "SSHR00", "@changed": "added", "@indent": "up1", "#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the State or other applicable authority may accept a surety bond in the\n\t\t\t\tamount of $25,000 if the annual gross receipts of the previous tax year for the\n\t\t\t\twholesaler is $10,000,000 or less.", "@entity-type": "act", "#text": "clause\n\t\t\t\t(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:b/p:3/sp:A/cl:i", "@proposed": "true"}, "#text": "For purposes of "}, "enum": {"#tail": "\n                        ", "#text": "(ii)"}, "@reported-display-style": "italic", "#text": "\n                        ", "@id": "idF253484AE21E43848335A341FED91106"}], "enum": {"#tail": "\n                      ", "#text": "(A)"}, "@id": "id793d35dcca9f45779088afa9473ba56a", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "If a wholesale\n\t\t\t\tdistributor can provide evidence that it possesses the required bond in a\n\t\t\t\tState, the requirement for a bond in another State shall be waived."}, "enum": {"#tail": "\n                      ", "#text": "(B)"}, "@id": "iddb48dfb4e9a740a494f458a955c32325", "#text": "\n                      "}]}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Mandatory background\n\t\t\t\tchecks and fingerprinting of facility managers or designated\n\t\t\t\trepresentatives."}, "enum": {"#tail": "\n                    ", "#text": "(4)"}, "@id": "id461ea4d1abfb4d0b81f633194a9ed114", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The establishment and\n\t\t\t\timplementation of qualifications for key personnel."}, "enum": {"#tail": "\n                    ", "#text": "(5)"}, "@id": "idc651125472124b0f9b27850ae2f81cc2", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:c", "@proposed": "true"}, "#text": "The mandatory physical\n\t\t\t\tinspection of any facility to be used in wholesale distribution within a\n\t\t\t\treasonable time frame from the initial application of the facility and to be\n\t\t\t\tconducted by the licensing authority or by the State, consistent with\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(6)"}, "@id": "id65a714360dc64371940156fd7c77dd22", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the prohibition of certain persons from receiving or\n\t\t\t\tmaintaining licensure for wholesale distribution.", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:d", "@proposed": "true"}, "#text": "in accordance\n\t\t\t\twith "}, "enum": {"#tail": "\n                    ", "#text": "(7)"}, "@id": "id3db3f924680147a6a40d3cafe08243a8", "#text": "\n                    "}], "#text": "\n                  ", "@id": "idc219932a86784bbda65399a4e9ce6e5d"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the Federal or\n\t\t\t\tState licensing authority may conduct the inspection or may accept an\n\t\t\t\tinspection by the State in which the facility is located, or by a third-party\n\t\t\t\taccreditation or inspection service approved by the ", "@entity-type": "act", "#text": "subsection (b)(6)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:b/p:6", "@proposed": "true"}, {"#tail": " or the State\n\t\t\t\tlicensing such wholesale distributor.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "To\n\t\t\t\tsatisfy the inspection requirement under "}, "enum": {"#tail": "\n                  ", "#text": "(c)"}, "header": {"#tail": "\n                  ", "#text": "Inspections"}, "#text": "\n                  ", "@id": "id2d1a7a1e8c244be399aa79a3ebc74df3"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\n\t\t\t\tinclude requirements to prohibit a person from receiving or maintaining\n\t\t\t\tlicensure for wholesale distribution if the person\u2014", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:a", "@proposed": "true"}, "#text": "The standards established under "}, "enum": {"#tail": "\n                  ", "#text": "(d)"}, "header": {"#tail": "\n                  ", "#text": "Prohibited\n\t\t\t\tpersons"}, "paragraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "subsection (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:i"}, {"#tail": ", or any felony\n\t\t\t\tviolation of ", "@entity-type": "act", "#text": "(k) of section 301", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:k"}, {"#tail": ", relating to product\n\t\t\t\ttampering; or", "@entity-type": "uscode", "#text": "\n                      ", "external-xref": {"#tail": " of title 18, United States Code", "@parsable-cite": "usc/18/1365", "#text": "section 1365", "@legal-doc": "usc"}, "@value": "usc/18/1365"}], "#text": "has been\n\t\t\t\tconvicted of any felony for conduct relating to wholesale distribution, any\n\t\t\t\tfelony violation of "}, "enum": {"#tail": "\n                    ", "#text": "(1)"}, "@id": "id575ea202f64d45a98ddd80db1534899c", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "has engaged in a pattern\n\t\t\t\tof violating the requirements of this section, or State requirements for\n\t\t\t\tlicensure, that presents a threat of serious adverse health consequences or\n\t\t\t\tdeath to humans."}, "enum": {"#tail": "\n                    ", "#text": "(2)"}, "@id": "ide78613db1a91449cb3b3ded090f0795e", "#text": "\n                    "}], "#text": "\n                  ", "@id": "id738438e74edc4e0a86ab704cffb7ac39"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", in promulgating any regulation pursuant to this section, shall,\n\t\t\t\tnotwithstanding ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\u2014", "@entity-type": "uscode", "#text": "\n                    ", "external-xref": {"#tail": " of title 5, United States Code", "@parsable-cite": "usc/5/553", "#text": "section 553", "@legal-doc": "usc"}, "@value": "usc/5/553"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(e)"}, "header": {"#tail": "\n                  ", "#text": "Requirements"}, "paragraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "issue a notice of\n\t\t\t\tproposed rulemaking that includes a copy of the proposed regulation;"}, "enum": {"#tail": "\n                    ", "#text": "(1)"}, "@id": "ide24b23c32e984958bf65d23d23dcb9ac", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "provide a period of not\n\t\t\t\tless than 60 days for comments on the proposed regulation; and"}, "enum": {"#tail": "\n                    ", "#text": "(2)"}, "@id": "idb239630a230b4e7da3744ac0d6f56a93", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "provide that the final\n\t\t\t\tregulation take effect on the date that is 2 years after the date such final\n\t\t\t\tregulation is\n\t\t\t\tpublished."}, "enum": {"#tail": "\n                    ", "#text": "(3)"}, "@id": "id74c7d373bd1540ee8403c1310f6995fa", "#text": "\n                    "}], "#text": "\n                  ", "@id": "idbd61fa305be74bd097e85686bcf46e7e"}], "#text": "\n                ", "@id": "id46e4fa2f7fd545359f0f3acd8ef6cb3d"}, "@reported-display-style": "italic", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t\t", "@id": "id516D324C4FF142E6BEFB150F62603583"}, "#text": "\n            ", "@id": "id053cdf2332204a4b9e8eeeaca6a0cceb"}], "#text": "\n          ", "@id": "idF163EB8B15DE4D9B8C40936395CD38B0"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding\n\t\t\t at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 503(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:d"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 353(d)", "@value": "usc/21/353/d"}, "@parsable-cite": "usc/21/353", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Authorized distributors\n\t\t\t of record"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "@reported-display-style": "italic", "paragraph": {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means those distributors\n\t\t\t\twith whom a manufacturer has established an ongoing relationship to distribute\n\t\t\t\tsuch manufacturer's\n\t\t\t\tproducts.", "#text": "authorized distributors of record"}, "#text": "In this subsection, the\n\t\t\t\tterm "}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "@id": "idA5C3443C928C4F0F9751F383F10CF095", "#text": "\n              "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "id1C868CDA936248B3B0772AFA18727B7B"}, "#text": "\n          ", "@id": "idEF99B87EDB714ABE9C72336D3ECEBB20"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subsections (a)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:204/ss:a", "@proposed": "true"}, {"#tail": " shall take\n\t\t\t effect on the day that is 1 year after the date of enactment of this\n\t\t\t Act.", "@entity-type": "act", "#text": "(b)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:204/ss:b", "@proposed": "true"}], "#text": "The amendments made by "}, "enum": {"#tail": "\n          ", "#text": "(c)"}, "header": {"#tail": "\n          ", "#text": "Effective\n\t\t\t date"}, "#text": "\n          ", "@id": "id1630CEF5641647AFB44BB7B93F2EC745"}], "#text": "\n        ", "@id": "id789f8b5aea394bc2b27455cbec46e78f"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is further amended by adding at the end the\n\t\t\t following:", "@entity-type": "act", "#text": "section 204", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:204", "@proposed": "true"}, "#text": "Subchapter H of chapter\n\t\t\t V, as amended by ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "205."}, "header": {"#tail": "\n        ", "#text": "National licensure\n\t\t\t standards for third-party logistics providers; uniform national\n\t\t\t policy"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": [{"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "584."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "National licensure\n\t\t\t\tstandards for third-party logistics providers"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "No third-party logistics provider in any State may\n\t\t\t\tconduct activities in any State unless each facility of such third-party\n\t\t\t\tlogistics provider\u2014"}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "License\n\t\t\t\trequirements"}, "paragraph": [{"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:d", "@proposed": "true"}, "#text": "is licensed by the\n\t\t\t\tState from which the drug is distributed by the third-party logistics provider,\n\t\t\t\tin accordance with the regulations promulgated under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n                  ", "@id": "idC6793948DC164CD7A2D21B34B6041F51", "@commented": "no"}, {"@committee-id": "SSHR00", "@changed": "added", "@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", in accordance with the\n\t\t\t\tregulations promulgated under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "; and", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:d", "@proposed": "true"}], "#text": "if the State from which the drug\n\t\t\t\tdistributed by the third-party logistics provider has not established a\n\t\t\t\tlicensure requirement, is licensed by the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@reported-display-style": "italic", "#text": "\n                  ", "@id": "id827BCE792A2C48E09008467148563BB7"}], "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "idf77d0df1dc664d72aa5123cd4b0f25b9", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as described in\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:a/p:1/sp:B", "@proposed": "true"}], "#text": "if the drug is\n\t\t\t\tdistributed interstate, is licensed by the State into which the drug is\n\t\t\t\tdistributed by the third-party logistics provider if such State licenses\n\t\t\t\tthird-party logistics providers that distribute drugs into the State and the\n\t\t\t\tthird-party logistics provider is not licensed by the "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "id8AA0272AD88C4E76920056285294B21D", "#text": "\n                "}], "#text": "\n              ", "@id": "idabf3370a48634d77a1cb0056f4fc2961"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": ",\n\t\t\t\ta facility of a third-party logistics provider shall report to the ", "@entity-type": "act", "@value": "Drug Supply Chain Security Act", "short-title": {"#tail": "\n                ", "#text": "Drug Supply Chain Security Act"}, "#text": "\n                  "}, {"#tail": ",\n\t\t\t\ton an annual basis pursuant to a schedule determined by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Beginning 1 year after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Licensure\n\t\t\t\treporting"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the State by which the\n\t\t\t\tfacility is licensed and the appropriate identification number of such license;\n\t\t\t\tand"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "idea48483d4b054dafacf3a3d531c9c461", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the name and address of\n\t\t\t\tthe facility, and all trade names under which, such facility conducts\n\t\t\t\tbusiness."}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "id83fed44bd75f4b7293745dad14757520", "#text": "\n                "}], "#text": "\n              ", "@id": "id6f85ec55acfa403090d05876b5abedd3"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Costs"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t\tlicense the third-party logistics provider located in such State and may\n\t\t\t\tcollect a reasonable fee in such amount necessary to reimburse the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tfor costs associated with establishing and administering the licensure program\n\t\t\t\tand conducting periodic inspections under this section. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall\n\t\t\t\tadjust fee rates as needed on an annual basis to generate only the amount of\n\t\t\t\trevenue needed to perform this service. Fees authorized under this paragraph\n\t\t\t\tshall be collected and available for obligation only to the extent and in the\n\t\t\t\tamount provided in advance in appropriations Acts. Such fees are authorized to\n\t\t\t\tremain available until expended.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If a State does not establish a\n\t\t\t\tlicensing program for a third-party logistics provider, the "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Authorized licensure\n\t\t\t\tfees of secretary"}, "#text": "\n                ", "@id": "id15c78c0fba93408e8639c7e0f6c28f0c"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Nothing in this Act shall prohibit a State that has\n\t\t\t\testablished a program to license a third-party logistics provider from\n\t\t\t\tcollecting fees from a third-party logistics provider for such a\n\t\t\t\tlicense."}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "State established\n\t\t\t\tprogram"}, "#text": "\n                  ", "@id": "id9a058ebb69b24812adf2db1c3db474be"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A State that does not establish a program to license a\n\t\t\t\tthird-party logistics provider in accordance with this section shall be\n\t\t\t\tprohibited from collecting a State licensing fee from a third-party logistics\n\t\t\t\tprovider."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "No State established\n\t\t\t\tprogram"}, "#text": "\n                  ", "@id": "id094123c5b38a4f72a1554b87de9fb7aa"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "State licensing\n\t\t\t\tfees"}, "#text": "\n                ", "@id": "idbf4aba1aa306471590387a742d020722"}], "#text": "\n              ", "@id": "id5b9d6623c93f47c7ac7ebba0ea7884b1"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "License\n\t\t\t\tregulations"}, "paragraph": [{"#tail": "\n              ", "text": {"short-title": {"#tail": ",\n\t\t\t\tthe ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                    "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall issue regulations regarding the minimum issuance and\n\t\t\t\teligibility requirements for licensing under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", including the\n\t\t\t\trevocation and reissuance of such license, to third-party logistics providers\n\t\t\t\tunder this section.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:a", "@proposed": "true"}], "#tail": "\n\t\t\t\t\t\t\t", "#text": "Not later than 2 years after the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "id9fc4750319ba4209a907afd2021c2234"}, {"#tail": "\n              ", "@id": "idda3b7a60250a4185a59737d102798137", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Content"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Such\n\t\t\t\tregulations shall\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall, upon request by a third-party logistics provider, issue a license to\n\t\t\t\teach third-party logistics provider that meets the minimum requirements set\n\t\t\t\tforth in this section;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "establish a\n\t\t\t\tprocess by which a third-party accreditation program approved by the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "ide4e079607eb244ffac29d0e077934cb3", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall issue a license to each third-party\n\t\t\t\tlogistics provider that meets the minimum requirements set forth in this\n\t\t\t\tsection if the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " is not able to approve a third-party accreditation\n\t\t\t\tprogram because no such program meets the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " requirements necessary\n\t\t\t\tfor approval of such a third-party accreditation program;", "@entity-type": "federal-body", "#text": "Secretary\u2019s", "@entity-id": "7500"}], "#text": "establish a\n\t\t\t\tprocess by which the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id6b4087267ce54f518675963f13ff4c4e", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for such\n\t\t\t\tfacility, including\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "require that the\n\t\t\t\tentity complies with storage practices, as determined by the "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "maintaining access to\n\t\t\t\twarehouse space of suitable size to facilitate safe operations, including a\n\t\t\t\tsuitable area to quarantine suspect product;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "id80c5ea7904bd48178b916932dc47f263", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "maintaining adequate\n\t\t\t\tsecurity; and"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "id5b6c5367752a4049821a7b688c7374a0", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "having written policies\n\t\t\t\tand procedures to\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "address receipt,\n\t\t\t\tsecurity, storage, inventory, shipment, and distribution of a product;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "id8b4d0a9e3522471c974c6ca284891ff7", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "identify, record, and\n\t\t\t\treport confirmed losses or thefts in the United States;"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "idc7600bc9717348449a7a5b6b6f907c49", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "correct errors and\n\t\t\t\tinaccuracies in inventories;"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "id33eff123ccb54a26a194d24d3b18088e", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "provide support for\n\t\t\t\tmanufacturer recalls;"}, "enum": {"#tail": "\n                      ", "#text": "(IV)"}, "@id": "idb9d716b2ee064d80b849c2c3bf452cb0", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "prepare for, protect\n\t\t\t\tagainst, and address any reasonably foreseeable crisis that affects security or\n\t\t\t\toperation at the facility, such as a strike, fire, or flood;"}, "enum": {"#tail": "\n                      ", "#text": "(V)"}, "@id": "id2a738e8a36704fd3bb3775ae003ba2cb", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "ensure that any expired\n\t\t\t\tproduct is segregated from other products and returned to the manufacturer or\n\t\t\t\tre-packager or destroyed;"}, "enum": {"#tail": "\n                      ", "#text": "(VI)"}, "@id": "ida5cdf1beee304f1db1fe78ce899e2ab7", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "maintain the capability\n\t\t\t\tto trace the receipt and outbound distribution of a product, and supplies and\n\t\t\t\trecords of inventory; and"}, "enum": {"#tail": "\n                      ", "#text": "(VII)"}, "@id": "id2081a0a10c074941851e333a7583c086", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine or destroy\n\t\t\t\ta suspect product if directed to do so by the respective manufacturer,\n\t\t\t\twholesale distributor, dispenser or an authorized government agency;"}, "enum": {"#tail": "\n                      ", "#text": "(VIII)"}, "@id": "id0e2b23a6f024474c85b53afce8ae0b26", "#text": "\n                      "}], "#text": "\n                    ", "@id": "id191427f569954cb9b9789e2afb720775"}], "#text": "\n                  ", "@id": "id7737451aee744d63ac5c96d74d3146b1"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",\n\t\t\t\tof such facility warehouse space to ensure compliance with this section;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "provide for\n\t\t\t\tperiodic inspection by the licensing authority, as determined by the "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id34660072ae884fd8aa461d9593bb79a5", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "subsection (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:i"}, {"#tail": " or any\n\t\t\t\tviolation of ", "@entity-type": "act", "#text": "(k) of section 301", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:k"}, {"#tail": " relating to product\n\t\t\t\ttampering;", "@entity-type": "uscode", "#text": "\n                    ", "external-xref": {"#tail": " of title 18, United States Code", "@parsable-cite": "usc/18/1365", "#text": "section 1365", "@legal-doc": "usc"}, "@value": "usc/18/1365"}], "#text": "prohibit a\n\t\t\t\tfacility from having as a manager or designated representative anyone convicted\n\t\t\t\tof any felony violation of "}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "id2471c4af99624b6c825040c56b4bfe14", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide for mandatory\n\t\t\t\tbackground checks of a facility manager or a designated representative of such\n\t\t\t\tmanager; and"}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@id": "id92e5dae1d6614f7b95bb735e3511ee5e", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", upon a request by the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", a list of all product manufacturers, wholesale distributors, and\n\t\t\t\tdispensers for whom the third-party logistics provider provides services at\n\t\t\t\tsuch facility.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "require a\n\t\t\t\tthird-party logistics provider to provide the "}, "enum": {"#tail": "\n                  ", "#text": "(G)"}, "@id": "idad98831e5b08418999aacd836a09b043", "#text": "\n                  "}]}, {"#tail": "\n            ", "@id": "id948c143b4a7641cc8886f068e3e33487", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Procedure"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall,\n\t\t\t\tnotwithstanding ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\u2014", "@entity-type": "uscode", "#text": "\n                  ", "external-xref": {"#tail": " of title 5, United States Code", "@parsable-cite": "usc/5/553", "#text": "section 553", "@legal-doc": "usc"}, "@value": "usc/5/553"}], "#text": "In\n\t\t\t\tpromulgating the regulations under this subsection, the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "issue a notice of\n\t\t\t\tproposed rulemaking that includes a copy of the proposed regulation;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "idc8f083c8c1994ae28b0fadf4954fadcb", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide a period of not\n\t\t\t\tless than 60 days for comments on the proposed regulation; and"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idb1a56325daff479a92d993f232b94a11", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide that the final\n\t\t\t\tregulation takes effect upon the expiration of 1 year after the date that such\n\t\t\t\tfinal regulation is issued."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "ideff0f394b52f4b9396c53830167504dd", "#text": "\n                  "}]}], "#text": "\n              ", "@id": "idea937351f7284d5596d7e3469b212f9f"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall develop procedures for license\n\t\t\t\trenewal. Licenses issued under this section shall expire on the date that is 3\n\t\t\t\tyears after issuance of the license. Such an expired license may be renewed for\n\t\t\t\tadditional 3-year periods according to procedures developed by the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n              ", "#text": "Renewal of\n\t\t\t\tlicenses"}, "#text": "\n              ", "@id": "ida5ceff423dc84482803f1ba22ba5c705"}], "#text": "\n            ", "@id": "id8b3909584f3a465e98244ef276148f3b"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "585."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Uniform national\n\t\t\t\tpolicy"}, "subsection": [{"#tail": "\n            ", "text": {"short-title": {"#tail": ",\n\t\t\t\tno State or political subdivision of a State may establish or continue in\n\t\t\t\teffect any requirements for tracing products through the distribution system\n\t\t\t\t(including any requirements with respect to statements of distribution history,\n\t\t\t\ttransaction history, transaction information, or transaction statement of a\n\t\t\t\tproduct as such product changes ownership in the supply chain, or verification,\n\t\t\t\tinvestigation, disposition, notification, or record-keeping relating to such\n\t\t\t\tsystems, including paper or electronic pedigree systems or for tracking and\n\t\t\t\ttracing drugs throughout the distribution system) which are inconsistent with,\n\t\t\t\tmore stringent than, or in addition to, any requirements applicable under\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                  "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (as amended by such Act) or this subchapter (or regulations\n\t\t\t\tissued thereunder), or which are inconsistent with\u2014", "@entity-type": "act", "#text": "section 503(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e"}, "#tail": "\n\t\t\t\t\t\t\t", "#text": "Beginning on the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Product tracing and\n\t\t\t\tother requirements"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "section 581", "@value": "Federal Food, Drug, and Cosmetic Act/s:581", "@proposed": "true"}, {"#tail": "; or", "@entity-type": "act", "#text": "582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}], "#text": "any waiver, exception, or\n\t\t\t\texemption pursuant to "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "id45F25DB9E1C7427D9196A4DD131CA19B", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}, "#text": "any restrictions\n\t\t\t\tspecified in "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "idC61D41DB51CC40E196E5BDC57452811C", "#text": "\n                "}], "#text": "\n              ", "@id": "ida7eba37d583e40ec911f4d96541f5350"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Distribution and\n\t\t\t\tlicensing standards"}, "paragraph": [{"#tail": "\n              ", "text": {"short-title": {"#tail": ",\n\t\t\t\tno State or political subdivision of a State may establish or continue any\n\t\t\t\tstandards, requirements, or regulations with respect to wholesale prescription\n\t\t\t\tdrug distributor or third-party logistics provider licensure that are less\n\t\t\t\tstringent than the standards and requirements applicable under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                    "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\t(as amended by such Act), in the case of a wholesale distributor, or ", "@entity-type": "act", "#text": "section 503(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e"}, {"#tail": ", in the case of a third-party logistics provider.", "@entity-type": "act", "#text": "section\n\t\t\t\t584", "@value": "Federal Food, Drug, and Cosmetic Act/s:584", "@proposed": "true"}], "#tail": "\n\t\t\t\t\t\t\t", "#text": "Beginning on the date of enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "id896cd02a95694462a77495effa35ad93"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "No State shall regulate\n\t\t\t\tthird-party logistics providers as wholesale distributors."}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "State regulation of\n\t\t\t\tthird-party logistics providers"}, "#text": "\n                ", "@id": "id2C49451AD5274DF197052D8CCE43ED98", "@commented": "no"}, {"#tail": "\n              ", "text": {"short-title": {"#tail": "), ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Drug Supply Chain Security\n\t\t\t\tAct", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                    "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", a State may administer fee\n\t\t\t\tcollections for effectuating the wholesale drug distributor and third-party\n\t\t\t\tlogistics provider licensure requirements under ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:585/ss:b/p:1", "@proposed": "true"}, {"#tail": " (as amended by\n\t\t\t\tthe ", "@entity-type": "act", "#text": "sections 503(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "583", "@value": "Federal Food, Drug, and Cosmetic Act/s:583", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "584", "@value": "Federal Food, Drug, and Cosmetic Act/s:584", "@proposed": "true"}], "#tail": "\n\t\t\t\t\t\t\t", "#text": "Notwithstanding "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Administration\n\t\t\t\tfees"}, "#text": "\n                ", "@id": "id506663cdf8e14cb984761638501952ca"}, {"#tail": "\n            ", "@id": "id2c56eca5d6784da49ae540dced9526c3", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Enforcement,\n\t\t\t\tsuspension, and revocation of licenses"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a State\u2014", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:585/ss:b/p:1", "@proposed": "true"}, "#text": "Notwithstanding "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"short-title": {"#tail": ")\n\t\t\t\tor this subchapter;", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                      "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (as amended by the\n\t\t\t\t", "@entity-type": "act", "#text": "section 503(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e"}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "may take administrative\n\t\t\t\taction, including fines, to enforce a licensure requirement promulgated by the\n\t\t\t\tState in accordance with "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id578cdff0f637470dae33e88394979a58", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "may provide for the\n\t\t\t\tsuspension or revocation of licenses issued by the State for violations of the\n\t\t\t\tlaws of such State;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "idc80c97fed838400086bff0c36330e877", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "upon conviction of\n\t\t\t\tviolations of Federal, State, or local drug laws or regulations, may provide\n\t\t\t\tfor fines, imprisonment, or civil penalties; and"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id46b41927d3d84d47800d0f20d50b54be", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}, "#text": "may regulate\n\t\t\t\tactivities of licensed entities in a manner that is consistent with product\n\t\t\t\ttracing requirements under "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "id1dde9b9e10fd4849967e8c40c4765d89", "#text": "\n                  "}]}], "#text": "\n              ", "@id": "idd2c1fcddf95d471ab8ebed5bf4d3f78f"}, {"#tail": "\n          ", "text": {"short-title": {"#tail": ")\n\t\t\t\tor this subchapter (or regulations issued\n\t\t\t\tthereunder).", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "Drug Supply Chain Security Act", "@value": "Drug Supply Chain Security Act", "@proposed": "true"}, "#text": "\n                  "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:585/ss:a", "@proposed": "true"}, {"#tail": " shall be construed to preempt State requirements\n\t\t\t\trelated to the distribution of prescription drugs if such requirements are not\n\t\t\t\trelated to product tracing as described in ", "@entity-type": "act", "#text": "(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:585/ss:b", "@proposed": "true"}, {"#tail": ", including any\n\t\t\t\trequirements applicable under ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:585/ss:a", "@proposed": "true"}, {"#tail": " (as amended by the\n\t\t\t\t", "@entity-type": "act", "#text": "section 503(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e"}], "#tail": "\n\t\t\t\t\t\t", "#text": "Nothing\n\t\t\t\tin "}, "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n              ", "#text": "Exception"}, "@display-inline": "no-display-inline", "#text": "\n              ", "@id": "id7613345DB5774D72A366B935E4C4861E", "@commented": "no"}], "#text": "\n            ", "@id": "idbebc2748d5ba419bbfd308593816b39f"}], "@reported-display-style": "italic", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id95B0C9A968964BABA476B1E3B63FF509"}, "#text": "\n        ", "@id": "idd67351dddf004eff9e0b4ae9d0e45e95"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "206."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Penalties"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "(", "@entity-type": "act", "#text": "Section 301(t)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:t"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 331(t)", "@value": "usc/21/331/t"}, "@parsable-cite": "usc/21/331", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Prohibited\n\t\t\t act"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " after ", "#text": "or"}, {"#tail": ";\n\t\t\t and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",", "@entity-type": "act", "#text": "section 503(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:d"}, "#text": "the requirements of "}], "#text": "by striking\n\t\t\t "}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "@id": "id1a5b7cf278f24a7ba87f612855123962", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " after\n\t\t\t ", "#text": ",\n\t\t\t failure to comply with the requirements under section 582, the failure to\n\t\t\t comply with the requirements under section 584, as applicable,"}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "act", "#text": "section 503(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e"}, "#text": "in violation of "}], "#text": "by inserting "}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "@id": "idf3dbe1b54b024640b82fe19de9d29fdf", "#text": "\n            "}], "#text": "\n          ", "@id": "id50b00bdd84524b7db102dbda65bbd094"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is further amended by adding at\n\t\t\t the end the following:", "@entity-type": "act", "#text": "section 103", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:103", "@proposed": "true"}, "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as amended by ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 502", "@value": "Federal Food, Drug, and Cosmetic Act/s:502"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 352", "@value": "usc/21/352"}, "@parsable-cite": "usc/21/352", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Misbranding"}, "quoted-block": {"@style": "OLC", "@committee-id": "SSHR00", "@changed": "added", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "@reported-display-style": "italic", "subsection": {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}, "#text": "If it is a drug\n\t\t\t\tand it fails to bear the product identifier as required by "}, "enum": {"#tail": "\n              ", "#text": "(ee)"}, "@id": "id4da15c7bfbf341c98ba1645b626804c2", "#text": "\n              "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "id8be843ad3a314d658098b00b879d1f25"}, "#text": "\n          ", "@id": "idb7e8574f4aee4968aaf4c485d4664878"}], "#text": "\n        ", "@id": "idbc50988f765742969ebc9251bee48e0c"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "207."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Conforming\n\t\t\t amendment"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "503(e)(2)(A)"}, {"#tail": ".", "#text": "503(e)(1)"}], "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by striking\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "(", "@entity-type": "act", "#text": "Section\n\t\t\t 303(b)(1)(D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:303/ss:b/p:1/sp:D"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 333(b)(1)(D)", "@value": "usc/21/333/b/1/D"}, "@parsable-cite": "usc/21/333", "#text": "\n                ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "In\n\t\t\t general"}, "#text": "\n          ", "@id": "id98A5831FDA1344A58B360F70EF0223DF"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall take effect on\n\t\t\t the day that is 1 year after the date of enactment of this Act.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:207/ss:a", "@proposed": "true"}, "#text": "The amendment made by "}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Effective\n\t\t\t date"}, "#text": "\n          ", "@id": "idCCF9C9EF9B2C4D1F917600A99101FA89"}], "#text": "\n        ", "@id": "id919BAF362748462F8C1AB792EDD7E534"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "paragraphs (1)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:204/ss:a/p:1", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(2)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:204/ss:a/p:2", "@proposed": "true"}, {"#tail": " and by\n\t\t\t ", "@entity-type": "act", "#text": "(3) of section 204(a)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:204/ss:a/p:3", "@proposed": "true"}, {"#tail": ", nothing in this title (including the amendments made by this\n\t\t\t title) shall be construed as altering any authority of the Secretary of Health\n\t\t\t and Human Services with respect to a drug subject to ", "@entity-type": "act", "#text": "section 206(a)", "@value": "Pharmaceutical Quality, Security, and Accountability Act/s:206/ss:a", "@proposed": "true"}], "#text": "Except as provided in\n\t\t\t the amendments made by ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " under any other\n\t\t\t provision of such Act or the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 503(b)(1) of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 353(b)(1)", "@value": "usc/21/353/b/1"}, "@parsable-cite": "usc/21/353", "#text": "\n              ", "@legal-doc": "usc"}}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Public Health Service Act", "@value": "Public Health Service Act"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C. 201 et\n\t\t\t seq.", "@value": "usc/42/201/etseq"}], "@entity-type": "law-citation", "#text": "\n            "}], "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "208."}, "header": {"#tail": "\n        ", "#text": "Savings\n\t\t\t clause"}, "#text": "\n        ", "@id": "id5374815F273F423C980ED14B747BC243"}], "enum": {"#tail": "\n      ", "#text": "II"}, "header": {"#tail": "\n\t\t\t", "#text": "Drug Supply Chain\n\t\t\t Security"}, "@reported-display-style": "italic", "#text": "\n      ", "@id": "idA6D5B3EFFDD347388F74014AC6650496"}]}], "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-05-15"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S959 RS: Pharmaceutical Quality, Security, and Accountability Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}